tun yaushe kake da alamun cutar?
irin wannan ciwon zuciya ba ya warkewa kamar yadda ya yi a shekarun baya
da kuma tsuntsaye
kuma dole ne a bincika yawan cholesterol a cikin jininka
Kuma yanzu kuna da takalma?
"Yaya kuke auna ta haka a zuciyarku?"
kuma kana da matsala da numfashi
Za a iya lissafa wasu alamun rashin lafiya da kake da su?
kuma ka yi tunanin yadda za a yi ka yi
kuma ina da wani abu da nake so
ina da ciwon daji da kuma ƙonewa
Ina cikin baƙin ciki da baƙin ciki a yau
lokaci ya yi da za a gama
da kuma zuciya da aka yi mini
kamar ina da ɗakin kwanciya
Ina so ka nuna wa toy cewa kana da tausayi
kuma akwai dukkan matakan
da kuma ciwon sukari da ke da
kuma kun san yadda nake a zuciyarku
Ka sani cewa mutane sun yi ta yi mini ba'a a ko'ina
da kuma zuciyarka
kuma kun ce akwai kamar yadda za a iya ganin ku
akwai wani a cikin iyalinka da ke fama da ciwon zuciya wanda ya shafi yawan cholesterol a cikin jini
wani alamun rashin lafiya ko wata cuta da ka samu a jikinka?
Akwai wasu mutane da suka kamu da cutar a cikin iyali da ke da irin wannan alamun cutar?
Shin akwai wata alama ta rashin lafiya da kuke da ita?
Ba ku da wani ƙarfi da zai iya cetonku?
zuciyarka ta yi sanyi a yanzu
saboda lokacin bazara ne
amma ba su kai mu kurkuku ba saboda ciwon zuciya da muke da shi
Babban matsalarmu a yanzu ita ce rashin tausayi
ina da matsalar numfashi
Na san mutane da yawa suna tunani game da ni
Dole ne mu bi da duk wani rashin jin daɗi da muke da shi
Shin, ba ka yi farin ciki sosai ba?
saboda wannan baƙin ciki da nake da shi
kamar akwai wani wanda ke damuwa da kai
Har yanzu ma akwai waɗansu shafaffu da za ku yi wa'azi,
suna cewa suna da irin wannan cutar kamar ku?
shin kuna da wata cuta da ta shafi jijiyoyinku kamar zubar jini ko wani abu makamancin haka?
shin kana da wata cuta da ta sa ka ji kamar zazzabi?
Ba ku da ƙarfi ne? Ba ku da ƙarfi ne?
Shin kuna da jini mai laushi?
Shin akwai wani rashin numfashi da ke tattare da cutar?
Shin kun san alamun cutar da ta kamu da ita?
Shin kuna kallon wannan hoton?
yau da yawa gishiri
amma dole ne in yi gwajin cutar kansa
amma tana da alamomi irin nawa
Yaya barcinku yake da zafi
"Wace irin azanci ne wannan?"
idan kun ci gaba da yin jima'i da jikinku na yanzu
Idan jikinka yana da ƙonewa kamar sau biyu ko fiye
Idan kuna tunanin cewa kuna da wata cuta ko matsala da ke bukatar bincike
jikina ya yi zafi kamar Kenya
ina da irin wannan ƙarancin jiki
jikina ya tashi kamar da ba shi da yawa
ina da ciwon zuciya na kullum
Ina da matsala da numfashi
zan aika maka da hoton
Ina da ciwon zuciya a nan
Ina da ciwon huhu kuma jikina yana ciwo sosai
Ina tsammanin wannan shi ne shekara
Ina tsammanin wannan ne farkon shekara
Kamar masu-ƙaunaci ne ku ke zaune a ƙofar da ke ƙofar birni?
duk ya fara da zazzaɓi da kuma ciwon ciki a lokaci guda
yana da rauni a tsakiyar zuciya
yana da zafi kamar ciwon zuciya
ka ɓoye a cikin zuciyata
yana cikin zuciyar zuciyata
a tsakiyar zuciya
Na sami irin wannan baƙin ciki a zuciyata
wannan baƙin ciki yana sa ni baƙin ciki
Ina so ku gaya mini yadda nake ji
kamar su ciwon sukari ko kuma hawan jini
kamar yadda ya faru a tsakiyar zuciya
Yanzu zaka iya shan tachipyrin don maganin ciwon ciki
Maryamu, tun daga ranar da ka fara nuna alamun cutar
Yanzu kun ce kuna da ciwon zuciya
sau da yawa ina jin ciwon zuciya
Hakanan, kuna da wasu alamun rashin lafiya masu alaƙa bayan kamuwa da cutar
Ko kuwa wani yana da raini a zuciyarku?
ba shi da lafiya a jiki saboda rashin lafiya, ciwon daji, da kuma ciwon jiki
ina da ƙauna a cikin zuciyata
Ka nuna mini wannan hoton da nake jin dadi a ciki
jikinka yana ƙonewa
Yaya kuke ganin cewa alamun cutar na iya zama ba a gani ba yayin da mutum ke da ciki?
Shin yaranku suna da wasu alamun cutar?
ka gaya mani game da aikinka na yau
jikin ya yi zafi sosai da dare
jikina ya fara rawa tun kwana biyu da suka gabata
jikina ya yi kuka dare da rana
duba likita a asibitin gaggawa
Ko kuwa za ku iya sake ni a kan baƙin cikin da nake yi muku?
Ina kuma da ciwon kai a jikina da kuma a zuciyata
Ƙarfin ruhuna ya fi ƙarfinka,
kuma, idan ina da wannan ciwon a cikin zuciyata
wane irin ciwo ne ke damun zuciyarka?
A ina ne baƙin ciki ya fara?
Yaya tsawon lokacin da kuka yi tunani?
NS
kamar zuciyarka tana cikin damuwa
ka san cewa ina da ciwon sukari da sauran cututtuka
ka ce kana da ciwon kai a wannan rana
Coronavirus na yau da kullun da ke haifar da cutar (COVID-19) a Tarayyar Turai / Hukumar Tsaro ta Turai da Majalisar Ingila, 1 ga Janairu zuwa 15 ga Maris, 2020
A halin yanzu, cutar coronavirus (COVID-19) ta nuna alamun cutar a cikin ƙasashen Turai da Turai da kuma Majalisar Dinkin Duniya, yayin da a wani lokaci, cutar COVID-19 ta kasance cikin gaggawa a cikin ƙasashen duniya.
Idan muka yi la'akari da abin da ke faruwa a Italiya, jihohi, asibitoci da kungiyoyin kulawa da marasa lafiya za su buƙaci su ƙara yin shiri don yawan mutanen da ke da COVID-19 da ke buƙatar kulawa ta musamman, da kuma yawan kulawa.
A ranar 31 ga Disamba, 2019, wani rukunin masu cutar kansa na musamman da ba a san sunayensu ba ya bayyana a Wuhan, Lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Hukumar Kula da Cututtuka ta kasar Sin ta sanar da cewa ba za a iya gano sabon coronavirus ba, wanda aka kira shi da coronavirus na numfashi na 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da SARS-CoV ya haifar ana kiranta cuta (COVI-19).
Rahotanni na baya sun ce kusan kashi 80% na mutanen da ke fama da cutar na da mummunar illa, kamar cututtukan huhu, da kuma ciwon sukari.
A cikin kashi 14% na masu kamuwa da COVID-19, an ba su magani mai kyau da kuma asibiti, kuma a cikin kashi 6% na masu kamuwa da cutar, an ba su magani mai kyau da kuma kula da likita.
Mutuwar marasa lafiya a asibiti saboda COVID-19 ya kai kashi 4 cikin dari.
A cikin wannan binciken, mun bincika yanayin COVID-19 a kowace ƙasashen Tarayyar Turai / Tarayyar Turai (EU/EEA) da kuma Majalisar ofishin Burtaniya (UK) yayin da mai magana da yawun ke lardin Hubei, China.
Hakanan zan iya kwatanta adadin masu cutar COVID-19 na yanzu a cikin EU/EEA da UK tare da waɗanda ke Italiya daga 31 ga Janairu zuwa 15 ga Maris 2020.
COVID-19 ya ɓarke a cikin EU/EEA da UK
Bayan China, COVID-19 ya yaɗu zuwa wasu ƙasashe kuma ɓarkewar cutar COVID-19 a wasu ƙasashe na duniya yanzu yana da tasiri a kan wannan ƙasar.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba.
A cikin rahoton Eurosurveillance na ranar 5 ga Maris, 2020, Spiteri et al. ya ba da rahoton farkon cutar COVID-19 a Turai bisa ga WHO.
A cikin EU/EEA, Faransa ta ba da rahoton mutum uku da suka kamu da cutar a ranar 24 ga Janairu, 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano cutar COVID-19 a cikin ƙasashe 30 na EU/EEA da United Kingdom, inda aka samu mutane 39,768 da suka kamu da cutar da kuma 1,727 da suka mutu a ranar 31 ga Disamba, 2019, da kuma 1,441 a Italiya.
Ƙungiyar ta yi kira ga ƙungiyar masu cutar COVID-19
A cikin Hukumar Kula da Cututtuka ta Turai (ECDC), an sabunta adadin masu kamuwa da COVID-19 a kowace ƙasa a duniya, wanda ya danganta da masu ba da shawara kamar Ma'aikatar Kiwon Lafiya ta Duniya, hukumomin kula da lafiya na jihohi da birane da WHO da kuma bayanan da aka samu a ranar Talata da misalin karfe 8:00 na safe.
Ana amfani da wannan bayanan don gwajin COVID-19 a cikin EU/EEA da kuma a cikin UK, tare da yin amfani da shi don gwadawa da Italiya.
A matsayin nazarin yanayin cutar COVID-19, mun tattara tarin cututtukan COVID-19 na asali, amma mun kuma tattara adadin COVID-19 a kowace EU/EEA da UK daga 1 ga Janairu zuwa 15 ga Maris 2020.
Mun kuma kawo jimlar adadin wadanda suka kamu da cutar a kowace kasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe a kasar Italiya daga ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
COVID-19 ya bullo ne a cikin ƙasashen EU/EEA da Burtaniya.
A cikin jerin jerin abubuwan da aka samu na yawan masu kamuwa da cutar COVID-19 a cikin EU/EEA a cikin kwanaki 14 da suka gabata, an bi mafi yawan Burtaniya da lardin Hubei na China (Hoto na 1).
Dangane da EU/EEA da UK, jimlar adadin masu cutar COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu kuma ya ragu zuwa 28 ga Fabrairu, 2020 (Bayanin).
Babban abin da ya kawo wannan damuwa shi ne cewa ba a kai yawan adadin masu cutar ba a Italiya, yayin da sauran ƙasashen EU/EEA da Birtaniya ke nuna irin wannan ci gaba a cikin adadin masu cutar COVID-19 (Bayanin).
Hoto na 2 ya nuna jimillar adadin masu kamuwa da cutar COVID-19, a cikin EU/EEA da UK idan aka kwatanta da na Italiya a lokacin 31 ga Janairu zuwa 15 ga Maris 2020.
A lura cewa, a ranar 15 ga Maris da karfe 8:00 na dare, ƙasashe 15 na EU/EEA da kuma wasu UK sun ba da sanarwar adadin mutanen da za su iya kamuwa da cutar a Italiya a cikin makonni 3 kafin ko bayan ranar ƙarshe.
Wannan ya nuna cewa adadin adadin COVID-19 da aka ruwaito bai yi daidai ba a cikin EU/EEA da UK.
Halin da muke ciki na COVID-19 ya nuna cewa cutar ta riga ta kamu da cutar da za ta iya haifar da cutar a ƙasashen duniya.
Wannan ya faru ne saboda ƙasashe da ke da bambancin ra'ayi, canje-canje a cikin tsarin kula da lafiya na ƙasa, da kuma bambancin bayyanar cutar a ƙasashe da sauran hanyoyin da za a iya tantance waɗanda suka buƙaci a sake duba su don COVID-19, da kuma sake gwada su.
A farkon Maris 2020, likitocin a cikin yankuna da ke fama da cutar Italiya sun gano cewa kusan kashi 10% na masu cutar COVID-19 suna buƙatar kulawa ta musamman kuma kafofin watsa labarai sun ce asibitoci da ƙungiyoyin kulawa na musamman a waɗannan yankuna sun ba da ƙarin bayani.
Bayanai kan COVID-19 a asibitoci da/ko kungiyoyin kula da marasa lafiya sun kasance a cikin EU/EEA na 6% da 1% na masu kamuwa da cutar, da sauransu (a cikin bayanan da aka nuna).
Bayan haka, za su haɗa su a cikin shafi ɗaya don samar da bayanai game da kula da dabbobin da aka gano da kuma mutuwar.
Wani bincike na 2010-2011 ya gano cewa akwai bambancin da ke tsakanin adadin gadaje da oda na kulawa da marasa lafiya marasa lafiya da marasa lafiya a Turai, daga gado 29.2 a Jamus zuwa 4.2 a Portugal.
A cewarsa, ƙasar za ta iya samun yawan masu cutar a ƙasar Italiya (12.5 yawan marasa lafiya da marasa lafiya a kowace 100,000 a shekara ta 2010-11).
Tsarin da ya shafi tsarin karba-karba, da kuma yiwuwar kowace ƙasa ta EU/EEA da UK za su karɓi marasa lafiya na COVID-19 waɗanda ke buƙatar asibiti da kuma buƙatun gado na musamman dole ne su sami umarnin kulawa na mutum aƙalla kashi 90% na ECDC na gwajin COVID-19 na asibiti.
Saboda karuwar yawan marasa lafiya a wasu sassan EU/EEA da UK, da kuma asibitoci da kungiyoyin kula da marasa lafiya da ke aiki a wuraren da aka yi wa allurar rigakafi, za a iya samun bayanan marasa lafiya da gadaje masu allurar rigakafi a kowace Talata a cikin dukkan biranen don dalilai na matakin 2 (NUTS-2).
Wannan ya faru ne a Italiya da kuma a wasu ƙasashe da ke nuna cewa cutar COVID-19 ta fi sauri a cikin EU/EEA da UK.
Kasashe, asibitoci da kungiyoyin kiwon lafiya dole ne su tsara dabarun da za su taimaka wa al'umma don magance SARS-CoV-2 da kuma karuwar yawan masu cutar COVID-19 da ke buƙatar kulawa ta musamman, kamar yadda ake yi a wuraren da cutar ta bulla a Italiya.
Kamar yadda aka nuna a cikin binciken ECDC na rigakafin cutar, akwai wani tsari wanda aka kammala wanda bai dace da haɗarin yaduwar SARS-COV-2 ba, kuma yana da tsari mai sauƙi daga magani zuwa magani, saboda yawan adadin masu cutar ba zai ba da isasshen lokaci ga masu kula da lafiya don ganowa, amsawa da kuma magance matsalar rigakafin su ba a cikin lokaci.
Ƙarin kula da cututtuka na yau da kullum ya danganci matakan kiwon lafiya na gwamnati don rage girman cutar.
Akwai yiwuwar samun damar da za ta taimaka wa ƙasashe wajen samun damar inganta tasirin su wajen rage yaduwar SARS-CoV-2 da kuma rage buƙatun kulawa da lafiya.
Idan aka ci gaba da yin haka, to da alama sauran kasashen EU/EEA za su fuskanci matsalar rashin lafiya saboda yawan marasa lafiya da ke bukatar kulawa da gaggawa zai karu a cikin 'yan kwanaki ko makonni masu zuwa.
Cutar kwayar cutar coronavirus ta 2019 (COVID-19), wacce ke haifar da cututtukan cututtukan huhu na SARS-CoV-2 (SARS-CoV-2), ta kashe mutane sama da 3 000 kuma ta kamu da fiye da 80 000 a China da sauran sassan duniya, wanda ya zama babban abin damuwa ga mutane.
Kamar yadda ya faru da SARS-CoV, wanda ya haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya zama kwayar cutar kwayar cutar ta kwayar cuta kuma yana ba da alamun bayyanar cutar ta hanyar irin wannan kwayar cuta.
Koyaya, COVID-19 ba shi da haɗari da haɗari kamar SARS kuma yana da haɗari sosai kuma yana shafar tsofaffi fiye da mata.
Saboda yawan adadin da ake samu na masu cutar, wannan rahoton ya yi adawa da bayar da lokaci da kuma damar yin nazari kan abubuwan da suka shafi bincike.
Za mu kuma tattauna kan nazarin yadda cutar ta kamu da mutane, da yadda za a iya magance ta, da nazarin yadda cutar ta kamu da mutane, da kuma bincike, da magani, da kuma yadda za a iya yin gwaji da kuma hana kamuwa da cutar.
Duk da cewa akwai wasu tambayoyi da yawa da za a amsa, muna tsammanin cewa wannan labarin ya taimaka wajen fahimtar da kuma magance wannan matsala.
Bikin bazara a ranar 25 ga Janairu 2020 ya zama abin tunawa ga duk Sinawa da ke cikin tsananin rashin jin daɗin hutun hutun hutun hutun hutun hutun ranar Lahadi da Lahadi saboda sabon annobar cutar.
Kwayar cutar ta yi kama da coronavirus (CoV) wanda ya haifar da cutar sankara mai saurin gaske (SARS) a 2003; kuma a sakamakon haka, Hukumar Lafiya ta Duniya ta kira cutar SARS-CoV-2, kuma an kira cutar COVID-19 (COVID-19).
Cutar ta fara ne a Wuhan, China, kuma daga nan ta bazu zuwa kusan kasashe 50 a duniya.
A ranar 2 ga Maris, 2020, cutar ta kama mutane fiye da 80,000 da aka tabbatar sun kamu da COVID-19, tare da mutane 40,000 da suka warke kuma fiye da 3,000 suka mutu.
WHO ta ce COVID-19 "babban barazana ce ga bil'adama" kuma yana da haɗarin kamuwa da cutar.
Kamar yadda aka bayyana a PubMed (https://www.ncbi.nlm.nih.gov/pubmed), kafin shekara biyu, fiye da littattafai 200 sun fito game da COVID-19 tare da ilimin kwayoyin cutar, ƙwarewa, bincike, da magani tun daga farkon rahoton a ranar 7 ga Janairu 2020 wanda ya nuna cewa kwayoyin cutar sun kasance masu saɓani ga yawancin marasa lafiya.
Wannan binciken ya nuna cewa akwai yiwuwar samar da cibiyar bincike a cikin sabon binciken da kuma gaggawa.
A wani bangare, mun haɗa COVID-19 da SARS da wata cuta, wato, Cutar Tsakanin Tsakanin Tsakanin Tsakanin Tsakanin Tsakanin Tsakanin (MERS, wani cuta a 2012).
Muna kuma fatan za mu yi magana game da abin da muka koya game da rigakafi da kuma abubuwan da ke faruwa a yau.
CoVs wani nau'in kwayar cuta ne wanda ba shi da haɗari, wanda ke haifar da mutuwar mutum da kashi 15% cikin shekaru 4.
Koyaya, a cikin wannan nau'in, zamu iya samun CoVs masu cutarwa sau biyu, misali, SARS-CoV da MERS-CoV, waɗanda suka fara fitowa a China a 2003 da Saudi Arabia a 2012, kuma daga baya suka bazu zuwa wasu ƙasashe tare da adadi da yawa da yawa.
Haka kuma, cutar COVID-19 ta yanzu ita ce ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a sama, Hoto na 1,1, an gano wani mutum da ke fama da cutar sankara a Wuhan a ranar 31 ga Disamba, 2019 a Hukumar Lafiya ta kasar Sin.
Bayan kwana shida, kwayar cutar ta CoV ta bayyana.
A ranar 15 ga Janairu, 2020 aka sami mutum na farko da ya kamu da cutar a Wuhan.
A wannan lokacin, cutar ta fara yaduwa zuwa birane, larduna, da sauran jihohi.
A ranar 20 ga watan Janairu, an sanar da cewa akwai wasu mutane da suka kamu da cutar, wanda hakan ya nuna cewa cutar ba ta iya yaduwa daga mutum zuwa mutum.
A ranar 23 ga Janairu, 2020, an rufe garin Wuhan kuma an dakatar da zirga-zirgar jiragen sama.
A ranar 24 ga Janairu, binciken farko na binciken asibiti ya ce, daga cikin mutane 41 da suka kamu da cutar, 21 sun kamu da cutar ta Wuhan, wadda aka yi la'akari da cewa wataƙila cutar ta samo asali ne daga wata cuta da ba a gano ba.
Bayan 30 ga Janairu, WHO ta ayyana gaggawa na gaggawa na kiwon lafiya na duniya.
A lokacin da aka rubuta wannan rahoto, an riga an kawar da cutar daga kasar Sin zuwa kusan kasashe 50 a duniya (Hoto (Hoto na 2).
Ko da kuwa cutar tana ci gaba, ba a san ƙarshen cutar ko kuma yiwuwar kamuwa da ita ba.
A ranar 11 ga Fabrairu, 2020, wani bincike da aka yi a kan mutane 8,866 da suka kamu da cutar COVID-19 ya nuna cewa mutane 4,021 a wasu dakunan gwaje-gwaje daban-daban sun kamu da sabon cutar (https://mp.weixin.qq.com/s/UIBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 na iya kamuwa da mutane a kowane zamani, amma ya fi dacewa da mutanen da ke tsakanin 30 zuwa 65.
Kusan rabin (47.7%) na masu cutar sun kasance sama da shekaru 50, kashi 20 cikin dari sun kasance marasa lafiya, kuma kashi 14 cikin 100 sun kasance marasa lafiya har zuwa shekaru 10.
SARS-CoV-2 ya fi kamuwa da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya bazu a cikin garuruwan da ke arewacin Hubei da yamma.
COVID-19 ya ɗauki kimanin kwanaki 5 (2 zuwa 9) daga farkon cutar zuwa ƙarshe.
Lokacin da aka yi amfani da shi don nunawa shine kimanin 4.8 days (3.0 zuwa 7.2).
Tsawon lokaci daga farkon zuwa ƙarshe ya kasance kimanin kwanaki 9.5 (4.8 zuwa 13).
Da farko adadin da aka bayar (R0) ya kai 3.77 (95% CI:3.51-4.05), kuma R0 da aka auna ya kai 2.23-4.82.
Adadin masu kamuwa da cutar ya yi yawa kafin 23 ga Janairu, 2020, wanda ya yi daidai da lokacin hutu na hutu kafin bikin bazara na China.
Hatsarin mutuwa a cikin waɗanda aka tabbatar da cutar ya kai kashi 1.44% (CI: 59: 1.10-1.86%), kuma yawan mutuwar da aka samu a cikin waɗanda aka gwada da cutar ya kai kashi 3.06% (CI: 95: 2.02-4.59%).
Abubuwa uku da suka fi sabawa a kamuwa da COVID-19 sune shekaru (ƙananan shekaru), shekaru (≥60), da kuma ciwon zuciya mai tsanani.
CoVs suna kama da rukuni na ƙwayoyin cuta da ƙwayoyin cuta masu kama da juna waɗanda ke da RNA guda ɗaya.
Ana iya gano shi ta hanyar rarrabuwa cikin rukuni huɗu, watau alpha, beta, gamma, delta, da cov alpha da beta, waɗanda suke da halayyar kamuwa da cutar a cikin ɗan adam.
Ƙungiyar S-glycoprotein ta haɗu da mai karɓar angiotensin mai karɓa da mai karɓa na 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) na SARS-CoV da MERS-CoV, da sauransu, da kuma haɗin haɗin haɗin gwiwa.
Kwayar RNA ta kwayar halitta an shirya ta a cikin cytoplasm; bayan an tsara kwayar halitta, RNA na kwayar halitta da kuma glycoproteins na sunadarai da nucleocapsid suna ɗaukar ƙwayoyin da ke karɓar kwayar cutar, wanda ke shiga cikin jini kuma ya fitar da kwayar cutar.
An fara samun SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 an gano shi a matsayin sabon beta-CoV tare da ƙimar kwayar halitta ta 99.98% a cikin nau'ikan 10 da aka ɗauka a farkon lokacin barkewar cutar, Huanan Seafood Market a Wuhan.
SARS-CoV-2 yana da kamannin kwayoyin halitta na SARS-CoV da ke da alaƙa da MERS-CoV.
Ta hanyar gwajin ƙaramin electron, SARS-CoV-2 ba zai iya shiga cikin ƙwayoyin ultrethin na epithelium na numfashi na mutum ba.
An gano ACE2 na mutum a matsayin mai karɓar SARS-CoV-2 a matsayin SARS-CoV.
Ko kuma, sunadarai S na SARS-CoV-2 sun fi ƙarfin ACE2 na ɗan adam fiye da SARS-CoV? wanda ya haɗa da SARS-CoV-2 wanda ke da haɗari sosai fiye da SARS-CoV.
SARS-CoV-2 na iya haɗawa da ƙananan sunadarai masu lamba tare da lambar orf3b da kuma sunadarai masu lamba tare da lambar orf8.
SARS-CoV-2 orf3b na iya zama mai amfani a cikin ƙwayoyin cuta na asali kuma yana haifar da wani abu mai suna IFNβ; duk da haka, orf8 ba shi da wani abu mai mahimmanci ko alama.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., sun bayyana cewa kwayar cutar ta cryu-EM ta dace da kwayar ACE2 ta mutum a 2.9 A kuma ta haɗu da mai ɗaukar BOAT1 amino acid.
An gano cewa wannan haɗin, wanda ke buɗewa da rufe kwayoyin halitta, ya haɗa da haɗin ACE2-B0AT1 kuma yana iya haɗawa da sunadarai guda biyu na S, wanda ya ba da alama ga juriya na CoV da kuma kamuwa da cuta.
BOAT1 na iya zama mai zaɓin maganin rigakafi don gwajin ƙwayoyin cuta don SARS-CoV-2 cutar.
Haikali mai tsayi da kewaye
An gano cewa duka SARS-CoV da MERS-CoV sun samo asali ne daga tsuntsaye kuma ana iya yada su zuwa ga mutane ta hanyar dabbobi kamar su tsuntsaye da raƙuman ruwa, da dai sauransu.
Ta hanyar haɗa kwayar SARS-CoV-2 da sauran CoVs, kwayar cutar ta kasance farkon kwayar cutar SARS-CoV-2 kamar yadda sabon kwayar cutar ya kasance kashi 96% na kwayar SARS-CoV da ke fitowa daga kwayar cutar ta kwayar cutar ta kwayar cutar-SL-CoVZX45 da kwayar cutar ta kwayar cutar-SL-CoVZX21.
A zahiri, gidan wasan yara yana kashe kwayar cutar ta hanyar wucewa ta wani gini don ya kamu da wani mutum mara lafiya, kuma motar da ya ɗauka ta ma dole ne wani ya bincika ta kuma ya gano ta.
Ji et al., sun yi la'akari da cewa ana iya daukar kwayar cutar daga kwayar cutar zuwa ga mutum ta hanyar haɗuwa da ƙwayoyin cuta a cikin furotin.
A wani binciken, masu bincike a Guanzhou, China, sun gano cewa wani nau'in halittar da ake kira pangolin mai tsayi, wanda ba shi da ƙwayoyin cuta, wanda ke da amfani a matsayin magani ga sauran mutanen China, na iya zama tushen asalin SARS-CoV-2 saboda kwayar halittar ta yi daidai da kashi 99% na CoV da aka samo a cikin pangolin da SARS-CoV-2.
Koyaya, bambancin 1% tsakanin genome guda biyu na iya zama bambancin manga; kuma, zamu iya ƙaryata sakamakon binciken (Hotuna (Hotuna 33).
Har yanzu ba a gano asalin kwayar cutar SARS-CoV ba.
SARS-CoV-2 da MERS-CoV za su iya rayuwa a cikin yanayi mai sanyi na tsawon sa'o'i 48 a cikin wani ɗaki da aka rufe da ruwa da kuma kwanaki 5 a zafin jiki na 20 °C da zafin jiki na 40% zuwa 50%.
SARS-CoV-2 na iya zama mai cutarwa.
An ce SARS-CoV-2 yana da ƙarfin ultraviolet da zafin jiki na sama da 56 ° C na minti 30; ether, 75% ethanol, sunadarin sunadarai masu guba da chlorine, peracetic acid, chloroform, da kuma kayan aikin wanka mai laushi, kamar chlorhexidine, na iya kashe kwayar da sauri.
Ba a riga an yi maganin cutar SARS-CoV-2 ga jama'a ba, kuma ba a yi maganin sabon kwayar cutar ba.
A halin yanzu, babu wani bincike ko bincike da ya shafi amsar SARS-CoV-2 da aka yi.
Hakanan, ya kamata muyi la'akari da nazarin kan wasu CoVs, musamman SARS-CoV da MERS-CoV (Hotuna (Hotuna 4).4).
A mafi yawan lokuta, idan kwayar cutar ta shiga jiki, ana samun masu garkuwar ta hanyar masu karɓa na sigina (PRR) kamar su lectin C, masu karɓa irin na Toll (TLR), masu karɓa irin na NOD (NLR), da masu karɓa irin na RIG-I (RLR).
Ta hanyoyi da yawa, ƙwayoyin cuta suna haifar da alamun bayyanar cututtuka, ƙwayoyin dendritic, da kuma irin abubuwan da ke tattare da su (IFNs) waɗanda ke hana ƙwayoyin cuta yaduwa da kuma hanzarta hallaka su.
Koyaya, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta haifar da amsawar garkuwar jiki.
Bugu da ƙari, ƙwayoyin cuta suna hana jiki ya haɗu da ƙwayoyin cuta.
T lymphocytes tare da CD4 + da CD8 + T ƙwayoyin cuta na iya zama masu tasiri a cikin wannan yaƙi.
Kwayoyin T na CD4+ sun kashe B cells don su kashe kwayoyin cutar, kuma kwayar T ta CD8+ ta kashe kwayoyin cutar da suka mutu.
Halin T na taimakawa wajen hana kwayar cutar cytokine daga kamuwa da cutar kansa.
A gefe guda, CoV na iya hana aikin T ta hanyar hana T cell ta apostosis.
Kwayar cutar ta C3a da C5a da kuma yadda suke aiki a cikin jini na da muhimmanci wajen maganin kamuwa da kwayar cutar.
Misali, maganin rigakafin da aka ba da izini ga wanda aka kamu da cutar ba shi da inganci kamar MERS-CoV.
A wasu lokuta, ƙwayoyin cuta na rigakafi suna ƙayyade adadin ƙwayoyin cuta a cikin wannan yanki wanda zai iya cutar da wasu ƙwayoyin cuta, kuma idan ba haka ba, ƙwayoyin cuta da yawa na iya haifar da rashin lafiya.
SARS-CoV, wanda ke kamuwa da cutar a cikin lokacin bazara, ya fi kamuwa da tsofaffi da ke da cututtukan ciki da kuma mata masu juna biyu.
Haka kuma, mutanen da ke da cutar kansa ko kuma suna da nauyin jiki, suna da damar da za su iya cutar da wasu mutane a cikin gida.
Lokacin bayyanar da aka yi tsammani na SARS-CoV-2 shine kwanaki 1 zuwa 14, mafi yawa 3 zuwa 7 bisa ga binciken da aka yi na 425 a Wuhan.
Duk da haka, wani bincike na mutane 1,099 ya nuna cewa tsawon lokacin bayyanar cutar ya kai kimanin kwanaki 3 kuma ya kai daga kwanaki 0 zuwa 24.
Wani sabon bincike, kamar yadda aka nuna a sama, ya nuna cewa tsawon lokacin bayyanar shine kimanin kwanaki 4.8 (3.0-7.2) a cikin adadin marasa lafiya 8,866.
Ma'aikatan kiwon lafiya sun bukaci a yi la'akari da cewa lokacin killacewa ya kamata a yi la'akari da lokacin da cutar ta kasance a cikin mutum, don gano ko cutar ta riga ta kasance a cikin jini amma ba ta nuna alamun cutar ba ta hanyar watsawa ga wasu.
A wasu lokuta, mutanen da suka kamu da cutar, ko kuma wadanda suka warke daga cutar, dole ne su yi kwanaki 14 a cikin gida.
Idan an kara tsawon lokacin da za a yi zaman gida a mako 24?
Halin da ake ciki shine farkon bayyanar COVID-19, wanda zai iya haifar da wasu alamomi kamar saurin numfashi, rashin numfashi, ciwon kai, rashin jin daɗi, hanci mai laushi, ciwon haƙori, ciwon hanci, rashin ƙarfi, ciwo, da rashin ƙarfi.
Wasu marasa lafiya suna da matsalar rashin numfashi da/ko rashin iskar oxygen a cikin mako guda bayan fara cutar.
Bayan an warke daga cutar, mai cutar yakan fuskanci ciwon numfashi, ciwon jiki, rashin jin daɗin ci, da kuma zubar da jini.
Masu cutar da ke da alamun numfashi da na numfashi da kuma na hanci, ko da kuwa hoton na nuna akwai ƙwayoyin cuta, ya kamata a kula da su da cutar don bincike da wuri.
Wani bincike na al'umma a watan Disamba 2019 ya nuna cewa yawan cututtuka ya kasance 98% na maƙarƙashiya, 76% na ciwon huhu, 55% na rashin numfashi, da 3% na rashin lafiya; 8% na marasa lafiya sun buƙaci taimakon iska.
An gano irin wannan sakamako a cikin wasu binciken da aka yi kwanan nan inda aka gano cewa wasu ƙwayoyin cuta da wasu ƙwayoyin cuta sun haifar da cutar ta hanyar haɗuwa da wani wanda ke nuna cutar.
Bugu da ƙari, wani bincike na 2012 ya gano cewa mutanen da ke da MERS-CoV suna da saurin kamuwa da cutar (98%), saurin kamuwa da cutar (47%), da kuma saurin numfashi (55%) a farkon rahoton cutar.
Koyaya, kashi 80% na waɗannan suna buƙatar iska mai ƙarfi, fiye da na COVID-19 kuma suna da ƙananan ƙimar mutuwar MERS fiye da COVID-19.
An gano cutar ta hanci (26%) da kuma hanci mai laushi (26%) a cikin marasa lafiya na MERS.
A cikin SARS, an gano cewa zazzaɓin jiki (99%-100%), zazzaɓin jiki (29%-75%), numfashi mai ƙarfi (40%-42%), hauka (20%-25%), da kuma hanci mai ƙarfi (13%-25%) sune alamun farko na cutar, kuma an ba da taimakon iska a cikin 14%-20% na marasa lafiya.
A ranar 14 ga watan Fabrairu, adadin mutanen da suka kamu da COVID-19 ya kai kashi 2 cikin dari, wanda ya kai adadin mutane 66,576 da aka tabbatar sun kamu da cutar a duniya.
A cikin wani bincike, yawan mutuwar SARS a watan Nuwamba 2002 ya kai kashi 10% daga cikin mutane 8,096 da aka tabbatar sun kamu da cutar.
A cikin MERS, bisa ga binciken da aka yi a Zwing 2012, yawan mace-mace ya kai kashi 37% a cikin marasa lafiya 2,494.
Nazarin farko ya nuna cewa R0 na SARS-CoV-2 ya kasance 6.47 tare da amintaccen rabo (CI) na 95% na 5.71-7.23, yayin da R0 na SARS-CoV ya kasance daga 2 zuwa 4.
Idan aka kwatanta SARS-CoV-2 da MERS-CoV da kuma SARA-CoV dangane da alamun cutar, yawan mace-mace, da kuma R0 an nuna su a cikin Table 1.1.
Bayanan da aka bayar sun nuna cewa SARS-CoV na da karfin yaduwa fiye da MERS-CoV da SARS-CoV, amma ba ya kashe mutane da yawa kamar yadda aka ambata a baya.
Hakanan, yana da wuya a hana ci gaban SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Aikin da aka yi na samar da wani abu da aka yi amfani da shi a cikin wani abu kamar mota ko mota.
Yawancin masu kamuwa da cutar sun yi tafiya ko sun yi tafiya a Wuhan ko wasu wuraren da cutar ta shafa ko kuma sun yi hulɗa da wasu mutanen da suka kamu da cutar ko kuma wanda ya kamu da cutar a cikin makonni biyu kafin a fara kamuwa da cutar.
Bugu da ƙari, an kuma ce mutane za su iya kamuwa da cutar ba tare da bayyanar cututtuka ba har tsawon makonni biyu kuma marasa lafiya da aka sallama daga asibiti za su iya kamuwa da cutar, wanda zai rage bayyanar cututtuka don tsawaita lokacin da ake bukata.
Yara suna da ƙananan ƙwayoyin jini na yau da kullum ko kuma ƙwayoyin jini na yau da kullum (ƙananan lymphocytes) a farkon lokacin da suka fara.
Misali, an gano cutar lymphopenia tare da adadin ƙwayoyin jini < 4×109/L da adadin ƙwayoyin lymphocytes < 1×109/L, tare da ƙimar aminotransferase na aspartate da kuma viremia a cikin mutane 1,099 da suka kamu da COVID-19.
A cikin wasu marasa lafiya, an sami karuwar yawan sinadarin hemoglobin da na myoglobin, kuma an sami karuwar sunadarin furotin C-reactive da kuma adadin erythrocytes.
A cikin marasa lafiya da ke fama da cutar, ƙimar D-dimer, wani sinadarin fibrin a cikin jini, ya ƙaru, kuma adadin lymphocytes ya ragu da lokaci.
Sautin zuciya yana nuna alamun cutar a mafi yawan mutanen da ke da COVID-19 kuma yana nuna alamun cutar a cikin jiki ko kuma a cikin iska.
A baya an gano cewa marasa lafiya na da cututtukan zuciya, na numfashi, da kuma na rashin numfashi (ARDS).
Lokacin da ARDS ya kai, zafin jiki ba zai iya yin aiki ba, ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwayar ƙwayar ƙwaƙwalwar ƙwayar ƙwayar ƙwayar ƙwaƙwalwar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuff ta ƙwar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar.
Pneumocytes irin na-1 da na-2 da ke aiki da kyau suna hana kamuwa da cutar ta hanyar rage yawan surfactant kuma suna ƙara yawan tashin hankali, kuma suna rage yawan ƙwayar cuta a cikin ƙwayar cuta kuma suna ƙara yawan ƙwayar cuta a cikin samfurin.
Hakanan, hotunan zuciya na rediyo na iya zama mafi dacewa da cutar da ke ci gaba da ƙaruwa.
A ranar 18 ga Fabrairu, 2020, gwajin farko na COVID-19 ya nuna cewa akwai ƙwayoyin cuta na huhu da ke cikin tsari, ba a samun ƙwayoyin hyaline, kuma ba a samun ƙwayoyin lymphocytes a cikin ƙwayoyin cuta, da kuma ƙwayoyin syncytial da yawa a cikin huhu na marasa lafiya da suka mutu daga cutar, tare da cutar ƙwayoyin cuta da ARDS da kuma rashin lafiyar SARS da MERS.
SARS-CoV-2 RNA ta hanyar reverse-transcriptase polymerase chain reaction (RT-PCR) ana amfani da shi a matsayin hanyar farko ta gwajin COVID-19.
Duk da haka, saboda ƙarancin ƙwayoyin cuta da ke haifar da cutar, wanda zai iya haifar da cutar, an fara gudanar da bincike na farko ta hanyar gwajin gwaji (wanda ba kawai ta hanyar RT-PCR ba) a China a ranar 13 ga Fabrairu, 2020.
Wannan ya faru a cikin gwajin SARS.
Bugu da ƙari, haɗuwa da tarihin cutar, alamun cututtukan likita, gwaje-gwajen gwaje-gwaje, da kuma bayanan rediyo yana da muhimmanci da gaggawa don yin gwaji mai kyau.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta tabbatar da cewa tsarin CRISPR ya dogara ne akan tsarin SHERLOCK don gano SARS-CoV-2, wanda ke gano RNA na SARS-CoV-2 na roba a 20 x 10-18 mol/L zuwa 200 x 10-18 mol/L (hotuna 10 zuwa 100 a cikin mililita) kuma yana da halal don ganowa a cikin rabin rabin ba tare da wani tsarin ba.
Muna fatan cewa wannan sabon tsarin zai iya inganta lokacin bincike da kuma daidaito idan aka gano shi a asibiti.
Saboda mutane ba sa iya yin maganin COVID-19 da farko, likitoci za su iya ba da shawara kan yadda za a kula da masu COVID-19 da farko, ta hanyar gwada hanyoyin da suka fi dacewa ko kuma waɗanda aka ɗauka kafin a magance SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table (Table 2).2).
Wadannan jiyya sun hada da kwayoyi masu guba, maganin rigakafin cututtuka, magungunan steroid, maganin rigakafin jini, maganin gargajiya na kasar Sin, da kuma taimakon jin daɗi.
Ba a bada magani ga marasa lafiya da ake sa ran za a yi musu magani ba.
Kamfanonin sarrafa magunguna suna ta fafutukar samar da alluran rigakafi da alluran rigakafi.
SARS-CoV-2 yana kama da ƙwayoyin cuta a farkon lokacin da ya kamu da cutar, amma ba tare da cutarwa ba, wasu kwayoyin da ke nuna alamun ACE2, kamar ciki da tsokoki da kuma hanci.
Duk da haka, ana yawan samun matsalar rashin lafiya a cikin marasa lafiya kuma wannan shine farkon abin da ya faru.
Bugu da ƙari, taimakon numfashi yana da tasiri wajen rage bayyanar cututtuka da kuma ceton rayuka ta hanyar yin amfani da iska mai tsabta, iska mai tsabta, iska mai tsabta, da iska mai tsabta wanda aka tsara don magance cutar.
Marasa lafiya da ke da alamun cututtuka na numfashi ya kamata a taimaka musu da numfashi na waje (ECMO), hanyar da za ta iya magance cututtuka na numfashi da ke da alaka da zuciya da kuma numfashi.
Bugu da ƙari, kula da tsarin electrolyte, hanawa da magance cututtuka marasa kyau da kuma amfani da kwayoyin, da kuma kare kwayoyin da ke da mahimmanci suna da amfani ga masu cutar SARS-CoV-2.
An gano cewa an samu karuwar cytokine a cikin SARS da MERS.
Cytokine yana haifar da rashin lafiya a cikin jiki wanda ke haifar da sakin cytokines kamar TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna hana kwayoyin halitta su fitar da kwayoyin halitta daban-daban wadanda ke haifar da ARDS da sauran cututtukan da ke haifar da cututtuka.
Yin amfani da rigakafi yana da mahimmanci wajen magance matsalar rashin isasshen ƙwayar cuta, musamman ma a cikin marasa lafiya.
Magungunan corticosteroids da tocilizumab, wani anti-IL6 wanda ke hana kwayar cutar ta kwayar halitta, ana amfani da su wajen maganin cytokine.
Sauran hanyoyin rigakafin cutar da cytokinedon ke haifarwa sun hada da hana T-cell; hana IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; hana siginar cytokine 4; da kuma hana HDAC.
Magungunan steroid, kamar maganin rigakafi, sun fi dacewa a maganin SARS don rage yaduwar cutar.
Duk da haka, magungunan steroid ba su da tasiri a kan maganin rigakafi na rigakafi a cikin SARS da COVID-19 marasa lafiya.
Hakanan, yana iya haifar da wasu cututtuka, musamman ma na haihuwa, wanda ke shafar ganewar asali.
Koyaya, ƙananan ƙananan karatu tare da ƙananan ko ƙananan corticosteroids ba a ba da shawarar ba kuma ya kamata a ɗauka tare da kulawa don kula da marasa lafiya na COVID-19 masu haɗari.
A lokacin wannan rubutun, babu wani magani da ya riga ya kashe cutar kuma ba a gano wani magani ba tukuna.
Duk da haka, ana iya amfani da maganin rigakafin rigakafi a cikin jini, kamar nucleotide, a matsayin magani na asibiti a cikin marasa lafiya da COVID-19
Remdesivir wani sabon maganin rigakafi ne da Gilead ta samar wanda ya riga ya zama maganin rigakafin cutar Ebola da kuma cutar Marlburg.
Daga baya, remdesivir ya tabbatar da cewa RNA na wasu ƙwayoyin cuta ya ɓace, ciki har da ƙwayoyin MERS da SARS.
A takaice dai, Gilead ya ba da maganin ga kasar Sin don gwajin cutar SARS-CoV-2, kuma ya bayyana yana da tasiri sosai.
Hakanan, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin na iya zama da amfani wajen magance cututtukan da ke tattare da cutar huhu da kuma ciwon huhu.
Cutar, kamar cututtukan fata, rashin lafiya, da kuma wasu cututtuka na iya haifar da ci gaba da magani tare da lopinavir/ritonavir.
Wannan magani da za a yi amfani da shi tare da wani magani a cikin marasa lafiya ya kamata a kula da shi sosai.
An ba da jini ga marasa lafiya da aka yi wa allurar rigakafi
An yi amfani da maganin rigakafi don magance cututtukan cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka.
Bugu da ƙari, waɗanda aka haifa da ƙwayoyin cuta suna da ƙwayoyin cuta masu kyau dangane da ƙwayoyin cuta a cikin jini.
Immunoglobulin (Ig) immunoglobulin ne wanda kwayoyin cuta ke fitarwa don yin garkuwa da kuma kare su daga abubuwan da suka shiga jikin mutum kuma suna gano ƙwayoyin cuta a cikin ƙwayoyin cuta da kuma fitar da su ta hanyar jini.
A takaice dai, an gano ƙwayoyin jini a cikin rukunin marasa lafiya da suka kamu da COVID-19 kuma an ba su magani ga marasa lafiya da suka kamu da cutar 10.
Sakamakon gwajin ya nuna cewa an samu raguwar cutar a cikin awa 24, ragewar ciwon baya da kuma yawan kwayar cutar, da kuma karuwar yawan jini a cikin jini.
Duk da haka, gwaji da kuma kulawa suna da amfani wajen samar da wani magani wanda zai iya amfani da kowa kafin a sami magani mai dacewa.
Bugu da ƙari, kamar yadda yake da amfani a magani, akwai wasu abubuwa da ba su da alaƙa da hawan jini da ya kamata a bincika su sosai.
Alal misali, masu ilimin halitta zasu iya hana rigakafin rigakafi da kuma samar da cytokines, wanda zai iya zama haɗari ga lafiyar mutum.
A cikin jini, ƙwayoyin cuta sun kasance ƙananan, kuma an yi amfani da jini mai yawa don magance marasa lafiya marasa lafiya.
Yana da wuya a gano da kuma kara masu garkuwar jiki da za su iya magance cutar gaba daya.
Haka kuma, yana da wuya a iya samun B-cells daga masu kamuwa da cutar ba tare da an yi musu allurar rigakafi ba, kamar a gwada gwaji ko a yi musu gwajin ƙwayoyin cuta.
Haka nan, za mu iya ƙara yawan adadin da aka ƙayyade.
TCM ya kasance wani nau'i na magani a kasar Sin shekaru dubbai da suka gabata.
Koyaya, tasirinsa ya dogara ne akan haɗuwa da abubuwa da yawa a cikin magungunan da aka canza da kuma binciken bincike na asibiti wanda aka samo a cikin nazarin TCM.
Babban abin da ke da muhimmanci a cikin waɗannan abubuwa shi ne rashin fahimta ko rashin hankali da kuma rashin iyawa don ƙayyadewa da kuma daidaita abubuwan da suka dace ko kuma haɗin su.
A halin yanzu, saboda rashin ingancin maganin COVID-19, TCM ya zama ɗaya daga cikin hanyoyin da za a bi don magance marasa lafiya tare da alamomi masu sauƙi zuwa marasa lafiya ko waɗanda aka warkar da su zuwa marasa lafiya.
Misali, Shu Feng Jie Du da Lian Hua Qing Wen sun gano maganin da zai iya magance COVID-19 yadda ya kamata.
An gano adadin farko na maganin COVID-19 a lardunan China da yawa waɗanda suka ba da TCM ga 87% na marasa lafiyar su, tare da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ya ba da TCM kawai ga 30% na marasa lafiyar COVID-19 ɗinsu, ya sami mafi ƙarancin maganin (13%).
Ko kuma, yana da mahimmanci a lura cewa akwai wasu sharuɗɗa kamar su yawan adadin da kuma kula da marasa lafiya da za a yi a cikin binciken.
A ranar 18 ga Fabrairu 2020, Boli Zhang da abokan aikinsa sun sake gudanar da wani bincike don gwada maganin maganin gargajiya na yamma (WM) da kuma maganin da ya haɗa da WM da TCM.
An gano cewa lokacin da ake bukata don rage yawan zazzabi, rage yawan alamun cutar, da kuma fitar da asibiti ya fi yawa a cikin ƙungiyar WM+TWM fiye da sauran rukunin WM.
Mafi mahimmanci, ƙimar bayyanar cututtuka na yau da kullum (daga ƙananan zuwa ƙananan) ya kasance mafi ƙasƙanci ga ƙungiyar WM+TCM fiye da ƙungiyar WM kaɗai (7.4% zuwa 46.2%) da kuma ƙananan ƙimar bayyanar cututtuka ga ƙungiyar WM+TCM fiye da ƙungiyar WM kaɗai (8.8% zuwa 39%).
Duk da haka, inganci da amincin TCM ya ba da damar samar da ingantattun hanyoyin yau da kullum a cikin gida da kuma a cikin sauran al'ummomi.
Zai zama da wuya a iya gano adadin ayyukan da kuma tsabtace kayan aiki don magance TCM ta hanyar kwayoyin halitta ko kuma haɗin su idan ya cancanta.
Wadanda suka kamu da cutar ko suka kamu da COVID-19 sun fi saurin kamuwa da cutar da kuma cutar da ke kashe mutane da yawa, kuma waɗanda suka kamu da cutar sun fi saurin kamuwa da rashin lafiya, rashin aiki, da rashin lafiya.
Duk da haka, bayyanar cututtuka kamar su ciwon kai, numfashi mai wuya, da kuma ciwon hauka da sauran cututtuka na rashin lafiyar da ake samu daga maganin maganin rigakafi na corticosteroids na iya zama mai saurin kaiwa ga rashin lafiya da rashin lafiya.
A farkon barkewar cutar SARS, yawan mutanen da suka kamu da cutar sun kasance masu rauni, rashin nutsuwa, rashin jin daɗi, rashin lafiyar hankali, rashin lafiyar jiki, rashin magana, da kuma rashin lafiya.
Tsaron sirri da zaman jama'a, kamar yadda aka yi a cikin martani ga cutar COVID-19, na iya haifar da damuwa da damuwa ga mutane game da haɗuwa, zaman jama'a, da kuma abin da mutane ke faɗi game da danginsu da abokan aiki.
Hakanan, ba za a bar lafiyar marasa lafiya COVID-19 ba, waɗanda ke da damar yin amfani da su, da kuma mutanen da ke kusa da su da sauran al'ummomin da ke cikin buƙata.
Harkokin kiwon lafiya ya kamata ya hada da tsara ƙungiyoyi daban-daban na ilimi tare don kula da lafiyar juna, ingantaccen bayani da kuma nazarin bayanan da aka samu game da cutar SARS-CoV-2 da kuma shirye-shiryen magani da aiki da umarni da aikace-aikace na masu amfani don hana haɗuwa da juna.
Tsaro yana da mahimmanci wajen hana yaduwar cututtuka daga dabbobi da mutane masu kamuwa da cutar zuwa ga waɗanda ba su da ƙwayoyin cuta kuma sau da yawa yana haɗuwa da maganin cututtukan ƙwayoyin cuta don hana kamuwa da cutar.
An yi niyyar samar da allurar rigakafin da ta dogara da sunadarin S don horar da kwayoyin halittar jiki don yin rigakafi da/ko yin rigakafi ga SARS-CoV.
An gwada kwayar cutar SARS a cikin dabbobi.
Koyaya, amfanin allurar rigakafin da aka gwada a cikin tsofaffi da kuma tabbatar da mutuwa da kariya daga kamuwa da cutar ta hanyar ƙwayar cuta dole ne a tabbatar da su kafin a fitar da su daga dakin gwaje-gwaje na asibiti.
SARS ya ɓace shekaru 17 da suka wuce kuma babu wani sabon abu da ya faru tun daga lokacin.
Koyaya, akwai wasu cututtuka a wasu wurare na duniya kamar MERS wanda ke ci gaba da bayyana a yankin Gabas ta Tsakiya kuma yana yaduwa a wasu yankuna da suka fito daga dabbobi a cikin dabbobin da ke da cutar.
An yi maganin rigakafi don MERS ta amfani da ƙwayoyin cuta marasa lafiya, DNA plasmid, ko kuma abubuwan da ke haifar da ƙwayoyin cuta, ƙananan colas, ƙwayoyin cuta masu kama da colas da kuma wasu sunadarai masu gina jiki waɗanda za su iya haɗuwa da sauran ƙwayoyin cuta a cikin dabbobi.
Samun ingantacciyar rigakafin SARS-CoV a cikin marasa lafiya ya zama babban gaggawa da aiki don hana ci gaba da cutar.
Duk da haka, yana da mahimmanci don kauce wa wannan matsala saboda yana daukan lokaci mai tsawo (ƙaranci har zuwa shekaru 18) kafin rigakafin cutar ta canza yanayin jikin mutum.
Kamar yadda aka saba, COVID-19 ya fara nuna alamun bayyanarsa a cikin dubban mutane da suka kamu da cutar.
A mafi yawan lokuta, marasa lafiya na iya yin magana da hankali ba tare da yin kuskure ba.
Amma, ba kamar SARS ba, COVID-19 yana da alaƙa da rashin lafiya da mutuwa a cikin marasa lafiya masu rauni.
Bugu da ƙari, samar da bayanan bincike na asibiti yana da mahimmanci ga ƙungiyoyin kiwon lafiya don kula da ayyukansu, musamman a wuraren da aka yi wa rauni.
Dangane da binciken da aka gudanar a halin yanzu, waɗannan abubuwan da ke ƙasa na iya shafar ko kuma danganta su da gwajin marasa lafiya na COVID-19 (Table (Table33):
Shekaru: Shekaru na da muhimmanci a gwajin SARS, kuma hakan na da muhimmanci ga COVID-19.
COVID-19 ya fi yaduwa tsakanin mutane masu shekaru 30 zuwa 65 da kashi 47.7 cikin 100 na marasa lafiya sama da shekaru 50 a cikin binciken mutum 8,866 da aka lissafa a sama.
Marasa lafiya da ke da bukatar kulawa da yawa sun fi nuna alamun rashin lafiya da kuma rashin lafiya, kuma sun fi sauran marasa lafiya shekaru (tsakanin shekaru 66 da 51), wanda ya nuna cewa shekaru ne mafi muhimmanci a cikin gwajin COVID-19.
Labari: SARS-CoV ya fi kamuwa da maza fiye da mata (0.31/100 000 zuwa 0.27/100 000), kamar yadda aka nuna a sama.
Mutuwa da kuma haɗari: Marasa lafiya da ke da COVID-19 da ke buƙatar kulawa na musamman sun fi fuskantar haɗarin kamuwa da cutar sankara da kuma kamuwa da cutar sankara.
Cutar ta shafi tunanin mutum kuma ita ce sanadin mutuwar mutane da yawa a cikin SARS.
Ya kuma ce SARS-CoV-2 na iya haɗuwa da kwayar cutar cholangiocytes mai suna ACE2 wanda zai iya haifar da cutar a cikin marasa lafiya na COVID-19.
Akwai kuma rashin fahimtar cewa shekarun haihuwa da rashin lafiya na iya zama masu alaƙa da juna kuma suna iya zama masu haɗuwa da juna.
Hanyoyin bincike na gaggawa: matakin C-reactive protein (CRP) a cikin jini yana nuna rashin lafiyar jiki ko rashin lafiyar jiki kuma yana iya haifar da rashin lafiya, amsawar magani, da kuma ƙarshen magani.
Ba a tabbatar da ingancin CRP na yau da kullun ba a cikin gwajin COVID-19.
Bugu da ƙari, lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen ƙayyade abin da ke faruwa.
Ana iya samun waɗannan ƙwayoyin a cikin sassan jiki da yawa, musamman a cikin zuciya da jijiyoyin jini, kuma ana iya samunsu a wurare da yawa kamar su ƙofar ciki.
Bugu da ƙari, yana da alama cewa alamun da ke nuna cewa zuciyarka ko jijiya ba ta aiki da kyau.
Alamun cutar na yau da kullun: za a bincika siginar jijiyoyin jini da yanayin cututtukan tare da sauran kayan aikin don bincika alamun cutar da haɗarin COVID-19.
Yin amfani da steroids: Kamar yadda aka ambata a sama, steroids sune magungunan da aka fi amfani da su a matsayin maganin cututtuka na cututtuka don rage lalacewar tsoka.
Lokacin da aka ba da shawarar maganin ƙwayoyin cuta na maganin SARS, yawancin marasa lafiya da suka kamu da cutar sun yi fama da rashin lafiya da kuma ciwo mai tsanani wanda ya ƙare har zuwa ƙarshen rayuwarsu.
Bugu da ƙari, idan ya cancanta, ya kamata a ɗauki steroids a hankali kuma a cikin gajeren lokaci a cikin marasa lafiya na COVID-19.
Rashin nutsuwa: kamar yadda aka bayyana a sama, a cikin COVID-19, yawancin marasa lafiya suna fama da rashin nutsuwa saboda rashin nutsuwa yayin da suke cikin ɗaki kuma suna damuwa game da rashin lafiya da rashin lafiya yayin da suke kallon mutuwar dangi.
Yana da muhimmanci a sami likita mai zaman kansa da kuma taimako a cikin lokaci don taimakawa marasa lafiya da ke fama da rashin lafiya da kuma gano kansu.
Kamar yadda binciken al'umma ya nuna, COVID-19 ya nuna cewa akwai wasu bambance-bambance tsakanin sa da SARS.
Baya ga cutar a cikin ƙananan ƙananan huhu, SARS-CoV-2 na iya yin tasiri sosai a cikin ƙananan huhu kuma yana iya sa mai cutar ya zama mai saukin kamuwa ko rashin kamuwa da cutar a farkon kamuwa da cuta kamar sauran CoVs masu saurin kamuwa da cutar.
Koyaya, marasa lafiya da suka kamu da cutar a farkon ko kuma lokacin da suka kamu da cutar na iya samun ƙwayoyin ƙwayoyin cuta a cikin rana, wanda ke haifar da rashin lafiya.
Koyaya, kamuwa da SARS-CoV yana da tasiri sosai a cikin waɗanda suka kamu da cutar, kuma cutar ba ta da saurin kamuwa da cutar.
Bugu da ƙari, cutar COVID-19 na yanzu ya fi haɗari da kuma sauƙin sarrafawa fiye da cutar SARS.
Yawancin matakan da aka dauka sun sabawa doka a China kuma dokar hana fita ta Wuhan da sauran biranen da ke kewaye da ita da kuma ci gaba da hana fitar da jama'a daga gida sun hana yiwuwar kamuwa da SARS-CoV-2.
Kodayake wannan aikin yana da alaƙa da haɗin gwiwar mutane da ƙungiyoyi da ƙungiyoyi na ƙasashe daban-daban, yawan adadin sababbin masu kamuwa da cutar ya ragu, wanda ke nuna cewa cutar na kan hanyar zuwa ƙarshe.
Masu hasashen da ke cikin gida sun yi hasashen cewa cutar za ta iya karewa a ƙarshen watan Maris kuma za ta ci gaba zuwa shekara ta 3 zuwa 4.
Duk da haka, kada ku yi shakka cewa wasu za su so ku.
Paul Hunter, et al. sun yi imanin cewa COVID-19, wanda ya kasance mafi haɗari a farkon SARS, ba zai ƙare ba a 2020.
Ira Longini, et al., sun ba da tabbaci cewa gwajin cutar ya nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu cikin uku na yawan mutanen duniya.
Wani rukunin mutanen Kanada sun nuna cewa an gano SARS-CoV-2 a cikin gwaje-gwajen da aka yi a tsakiyar bazara da kuma a cikin ƙwayoyin cuta na marasa lafiya da aka yi wa asibiti da aka sallame su makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano ba ta da wata alaƙa da cutar.
Koyaya, alamun da ke ba da tabbaci sun bayyana a cikin China dangane da yawan sabbin masu kamuwa da cutar, wanda ke nuna cewa matakan na yanzu na iya zama mai tasiri.
An yi hasashen cewa Ebola za ta iya kama mutum miliyan daya da kuma kashe mutum miliyan daya da rabi.
Duk da haka, ta hanyar warewa da kuma rarrabewa, cutar ta zama mai yiwuwa ga mutane su magance ta.
Wataƙila, kamar SARS-CoV, cewa ƙarfin SARS-CoV-2 ya ragu a cikin ƙwayar cuta kuma yana iya ɓace ko cutar ta ɓace ba tare da yin tasiri a cikin mutane ba.
An nuna alamun cutar COVID-19 da SARS da MERS a ƙasa (Hotuna (Hotuna55).
SARS-CoV-2 na iya yaduwa ta hanyar yin wanka ko shaƙatawa, kuma yana iya yaduwa ta hanyar tuntuɓar kayan da cutar ta shafa.
An kuma gano kwayar cutar a cikin hanci, wanda ke nuna cewa ana iya yada cutar ta hanci ta hanyar hanci.
Wani sabon bincike da aka yi a kan mutane 138 ya nuna cewa kashi 41 cikin 100 na iya kamuwa da cutar daga ƙwayoyin cuta, da kuma kashi 17 daga cikin mutane 40 da suka kamu da cututtukan ƙwayoyin cuta.
Hakanan, dole ne a yi aiki da haƙƙin haƙƙin mutum, musamman ma'aikatan kiwon lafiya, ma'aikatan al'umma, masu kula da gida, abokan hulɗa, da waɗanda ke tare da masu haƙuri ko mutanen da ke da wannan cutar.
Hanya ta farko da za a iya amfani da ita don rage yaduwar cutar ita ce ta hanyar sanya abin rufe fuska; sanya kayan aikin N95 da na N95 (lambar 1860s) na iya taimakawa wajen yada kwayar cutar.
Rufe fuska yana hana yaduwar cutar daga cikin wanda ya kamu da cutar kuma idan ta iska ko taɓawa, za ta iya yaduwa zuwa wasu mutane.
Koyaya, N95 (lambda # 1860s) na iya hana ƙananan ƙwayoyin cuta daga 10 zuwa 80 nm, tare da kusan 5% na ƙananan ƙwayoyin cuta waɗanda za su iya shiga cikin jiki; SARS-CoV-2 yayi kama da SARS-CoV kuma yana da nau'in haske mai haske na 85 nm.
Kamar yadda likitoci zasu iya shiga cikin rigunan rigakafin idanu na likitoci har sau shida, masu kula da lafiya da ke kusa da marasa lafiya dole ne su sa rigunan N95 (lambar # 1860s) ko rigunan rigakafin idanu na likitoci.
Bugu da ƙari, a kan rigunan fuska, ma'aikatan kiwon lafiya dole ne su sa rigunan da za su iya hana yaduwar ƙwayoyin cuta.
Wannan kwayar cutar kuma tana iya kamuwa da mutum ta hanyar idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 yayin da yake sanye da abin rufe fuska na N95; wataƙila kwayar ta shiga jikinsa ta hanyar idanunsa da ke da ƙazanta.
Sa'an nan, ma'aikatan kiwon lafiya dole ne su yi amfani da suturar rigakafi da rigakafi yayin kula da marasa lafiya.
Ga duk mutanen da ke yankunan da cutar ta shafa ko kuma ta iya kamuwa da cutar, yana da muhimmanci a wanke hannu da sabulu a kai a kai, a yi amfani da hanyoyin da suka dace ko kuma a zauna a gida da kuma guje wa hulɗa da mutanen da cutar ta shafa.
Dole ne mutum daya da rabi su kasance a cikin jama'a don su kula da marasa lafiya.
Wannan mataki na da muhimmanci wajen rage kamuwa da cutar da kuma dakile yaduwar cutar gaba daya.
Ko da yake SARS-CoV-2 ya bayyana a matsayin sabon kwayar cutar a cikin ɗan adam, kusancinsa da SARS-CoV kamar yadda aka lissafa a ranar 7 ga Janairu 2020 ya buɗe matsayin China na mai da hankali ga abin da ya faru a lokacin cutar SARS ta 2003.
Koyaya, a ranar 19 ga Janairun, 2020 wani jami'in kula da cututtuka a Wuhan ya yi gargadin jama'a cewa sabon kwayar cutar tana da saurin yaduwa da kuma yaduwar cutar daga mutum zuwa mutum kuma hakan zai zama matsala ga rigakafin cutar.
Wannan sanarwa ta haifar da damuwa ga jama'a, musamman ma yayin da kasar ke shirin bikin bazara, kuma ba a san lokacin da cutar za ta ƙare ba kamar yadda aka yi a Wuhan.
Masu bincike a China sun yi amanna da cewa za a iya yin bincike a kan hanyoyin da za a iya amfani da su a nan gaba.
Misali, waɗannan ƙa'idodin dole ne (1) su kula da kuma ba da bayanai ga jama'a saboda kowane mai magana yana da daraja a idanun jama'a kuma yana iya cutar da haƙƙinsu da ƙwarewarsu; (2) a daidaita kuma a ba da amsa daidai ga bayanan da aka ba da izini game da cutar da kuma bayar da shawarwari ga likitoci ko hukumomi; (3) a gano hanyoyin da za a iya hana kamuwa da cutar tun da wuri idan akwai buƙatar jama'a; da kuma samar da hanyoyin da za a iya tsara haƙƙin jama'a game da cutar da aka gano da kuma magance matsalolin jama'a a kan lokaci.
COVID-19 wani sabon nau'in kwayar cuta ne wanda aka fi sani da SARS-CoV-2 wanda ya bayyana a ƙarshen Disamba 2019.
A cikin shekaru biyu, ya yaɗu a ko'ina cikin China da kuma fiye da kasashe 50 a duniya a lokacin wannan rikici.
Saboda wannan kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, cutar COVID-19 ta sake zama SARS.
Koyaya, akwai bambance-bambance da yawa tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don hana yaduwar cutar da kuma magance masu cutar.
COVID-19 ya shafi tsofaffi fiye da mata, kuma ya fi saurin kamuwa da cutar da kuma mutuwa fiye da tsofaffi.
SARS ya fi COVID-19 yawan kashewa (10.91% da 1.44%).
Masu cutar COVID-19 na iya yada kwayar cutar ko da kuwa ba su da alamun cutar, amma masu cutar SARS ba za su iya ba sai dai idan sun warke, wanda hakan ya sa COVID-19 ta zama mafi muni a kan SARS.
Wannan ya nuna cewa SARS-CoV-2 ya fi sauƙin shiga kuma ya fi SARS-CoV saurin yaduwa.
Ana iya samun gwajin RNA na SARS-CoV-2 a cikin wasu marasa lafiya na COVID-19.
A wasu lokuta, marasa lafiya da suka kamu da cutar na iya samun cutar.
Wannan ya nuna cewa cutar na iya yaduwa sosai.
Saboda irin wannan yanayin a cikin binciken COVID-19, yawancin buƙatu suna buƙatar amsawa, kamar:
Shin SARS-CoV-2 ya samo asali ne daga kwayar cuta?
Ko da yake an gano kusan kusan kashi 96 cikin 100 na SARS-CoV-2 da SARS-CoV-2 masu kama da COV, ba za a iya cewa SARS-CoV-2 ya fito ne daga ƙwayoyin cuta ba.
Shin dabba ce matsakaici tsakanin dabbobi da ke da kwayar cutar da ta fara watsawa daga dabba, kamar tsuntsaye, zuwa mutum?
Ba tare da amsoshin #1 da 2 ba, ba za mu iya guje wa kamuwa da cutar ba, kuma cutar na iya sake barkewa a kowane lokaci.
Ko da yake nazarin kwayoyin halitta da nazarin halittu sun nuna cewa SARS-CoV-2 ya yi daidai da ACE2, ta yaya kwayar cutar ta shiga cikin ƙwayoyin cuta na huhu kuma ta sauya alamun cututtukan cututtukan cuta?
Shin kwayar cutar ta riga ta gano cewa ƙwayoyin ACE2 suna aiki a cikin wasu ƙwayoyin cuta?
Ba tare da amsoshin da suka dace ba, ba za a iya magance matsalar ba kuma a sami magani mai kyau.
Har yaushe ne za a ƙyale wannan?
Ta yaya kwayar cutar ta tashi daga tushe har zuwa mutum?
Shin za a iya samun cutar da ta shafi duniya baki daya, ko za a iya kawar da ita kamar SARS ko kuma za a iya sake farfado da ita kamar cutar zazzabin cizon sauro?
Yana da mahimmanci cewa zai iya ɗaukar lokaci kaɗan don amsa tambayoyin da ke sama da sauran tambayoyin.
Duk da haka, ba mu da wata mafita, sai dai mu yi iya ƙoƙarinmu wajen magance wannan cuta da kuma rage munin halin da muke ciki.
Kwayar cutar coronavirus ta mutum ta hanyar dabbobi
Kwayar cuta da ke haifar da cutar coronavirus (CoV) ta kasance mai yaduwa da kuma karɓa daga wasu mutane, a cikin shekaru da yawa.
Kafin 2003, an gano wasu CoVs na mutum (HCoVs) guda biyu da suka haifar da cututtukan cututtuka, kamar su mura.
Cututtuka kamar su SARS da MERS sun nuna yadda cutar ke shafar mutane.
Bayan ɓarkewar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya kamu da cutar CoV da kuma haifar da mummunar cuta mai saurin kamuwa da cutar SARS-CoV-2 a cikin ƙwayoyin cuta.
HCoVs na da ƙwayoyin cuta kuma gano asalin ƙwayoyin cuta na HCoVs na iya zama da amfani a gare mu.
Yawancin HCoVs sun fito ne daga kwari kuma ba su da wata cuta.
An kuma gano wasu kwayoyin HCoV masu matsakaicin matsayi.
Koyon dabbobi masu kama da gidaje yana da matukar muhimmanci wajen koyon yadda mutum zai iya kare kansa.
Nazarin halittar CoV a cikin dabbobi ya nuna cewa CoV na iya yaduwa zuwa ga mutane.
A cikin wannan bita, mun yi nazari kan abin da muka sani game da HCoVs bakwai da aka sani, kuma mun tattauna tarihin su da nau'in da aka gano a can da kuma hulɗarsu.
Hakanan, muna ƙoƙarin gwada da kuma magance bambance-bambance tsakanin HCoVs dangane da yanayin kwayar cutar da kuma tsarin kwayoyin halitta.
Ba a yi nazarin cutar COVID-19 ba a cikin binciken.
Bugu da ƙari, muna ƙididdige abin da ƙwayoyin cuta ke yi a cikin ƙwayoyin cuta daban-daban da kuma yadda suke shafar cutar a cikin yanayin rashin lafiya.
Kwayar cutar coronavirus (CoV) na cikin Coronaviridae, wanda ya ƙunshi rukunin ƙwayoyin cuta masu saurin kamuwa da cutar, masu saurin kamuwa da cutar, da RNA da kwayar cutar guda ɗaya.
Kwayoyin da ke da kwayar cutar ta kwayar cutar ta kwayar cuta mai dauke da 26 zuwa 32 kilobase na kwayar cutar RNA ana kiranta "CoV" saboda suna da yawa don a iya gani a cikin microscope.
Ta hanyar rarraba kwayoyin, CoVs ba su da kwayoyin halittar kwayoyin halitta guda biyu.
Hanyoyi biyu a cikin uku na genome suna da nauyin nau'i biyu na kwayoyin halitta da kuma kwakwalwa (ORF1a da ORF1b), wanda ya dogara ne akan pp1a da pp1ab polyprotein replicase.
Ana iya amfani da polyproteins don samar da furotin mai ƙwayoyin cuta 16, wanda aka kira nsp1~16.
Ƙungiyar taƙaitaccen tsari ta genome ta ƙunshi ORFs na sunadarai masu rai, da kai (S), ƙira (E), jiki (M) da nucleoprotein (N).
Akwai nau'in sunadarai da suka danganci wannan kwayar cutar kuma akwai nau'in sunadarai na CoVs daban-daban.
Dangane da rarrabawar kwayoyin halittar sunadarai, ana iya rarraba CoV zuwa rukuni huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), daga cikinsu rukunin beta-CoV yana da mafi yawan CoV kuma yana da asali huɗu (A, B, C da D).
Bayanan phylogenetic ya nuna cewa tsuntsaye da dabbobi sun kasance farkon farkon CoV alpha-class da CoV beta-class, kuma sanyi shine farkon farkon CoV gamma-class da kuma CoV delta-class.
A cikin shekaru dubu huɗu, CoVs sun yadu daga nau'in kwayar cuta zuwa nau'in kwayar cuta daban-daban kuma wasu daga cikinsu sun kasance kwayoyin cutar da ke lalata jikin mutum.
A halin yanzu, akwai sanannun CoVs na ɗan adam (HCoVs) guda bakwai.
HCoV-229E da HCoV-NL63 sune alamun alpha-CoV.
Sauran nau'in beta-CoV guda shida sune HCoV-OC43, HCoV-HKU1, coronavirus wanda ke haifar da cutar hawan jini mai tsanani (SARS-CoV), cutar coronavirus na Tsakiyar Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da alamun kamuwa da cuta kamar farfajiya mai rauni da / ko kuma kumburi.
Koyaya, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan sun fi cutarwa ga mutane, suna haifar da ƙananan cututtukan numfashi a cikin mafi yawan marasa lafiya waɗanda ke da damar yin amfani da maganin rigakafin cutar huhu (ARDS) da kuma cututtukan da suka shafi huhu kawai.
An fara gano kwayar cutar HCoV-229E, B814, a cikin wani nau'in cutar da aka sani da cutar a cikin shekarun 1960.
Tun daga wannan lokacin, an gudanar da bincike mai zurfi a kan HCoV-229E da HCoV-OC43, duka biyu suna nuna alamun cutar da ke da bambanci.
Koyaya, duk da haka, an yarda cewa cutar ta HCoV ta wanzu tun kafin barkewar SARS.
Cutar SARS ta bayyana a 2003 kuma ta kasance ɗaya daga cikin cututtukan da suka fi tsanani a tarihin duniya, inda ta kamu da mutane fiye da 8,000 kuma ta kashe kusan kashi 10% na masu kamuwa da ita.
Shekaru goma da suka gabata, cutar sankarar bargo ta yankin gabas ta tsakiya (MERS) ta zama abin da ya zama dole a yankin Larabawa kuma ya zama dole a sauran duniya.
Sabuwar HCoV 2019 (2019-nCoV), wanda aka sake masa suna dangane da SARS-CoV-2, shine asalin cutar coronavirus ta 2019 (COVID-19), wanda ya kashe kusan mutane 3 100 kuma ya kamu da fiye da mutane 91 000 har zuwa 3 ga Maris 2020.
Akwai rahotannin da ke nuna cewa duniya na bukatar yin taka tsantsan game da yiwuwar kamuwa da SARS-CoV-2 a nan gaba.
HCoVs sun samo asali ne daga tsuntsaye, dabbobi da dabbobi masu gida.
Yawancin shaidu sun nuna cewa HCoVs sun samo asali ne daga kwari, inda ƙwayoyin cuta ke canza jikin su kuma suna kashe su amma suna nuna alamun cutar.
Annobar COVID-19 ta haifar da babbar matsala ga likitoci, masana kimiyya, al'umma, da kuma masana kimiyya a Sin da ma duniya baki daya.
Binciken asalin HCoV na samar da hujjoji don gano tarihin, abubuwan da suka haifar da shi da kuma yiwuwar sauya fasalin jikinsa.
Wannan na iya nuna rashin inganci ko rashin ingancin gwajin asibiti na farko, na biyu da na uku na kwayar cutar da ke cikin kwayar cutar SARS-CoV-2 ko kuma tsarin rigakafi na mutum wanda zai iya kamuwa da cutar.
Wannan ya sa aka yi amfani da maganin rigakafi, wanda aka yi amfani da shi wajen gano kwayoyin HCoV.
Yawancin lokaci, muna lura kuma muna magana game da maganganun cewa masu ɗaukar HCoVs ba su da lafiya a cikin ɗakunan farko amma suna iya zama masu cutarwa idan aka kamu da su ta hanyar wasu ƙwayoyin cuta a cikin sabon ɗakunan.
Har ila yau, muna nazarin yanayin HCoV na kamuwa da cuta wanda ke haifar da rashin lafiyar ƙwayoyin cuta.
An gano cewa cutar SARS-CoV da ke da nasaba da cutar ba a gano ta ba.
An gano CoVs a cikin shekarun 1930s.
Kafin a fara gano kwayar HCoV-29E B814 a cikin ƙwayoyin cuta da aka kamu da cutar da ba a san su ba, CoV ya bambanta a cikin nau'ikan da yawa da suka kamu da cutar kamar su tururuwa, dabbobin gida, dabbobin gida, dabbobin gida, dabbobin gida da kuma tsuntsaye.
A cikin shekaru goma da suka gabata, an gano HCoVs guda goma sha biyu.
Akwai tarihin gano HCoVs dangane da lokaci da kuma shekara (Table 1) wanda zai iya zama da amfani ga bayanai da kuma nazarin.
Kwayar cutar HCoV-229 an fara gano ta ne a cikin ƙwayar huhu na marasa lafiya da suka kamu da cutar sankarar sankarar sankararsu a shekarar 1966, kuma ƙwayoyin halittarta sun taso ne a cikin ƙwayoyin cuta na WI-38.
A cikin marasa lafiya da ke dauke da HCoV-229E, an yi hasashen cewa za a iya samun alamun rashin lafiya kamar mura, mura, farfajiya, rashin jin magana, zazzafan hanci, da kuma zazzaɓin hanci da hanta a tsakanin 10 zuwa 20% na marasa lafiya.
Daga baya a 1967, an gano HCoV-OC43 a cikin gwajin gwajin gwaji tare da lambar da ta dace a cikin kwayoyin halittar da aka gano.
HCoV-OC43 yana da alamun bayyanar da ke kama da waɗanda ke haifar da HCoV-229E, wanda alamunsa ya yi daidai da sauran ƙwayoyin cuta na numfashi kamar su ƙwayoyin cuta na A da na mura.
HCoV-229E da HCoV-OC43 suna da saurin yaduwa a duniya, kuma suna iya kamuwa da cutar ta hanyar hunturu a lokacin da ya dace.
Yawanci, lokacin bayyanar kwayar cutar ya kai mako guda, sannan ya ci gaba da kamuwa da cutar har tsawon makonni 2.
A cewar wani binciken da aka yi a kan mutane, mutanen da ba su da lafiya da suka kamu da HCoV-229E sun kamu da cutar.
Wasu marasa lafiya da ke da lafiya ba su da alamun cutar ta numfashi mai tsanani.
SARS, wanda aka fi sani da " atypical pneumonia ", shi ne farkon kamuwa da cutar HCoV da aka ba da labari a cikin tarihin ɗan adam kuma kwayar cutar SARS-CoV ce, na uku HCov da aka gano.
An gano farkon cutar SARS a 2002 a lardin Guangdong na China.
SARS ya yi sanadiyar mutuwar mutane 8,096 da kuma mutuwar mutane 774, wanda ya bazu a ƙasashe da kuma duniya baki ɗaya.
Bayan an yi saurin kamuwa da cutar, an gano cewa kowane mutum zai iya kamuwa da cutar sau biyu, tare da lokacin bayyanar tsakanin kwanaki 4 zuwa 7 da kuma yawan adadin ƙwayoyin cuta da ke kamuwa da cutar bayan kwanaki 10 na kamuwa da cutar.
Mutanen da suka kamu da SARS-CoV sun nuna rashin lafiya, ciwon baki, tari, rashin lafiya, rashin lafiya da rashin lafiya, tare da rashin lafiya, rashin lafiya, da rashin lafiya na numfashi a matsayin alamun bayyanar cututtuka.
Lymphoma, gwajin gwajin aiki na jiki, da creatine kinase sun kasance a cikin gwajin SARS a cikin lab.
An gano wani nau'i na alveoli, wani nau'i na epithelial cell da kuma wani nau'i na macrophage a cikin marasa lafiya na SARS.
Kusan kashi 20 zuwa 30 cikin 100 na marasa lafiya na bukatar kulawa ta musamman kuma ana iya samun magani ta hanyar wasu magunguna.
Bugu da ƙari ga cututtukan da ke cikin ƙwayar huhu, wasu ƙwayoyin cuta kamar ƙwayoyin cuta, huhu da kuma hanci na iya kamuwa da cutar yayin da cutar ta ci gaba, wani lokaci kuma ta hanyar ƙwayar cytokine, wanda zai iya zama mai haɗari ga marasa lafiya marasa lafiya.
Kwayar cutar ta zama mai karɓar rigakafin farko a cikin gwajin jini na mahaifin wani mai cutar da ya yi tafiya zuwa Hong Kong da Guangzhou.
Tun daga wannan lokacin, an yi amfani da hanyoyi daban-daban don gano HCoV.
HCoV-NL63 ya zama mai yaduwa a cikin wani jariri mai shekaru 7 wanda ya fito daga Netherlands a ƙarshen 2004.
An gano cewa cutar ta fi bayyana a cikin yara, tsofaffi da kuma marasa lafiya da ke fama da cututtukan numfashi.
Kwayar cutar coryza, ciwon ido, rashin jin daɗi, da kuma cutar bronchiolitis sun kasance a cikin yanayin HCoV-NL63 na yau da kullum.
Wani bincike ya nuna cewa an samu kwayar cutar ta HIV ta hanyar kwayar zuma daga wani jariri dan wata takwas da ke Netherlands wanda ke dauke da cutar nimoniya.
Ko da yake an samo asali ne a cikin Netherlands, yanzu ya yadu a duk duniya.
An gano cewa HCoV-NL63 yana da kusan 4.7% na cututtukan numfashi na kowa, tare da mafi yawan kamuwa da cutar a lokacin bazara, bazara da kuma hunturu.
HCoV-NL63 yana da alaƙa da ƙwanƙwasawar ƙwanƙwasawa, wanda ake kira croup.
A wannan shekara, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 wanda aka yi asibiti don ciwon huhu da kuma cutar bronchiolitis a Hong Kong.
Baya ga cutar huhu da kuma mura, HCoV-HKU1 ana zaton yana da alaƙa da cutar ƙwaƙwalwa mai saurin yaduwa.
An gano cewa akwai ƙwayoyin cutar coronavirus a cikin kwayoyin HCoV-XNUMX da ke haifar da cutar coronavirus, wanda ke haifar da cutar ƙwayoyin cuta na SARS-CoV-2 da SARS-CoV-2.
HCoVs da ke kamuwa da cutar a cikin jama'a ba sa shiga cikin jikin mutum kuma suna iya canzawa don haifar da wasu cututtuka masu haɗari, kodayake akwai wasu cututtukan da ba a sani ba kuma ba a san su ba kamar yadda yake a cikin wani nau'in HCoV-NL63 da aka gano, wanda aka ce ya haifar da cutar huhu a cikin China.
Mafi sau da yawa, idan HCoVs suka sami isasshen iskar kwayar cuta kuma suka zauna a cikin jikin mutum, za su iya zama masu cutar ko kuma nuna alamun cutar.
An fara gano MERS-CoV a 2012 a cikin wani mutum mai shekaru 60 da haihuwa wanda ya kamu da cutar huhu mai tsanani a Saudiyya.
A cewar cibiyar bincike, cutar ta kanjamau ta samo asali ne a Gabas ta Tsakiya, yayin da cutar ta samo asali ne a kasashen waje kuma an samu karuwar kamuwa da cutar a kasashen Turai da Tunisia.
An sake samun bullar cutar a Koriya ta Kudu a 2015 inda aka samu mutum 186 da suka kamu da cutar.
Kwayoyin cutar MERS sun yi kama da na SARS, wanda ya haifar da cutar huhu mai saurin kamuwa da cutar huhu.
Ba kamar SARS ba, yawancin mutanen da suka kamu da MERS sun kamu da cutar sankara, wanda ya bambanta MERS daga sauran cututtukan da HCoV ke haifarwa.
Fiye da kashi 30% na marasa lafiya suna da alamun cututtuka na cututtuka na ciki, kamar su naƙuda da kuma naƙuda.
Tun daga ranar 14 ga Fabrairu, 2020, an sami fiye da mutane 2500 da suka kamu da cutar, kuma an sami mutuwar kusan kashi 34.4 cikin dari, wanda ya sa MERS-CoV ya zama ɗaya daga cikin mafi yawan ƙwayoyin cuta a cikin mutane uku.
A tsakiyar da kuma ƙarshen Disamba, an gano wani sabon kamuwa da cutar huhu a cikin marasa lafiya da aka gano ba a san su da cutar SARS-CoV-2 ba a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta sanar da cewa cutar huhu mai saurin numfashi mai saurin numfashi mai saurin numfashi ta SARS-CoV-2 ta zama matsalar gaggawa ta gaggawa ta kasa da kasa kuma ta kira cutar COVID-19.
Tun daga barkewar cutar a ranar 3 ga Maris 2020, an sami mutane 90,053 da suka kamu da cutar a duniya, kuma yawan mace-mace ya kai 3.4 cikin 100.
Yawanci, yawan mutuwar a Hubei, China ya kai kashi 4.2%, yayin da a wasu wurare ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan numfashi na numfashi kamar SARS-CoV da MERS-CoV, wanda ke haifar da kumburi, rashin lafiya da kuma wahalar numfashi.
An kuma ba da rahoton cutar a cikin wasu marasa lafiya.
Pneumonia ita ce mafi yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka kuma ana iya la'akari da su a matsayin cututtukan cututtukan cututtukan cututtuka.
Kodayake SARS-CoV da SARS-CoV-2 sun yi kama da juna saboda an gano kashi 82 cikin ɗari na nucleotide, sun haɗu da juna a cikin jinsin su.
SARS-CoV-2 yana da nau'in kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cuta.
Ba a gano mutanen da ke da SARS-CoV-2 ba amma ba su da alamun cutar kuma ana iya ɗaukar su a matsayin masu ba da damar cutar ta yaduwa a duniya.
Gwaje-gwaje da kuma nazarin SARS-CoV-2 da sauran HCoVs guda shida sun nuna bambancin da ke tattare da feveretrol da ke haifar da damuwa.
Da farko dai, lokacin bayyanar da kuma lokacin kamuwa da cutar HCoV ba su da daidaito.
Bugu da ƙari, SARS-CoV-2 yana ci gaba da kasancewa a cikin jerin jerin HCoVs.
Na biyu, cutar COVID-19 ta kasance mai saurin yaduwa a tsakanin SARS-CoV da HCoVs hudu da suka kamu da cutar (kamar HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A wani yanayin, SARS-CoV-2 yana nuna alamun bayyanar cututtuka da aka gano a cikin HCoV da ke haifar da cutar HCoV tare da bayyanar cututtuka daban-daban, ko dai sun mutu ko kuma ba su mutu ba.
A wani bangare, akwai ƙananan ƙananan ƙananan mutanen da ke fama da cutar COVID-19 kamar yadda aka gano a cikin SARS-CoV, ko da yake ƙananan ƙananan ƙananan ba su da yawa.
Na uku, kamuwa da SARS-CoV-2 ya nuna alamun alamun alamun alamun da suka haɗa da kamuwa da HCoV da SARS-CoV ta hanyar al'umma.
A wani bangaren kuma, kamuwa da SARS-CoV-2 ya yi kama da kamuwa da HCoV daga HCoV a cikin al'umma.
A wani bangare, ya kamata a bincika ko cutar SARS-CoV-2 ta ragu bayan kamuwa da cutar a cikin mutane kamar yadda SARS-CoV da MERS-CoV suke.
A ƙarshe, ba kamar sauran HCoVs ba, SARS-CoV-2 za a iya gano shi a cikin ƙwayar ƙwayar cuta.
Idan har ana iya samun SARS-CoV-2 daga hanci zuwa baki, yana da mahimmanci a yi la'akari da SARS-CoV-2 a matsayin mai yiwuwa a sake nazarin shi a cikin makarantu masu zuwa.
SARS-CoV-2 na iya bayyana nan da nan kamar yadda sauran HCoVs na al'umma suka bayyana.
Duk da haka, alamun SARS-CoV-2 da yanayin kamuwa da cutar, alamun cutar, da kuma yadda za a iya yada shi a cikin jikin mutum zai taimaka wajen tantance yiwuwar kamuwa da cutar COVID-19 na yanzu.
Dukkanin HCoVs huɗu suna da alaƙa da juna kuma suna haifar da alamun bayyanar cututtuka masu haɗari.
A wani bangare, yana iya zama cewa cutar ta ɓarke daga mutum zuwa HCoV gaba ɗaya.
A cewar wannan, duka biyun na iya zama asalin asalin cutar HCoV.
HCoVs da ke haifar da cutar a cikin mutum da kuma mutanen da suka kamu da cutar HCoV ta asali ba za su shiga cikin jerin ba.
Don haka, HCoVs dole ne su kasance a cikin mutane don su iya rayuwa kuma su iya haɗuwa da bambancin bambancin da ke haifar da rashin lafiya.
Duk da haka, idan SARS-CoV-2 ya kamu da mutane, babu yiwuwar kamuwa da cutar ta hanyar jiki.
Idan har an samu ciwo mai tsanani, kamuwa da cutar a cikin gida zai iya zama da wuya a hana shi shiga asibiti ko kuma a bi wasu hanyoyin kariya.
A cikin shekaru da yawa, CoVs marasa cutarwa sun kasance suna yaɗuwa a cikin al'umma, suna ba da kariya ga marasa lafiya waɗanda ke da ƙwaƙwalwar ƙwayar cuta.
Wannan kwayar cutar ba ta buƙatar wani abu kamar gida.
SARS-CoV da MERS-CoV sun yi daidai da jikin mutum amma ba su kai ga jama'a ba cikin dogon lokaci.
Suna buƙatar adanawa da rarraba su a cikin gidajen dabbobi da kuma samar da hanyar da za ta iya kaiwa ga mutum, musamman a cikin gida ko gidajen da cutar ta fi dacewa.
SARS-CoV-2 yana da alamun bayyanar cututtuka na SARS-CoV/MERS-CoV da HCoVs guda huɗu waɗanda ke da haɗari ga jama'a.
Ba zai iya cutar da mutane kamar HCoVs ba, har sai an gano cewa yana da cutar.
Koyaya, mafi yawan kamuwa da HCoVs suna da haɗari ga jama'a kuma sun fi na SARS-CoV ko MERS-CoV.
Bincike ya nuna cewa mutum da dabba za su iya zama abokan kirki ba tare da samun wata cuta ko wata cuta da za ta iya cutar da su ba.
Kafin mu yi magana game da bayyanar HCoVs ta hanyar kwayoyin halitta, ya kamata mu yi magana game da abin da HCoVs suke, da farko, da matsakaici da kuma yanayin da suke ciki.
Kwayar halitta tana aiki a matsayin mai ɗaukar hoto na HCoV ta hanyar samar da kwayar halittar da ke iya zama mahaifa mai mahimmanci a cikin wani ɓangaren kwayar halitta a cikin kwayoyin halittar.
Yawancin ƙwayoyin cuta suna rayuwa ne a cikin mahaifa.
Hakanan, gidan mai ba da abinci yana kiyaye HCoVs a cikin iska da iska.
Duk da haka, ƙwayoyin cuta masu kamuwa da cutar suna da wannan ƙwayar cuta a cikin jikin su kuma sune farkon kwayoyin HCoV ko kakanninsu.
Koyaya, idan HCoV ya kamu da sabon kwayar cuta a cikin matsakaiciyar cuta kafin ko bayan shigar mutum, ba zai iya haɗuwa da sabon kwayar cuta ba kuma yana iya zama mai cutarwa.
Wannan na tsakiya yana iya zama matattarar cutar daga dabba zuwa mutum kuma yana aiki a matsayin matattarar cutar ta hanyar sanya kwayar cutar ta zama mai saurin kamuwa da cutar.
HCoV na iya zama mai saurin lalacewa idan ba za a iya yada shi ta hanyar kwayar halitta ba kafin ya shiga jikin mutum.
Hakanan, HCoVs na iya zama masu haɗuwa da matsakaiciyar matsakaici kuma suna iya zama masu kamuwa da lokaci a cikin shekaru da yawa.
Hakanan, ɗakin da ke tsakiya ya zama ɗakin ɗakin ajiya na farko.
Rahotanni na wannan cutar ya nuna cewa akwai wasu ƙananan ƙwayoyin SARS da suka shiga cikin dabbobin daji.
Binciken da aka yi a kan rayuwar kwayar cutar ya nuna cewa dabbobi masu shayarwa suna da matakan anti-SARS-CoV IgG idan aka kwatanta da na al'umma.
Wasu ƙwayoyin cuta kamar larvae (Paguma larvata) da kuma wasu ƙwayoyin cuta kamar su worms a cikin dabba sun kasance farkon waɗanda suka kamu da SARS-CoV, wanda ke da alaƙa da SARS-CoV.
Wannan ya faru ne saboda rashin tabbacin da aka bayar cewa ba a sake samun rahoton SARS ba bayan da aka kashe nau'in a cikin daji.
Koyaya, sun yi rahoton cewa ƙwayoyin cuta kamar ƙwari na daji ko ƙwayoyin gonaki waɗanda ke shiga cikin ƙwayoyin cuta ta hanyar ido ba su da kwayar cutar SARS-CoV, wanda ke nuna cewa ƙwayoyin cuta na iya zama matsakaiciyar ƙwayar cuta amma ba ainihin SARS-CoV ba.
A cewarsa, yayin da kashi 80% na dabbobi a cikin gonakin Guangzhou suna da rigakafin anti-SARS-CoV, akwai yiwuwar wasu ƙananan dabbobi su zama masu cutar SARS-CoV.
Wannan ya zama babban abin da ya faru a SARS-CoV.
Binciken da aka yi a kan wani kwayar cutar da ke da alaka da SARS-CoV ya gano CoV da ke da alaka sosai da kwayar cutar, wanda ake kira CoVKU3 (SARSr-Rh-BatCoV HKU3) wanda ke da alaƙa da Rhinolophus, wanda aka gano a tsakanin wasu kwari a China.
Kwayar cutar tana dauke da kwayar cutar anti-SARS-CoV da kuma kwayar SARSr-Rh-CoV HKU3 mai suna Bat.
Wannan da sauran CoVs na kwayar cutar suna da kusan kashi 88-92% na kwayar kwayar nucleotide da SARS-CoV.
Cibiyoyin bincike sun gina sababbin hanyoyin da tsuntsaye suke da alamun da suka samo asali daga mutane.
An gano CoVs masu kama da SARS (SL-CoVs) a cikin tsuntsaye, amma babu wanda ya tabbatar da cewa WIV1 zai iya zama mai guba a matsayin kwayar cutar.
Kwayar cutar angiotensin 2 (ACE2) tana da alaƙa da SARS-CoV.
WIV1 da aka samo daga kwayar cutar kwayar cutar ta kwayar halitta ta nuna kwayar cutar kwayar halitta, tare da ACE2 mutum a matsayin mai karɓar mai karɓar mai karɓar mai karɓar.
Duk da haka, ana iya samun ƙwayar cutar ta SARS a cikin marasa lafiya ta hanyar WIV1.
Bugu da ƙari, WIV1 ya nuna cewa SARS-CoVs sun fi kusa da tsuntsaye, suna da kashi 95% na ƙwayar nucleotide.
Duk da cewa akwai kamanceceniya da yawa tsakanin waɗannan ƙwayoyin cuta guda biyu, yawancin mutane sun yi imani da cewa WIV1 ba shine asalin asalin SARS-CoV ba kuma ba shine asalin SARS-CoV ba.
Binciken phylogenetic na samfurin MERS-CoV ya danganta da bambancin jinsin CoV-HKU4 da CoV-HKU5.
CoV-HKU4 da MERS-CoV suna da mai karɓar mai karɓa guda ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da ƙwayoyin cuta.
Kwayoyin RNA na RNA-dependent polymerase na MERS-CoV sun yi kama da su ta hanyar haɗuwa da abubuwan da aka gano a cikin beta-CoVs na ƙwayoyin cuta na Turai da Afirka.
A halin yanzu, ba a gano wani sabon MERS-CoV a cikin tsuntsaye ba.
MERS-CoV da CoV-HKU25 sun yi daidai da kashi 87% na ƙididdigar ƙididdigar ƙididdigar su.
Hakanan, ƙwayoyin cuta ba za su iya zama matsakaiciyar matsakaiciyar MERS-CoV ba.
A wani bangare kuma, binciken da aka yi a Gabas ta Tsakiya ya gano cewa, ana samun ƙwayoyin cuta daga raƙuman MERS-CoV a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra raƙuman ra raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra ra raƙuman ra raƙuman ra ra raƙuman raƙuman raƙuman ra ra ra ra ra ra ra raƙuman ra ra ra ra ra ra ra ra ra ra ra ra raƙuman ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra
An gano MERS-CoV mai kama da kwayar cutar da aka gano a cikin mutum a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra ra ra raƙuman ra ra raƙuman ra raƙuman raƙuman raƙuman ra ra ra ra ra ra ra ra ra raƙuman ra ra ra ra ra ra raƙuman ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra
Hakanan ya kamata a lura cewa yawancin alamun cutar ba su bayyana ba tun lokacin da aka gano ƙwayoyin cuta masu yawa a cikin raƙuman da aka yi wa gwajin MERS-CoV.
Ƙwayoyin cuta masu cutar suna fitar da ƙwayoyin cutar ba kawai ta hanyar numfashi ba amma ta hanyar numfashi da kuma hanci, wanda shine maɓallin farko na fitar da ƙwayoyin cuta.
Koyaya, a halin yanzu akwai wasu maganganu da ke nuna cewa wasu nau'ikan MERS-CoV ba su taɓa yin kama da ƙwayoyin cuta ba kafin bayyanar cututtuka, kamar su cewa an yada su ne daga mutum zuwa mutum ko kuma daga dabba zuwa dabba kuma asalin ƙwayoyin cuta da ke ɗauke da MERS-CoV an gano su.
SARS-CoV-2 yana da kashi 96.2% na ƙwayoyin nucleotide na CoV RaTG13 na ƙwayoyin cuta wanda ƙwayoyin cuta na Rhinolophus affinis suka ware.
Kamar SARS-CoV da MERS-CoV, yanayin bambancin tsakanin SARS-CoV-2 da RaTG13 ya zama dole don hana su daga cutar.
A bayyane yake, ƙwari ba za su iya zama asalin SARS-CoV-2 ba idan an gano CoVs na asali na ƙwari a nan gaba.
Ana sa ran cewa, wata kwayar cutar SARS-CoV-2 za ta kasance a cikin dabbobin da ke da cutar a cikin dabbobin dabbobin da ke da cutar a Huanan Zoo, kuma a cikin abin da yawancin mutanen farko da ke da COVID-19 suka danganta da shi, wanda zai iya nuna cewa cutar ta kamu da cutar daga dabbobi zuwa mutane.
Wani sabon bincike da aka yi a kan ƙwayoyin cuta ya nuna cewa akwai ƙananan ƙwayoyin cuta masu suna pangolin (Manis javanica) waɗanda za su iya ɗaukar beta-CoVs masu kama da SARS-CoV-2.
Sabon kwayar halittar kwayar halittar kwayar halittar kwayar halittar kwayar halitta ta zamani tana da kashi 85-92% na ma'aunin nucleotide na SARS-CoV-2.
Duk da haka, sun fi dacewa da RaTG13 tare da kashi 90% na ƙarancin ƙarancin ƙarancin nucleotide.
Suna da nau'ikan kwayoyin halitta iri ɗaya da na SARS-CoV-2-like virus a cikin asalin su, ɗayan an gano shi ta hanyar mai karɓar mai karɓar mai karɓa (RBD) tare da SARS-CoV-2, tare da kashi 97.4% na amino acid na asali.
Koyaya, RBDs na SARS-CoV-2 da RaTG13 sun fi juna yawa, kodayake ma'aunin kwayoyin halittarsu ya yi kama sosai.
A cikin binciken farko na ƙwayoyin pangolin masu cutar, an gano ƙwayoyin cuta a cikin ƙwayoyin cuta, wanda ya dace da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi guda biyu na haɗin gwiwa da kuma yin amfani da hannayen hannu don samar da wani ɓangaren kwayoyin halittar da ke da kashi 86.3% na ƙwayar kwayar cutar.
Ba za mu iya watsi da cewa binciken da aka yi ya gano cewa pangolin yana ɗaya daga cikin nau'ikan da ke cikin SARS-CoV-2 na farko.
Koyaya, a halin yanzu babu tabbacin cewa pangolin shine asalin SARS-CoV-2 saboda akwai bambancin tushe tsakanin SARS-CoV-2 da beta-CoV SARS-CoV-2-pangolin.
Bugu da ƙari, bambancin tsakanin SARS-CoV-2 da RaTG13 ya fi na tsakanin SARS-CoV-2 da CoV jipangolin da beta-CoV na SARS-CoV-2-pangolin.
Ya kamata a sake nazarin yiwuwar SARS-CoV-2 a cikin tsuntsaye, pangolins da sauran dabbobi.
Kamar yadda mafi yawan kwayoyin halittar da aka gano a cikin RBDs suka haɗa da SARS-CoV-2 da pangolin, beta-CoVs na SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da kwayoyin halittar da aka gano a cikin tsarin su.
Mutane da yawa suna magana game da wannan babban bambanci tsakanin RBD da beta-CoV na SARS-CoV-2 da SARS-CoV-2 suna cikin haɗuwa da haɗuwa.
Wani bincike ya nuna cewa akwai yiwuwar haɗuwa tsakanin beta-CoV SARS-CoV-2 PANGOLIN da RaTG13 a cikin nau'in asali na uku.
A matsayin mai ƙarfi, wannan haɗin yana yaduwa tsakanin beta-CoVs.
Masu bincike sun yi bincike kan nau'in da SARS-CoV-2 ya fito daga.
Bugu da ƙari, HCoV masu saurin kamuwa da cutar, HCoV-229E da HCoV-OC43, HCoV-NL63 da HCoV-HKU1 sun kasance masu bincike.
Binciken asali ya nuna cewa duka HCoV-NL63 da HCoV-229E za su iya fitowa daga CoV na ƙuda, amma an gano ƙwayoyin cuta na asali na HCoV-OC43 da HCoV-HKU1 a cikin ƙuda.
An gano cewa CoV na kwari mai suna ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin kwari na uku na Arewacin Amurka yana da nau'in HCoV-NL63.
A wani bangare kuma, an danganta kwayar HCoV-229E da CoV na tsuntsaye, wanda aka fi sani da Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, kuma an dauki raƙuman kamar cibiyar cutar.
Don ƙarin bayani, ana haɗa ilimin da ake da shi a yanzu game da ƙwayoyin cuta na HCoVs da aka gano a cikin Hoto na 1 da Table na 2.
Binciken da aka yi a baya ya nuna cewa akwai yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwuwar yiwu.
Lokacin da HCoV-OC43 ya sauko daga ƙwari zuwa ƙwari ta hanyar kamuwa da mutum a cikin shekarun 1890, akwai yiwuwar kamuwa da cutar huhu.
Ba a iya gano cutar ba a cikin tarihin HCoV-229E.
An gano nau'in alpha-CoV mai kama da HCoV-229E.
Daga cikin su akwai alpha-CoV alpaka.
Akwai kuma rashin tabbaci da ke nuna cewa cutar ta yadu daga tsuntsaye zuwa ga mutane.
Na farko, mutane da ba alpacas ba za su iya saduwa da tsuntsaye a lokaci guda a rayuwa.
Haka kuma, mutane suna iya yin gasa da alpacas.
Na biyu, alpha-CoV na HCoV-229E ya bayyana ba shi da alamun kamuwa da cuta a cikin tsuntsaye, amma alpha-CoV alpaca ya haifar da kamuwa da cutar huhu a cikin dabbobi da suka kamu da kwayar.
A ƙarshe, an gano alpha-CoV a cikin dabbobin daji.
Saboda haka, ba za a iya cewa al'amuran da ke faruwa a duniya ya sa al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al' amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al' amuran al'amuran al' al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al'amuran al' al'amuran al'amuran al' al'amuran
Koyaya, ƙwayoyin cuta sune tushen ƙwayoyin cuta da ke haifar da cututtukan mutum kamar su rabies, Ebola, Nipah, da Hendra.
Kuma a cikin wannan yanayin, akwai yiwuwar cewa tsuntsaye ne suka kawo HCoV-229e ga mutane ba tare da wata sanarwa ba.
Ko kuma, idan an gano alpha-CoV na dabba a matsayin mai ɗauke da kwayar halittar HCoV-229E, al'amuran al'ada da na kamel za a iya ɗauka su ne masu ɗauke da cutar da ke iya kai mutum ga cutar, kamar yadda yake a cikin MERS-CoV.
MERS-CoV ya zama sanadin yaduwar cutar daga tsuntsaye zuwa al'amuran da ke cikin al'umma da kuma daga al'amuran da ke cikin al'umma zuwa mutane.
An gano yiwuwar watsa MERS-CoV daga ƙudaje a farkon wannan annoba kuma an tabbatar da hakan ta hanyar binciken da aka yi.
A cewar wasu, ƙwayoyin cuta suna aiki ne a matsayin ƙwayoyin cuta ta hanyar watsa kwayoyin halittar jini tsakanin ƙwayoyin halittar da kuma watsawa ga mutane.
Yin jima'i, yin tarayya da ƙungiyoyi, kasancewa a wuri ɗaya da kuma yin iska mai iska duk suna da alaƙa da yin ƙwari da kuma yin amfani da ƙwayoyin cuta a matsayin 'mai watsa kwayar cutar'.
A wani bangare, an gano MERS-CoV a cikin raƙuman raƙumi fiye da sau goma.
Wannan ya yi daidai da yawan adadin da aka yi a cikin ɗakin da ke tsakiyar ɗakin da ke cikin ɗakin farko na ɗakin.
MERS-CoV yana haifar da cututtuka masu tsanani kuma yana sa kwayoyin ba su da wani tasiri.
Cutar cututtukan fata da ke yaduwa a cikin mutane ta zama matsala kuma mutane za su zama ƙarshen rukunin MERS-CoV saboda ba za a iya yin hakan ba.
Ba kamar aikin da ƙwayoyin cuta ke yi wajen watsa MERS-CoV ba, aikin ƙwayoyin cuta, idan akwai, wajen watsa SARS-CoV-2 ya bambanta.
Mafi yawan lokuta, beta-CoVs na kwayoyin cutar suna haifar da rashin lafiya da rashin lafiya.
Ƙila za a iya zaɓar ƙwayoyin beta-CoV na SARS-CoV-2 a ƙarshen, kamar ƙwayoyin cuta da cutar SARS-CoV.
Akwai wasu hanyoyin da za a iya amfani da su don watsa SARS-CoV-2 daga dabbobi zuwa mutane da za a yi bincike a ciki da wajen makarantu a nan gaba.
Da farko, ƙwari na iya zama tushen SARS-CoV-2 wanda ke da alaƙa da SARS-CoV-2.
Mutum na iya samun wani wuri a cikin rayuwarsa tare da tsuntsaye ta hanyar kiwon dabbobi ko kuma rarraba ƙasa.
A takaice, ana iya amfani da kwari a matsayin matsakaiciyar hanyar watsa kwayar cutar SARS-CoV-2 da aka shigo da ita cikin binciken.
Mutum yana iya kamuwa da cutar ta hanyar numfashi da kuma shan kwayoyin cutar ta dabbobi.
Ba a yarda da cewa dabbobi masu shayarwa da dabbobi masu shayarwa na iya kamuwa da SARS-CoV-2 ba.
Binciken da aka yi a kan dabbobi da kuma na daji don likitoci na da nasa manufa.
Na uku, kamar yadda aka ambata a sama, haɗuwa da gwajin SARS-CoV-2 na iya haifar da cutar a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau nau'i nau'i nau'i nau'i nau'i nau nau'i nau'i nau'i nau'i nau'i nau nau'i nau'i nau'i nau'i nau nau'i nau nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau nau'i nau nau nau nau'i nau'i nau nau'i nau'i nau'i nau'i nau nau nau nau'i nau'i nau'i nau nau nau'i nau nau nau nau'i nau'i nau'i nau nau nau nau nau'i nau'i nau nau nau'i nau nau nau nau nau'i nau nau nau'i nau'i nau nau nau'i
An ci gaba da binciken maganin SARS-CoV-2 na likitanci.
Bayan sauran kwayoyin da ke dauke da kwayar cutar, akwai wasu kwayoyin halitta guda uku da ke dauke da kwayar cutar da ke da muhimmanci wajen hana kwayar cutar ta CoV yaduwa.
Tun daga farko, mun san cewa suna sayar da RNA a fili.
Idan aka kwatanta da sauran ƙwayoyin cuta masu RNA guda ɗaya, yawan canjin CoVs ana iya ɗauka a matsayin dehy zuwa dehy tare da matsakaicin canjin canjin daga ~10-4 a shekara a cikin lokaci 2, dangane da ci gaban gwajin CoV a cikin sabon ƙira.
CoVs suna da mai karɓar exoribonuclease, wanda a bayyane yake yana canza yanayin haɓakar haɓakar ƙwayoyin cuta ko kuma mutu.
Abin farin ciki shine, an gano cewa nucleotide na Remdesivir mai kama da juna yana da tasiri a kan CoV ta hanyar kashe exoribonuclease da RNA mai juyawa RNA polymerase.
Remdesivir yana daya daga cikin magungunan SARS-CoV-2 da za a iya gwadawa a cikin bincike.
Duk da haka, yawan adadin masu kamuwa da kwayar cutar ta CoV ya ninka na iyalai sau miliyan fiye da na iyalai na asali.
Duk da haka, yawan adadin cutar ba shi da yawa idan COV ba shi da kyau tare da ɗakin da aka gina.
Idan aka kwatanta da SARS-CoV tare da babban adadin canji, yawan canjin SARS-CoV-2 ya yi ƙasa, wanda ke nufin cewa yana iya yin tasiri ga ƙwayoyin cuta da jikin ɗan adam.
Wannan yana nufin cewa an yi amfani da ƙusa da kuma mai ba da shawara wanda yake kusa da mutum.
Baya ga SARS-CoV-2, wannan ya haɗa da MERS-CoV, wanda ke da alaƙa da raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra ra raƙuman ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra
A wasu kalmomin, ba a iya yin amfani da kwayar halitta don yin rigakafi ko maganin SARS-CoV-2 ba.
Na biyu, mahimmancin kwayar halittar CoVs ya sa an tsara kwayar halittar don sauyawa da kuma haɗuwa, wanda hakan ya sa ya zama mafi sauƙi ga kwayoyin halitta su yi aiki tare, wanda hakan ya haifar da fa'idodi don samar da sabon kwayar cutar CoVs ga masu karɓar ta.
An rufe shi ta hanyar wani ɓangaren jiki kuma an rufe shi da furotin mai laushi ta hanyar 3' na tsakiya.
Na uku, CoVs suna canzawa sau da yawa a cikin kwayar RNA ta hanyar da ake kira "zaɓi-kwafi".
A cikin wannan dakin da ake amfani da shi a matsayin wurin ajiyar kayan aiki, ana iya yin gyare-gyare a lokacin da ake hada RNA.
RNA mai saurin yaduwa da kuma saurin karuwa na iya zama mai haɗuwa don samar da sabbin CoVs.
An gano asalin asalin haɗin gwiwa a cikin HCoV-HKU1 da HCoV-OC43 duka, da kuma CoVs na dabbobi kamar su SL-CoV da CoV-HKU9.
Cirewar ƙwayar cuta ta hanyar yin amfani da maganin rigakafi
Baya ga abubuwan da muka lissafa a baya, cutar tana da muhimmancin gaske a yayin da take yaduwa tsakanin dabbobi da mutane.
A halin yanzu, an dauki haɗuwa da SARS-CoV a matsayin alamar cutar, wanda kuma ya nuna rashin daidaituwa a lokacin watsawa tsakanin dabbobi da mutane.
Bisa ga gwajin gwaji tsakanin SARS-CoV na mutum da na ƙwayoyin cuta da aka gano, SARS-CoV ya bayyana yana canzawa a cikin dabba ko mutum, musamman tare da maye gurbi a cikin rukunin RBD protein S.
A mafi yawan lokuta, RBD a cikin sunadarai S CoV yana haɗuwa da mai karɓar mai karɓar kwayar halitta kuma an zaɓi shi ta hanyar mai karɓar mai karɓa.
A cikin SARS-CoV, RBD ya kasance tsakanin amino acid 318 da 510 a kan layin S1, wanda ke haɗa ACE2 da mai karɓa don shigar da kwayar cutar.
RBD na SARS-CoV na iya zama tushen ACE2 a cikin nau'ikan halittu daban-daban, ciki har da, ƙuda, tururuwa, dabbobin daji da kuma ƙwayoyin daji, wanda ke taimakawa watsa kwayar cutar tsakanin dabbobi da mutane.
A gaskiya, amino acid 6 sun tabbatar da cewa sunadarai ne na kwayar cutar da ke hana mutum ya kamu da cutar a cikin RBD kuma 4 daga cikinsu suna cikin masu karɓar mai karɓar mai karɓar mai karɓar ACE2.
Kwayoyin SARS-CoV suna da K479N da S487T a cikin RBD na shi, wanda zai iya haifar da rashin fahimtar abubuwan da ke tattare da sunadaran sunadarai na mutum.
A cewarsa, waɗannan amino acid guda biyu masu canji ne suka haifar da canjin kwayar cutar a cikin mutum.
Yana da kyau a lura cewa SARS-CoV-2 yana da mai karɓar kwayar cuta ɗaya tare da SARS-CoV.
Bambanci tsakanin kashi 30% na SARS-CoV-2 da SARS-CoV a cikin S1 sun nuna cewa haɗin haɗin S na sunadarai na ACE2 na mutum ya canza.
A gaskiya ma, ƙididdigar cryo-EM ta nuna cewa haɗuwa da haɗuwa ta kasance sau 10 zuwa 20 fiye da tsakanin ACE2 mutum da ACE2 S furotin da SARS-CoV.
Hakanan yana da mahimmanci a gano ko akwai wasu masu karɓa da za a iya ɗauka don magance SARS-CoV-2.
A cikin yanayin da ake ciki, HCoV-NL63 yana da alaƙa da ACE2 amma tare da wani rukunin S.
Akwai wasu masu karɓar HCoV, kamar aminopeptidase N na HCoV-229E, da 9-O-acetylated sialic acid na HCoV-OC43.
Hakanan yana da amfani ga maye gurbin CoVs a cikin mutane bayan an yi musayar su daga dabbobi zuwa dabbobi.
Baya ga masu karɓar sel, ƙarancin watsawar HCoVs a cikin dabbobi da wasu abubuwan da ke cikin gida ba su hana su ba.
Rashin daidaito na sunadaran dake cikin mutum da kuma cikin HCoV kamar tsuntsaye, raƙuma, ko kuma kwari na iya zama wani abu da zai iya hana watsawa tsakanin jinsin.
HCoVs dole ne su kasance a cikin tsarin rigakafi kuma su canza yanayin don kada su iya samun saurin watsawa tsakanin ƙwayoyin cuta.
Hakanan, masu binciken kwayoyin halitta a cikin wani bangare na kwayar cutar dole ne su gano cewa suna da aiki.
Wasu gwaje-gwaje marasa amfani da aka yi a cikin SARS-CoV-2 da kuma maganin hana yaduwar cutar ta hanyar CRISPR za su iya ba da damar haifuwa.
Sabon HCoV: farkon kamuwa da cutar
Halin da ake ciki na CoVs yana ba da dama ga sababbin hanyoyin da za su iya haifar da HCoVs.
Hakanan, kwayar cutar ta CoV ta kwari ta kasance a matsayin kwayar cutar HCoV.
Bugu da ƙari, maye gurbin kwayar halitta da kuma haɗin asali na iya haifar da HCoVs da ke haifar da kwayoyin halitta a cikin wannan tsari.
Alal misali, samun ko rasa sabon kwayar halitta na iya canza kwayar cutar ta hanyar da ta dace.
Daga cikin alluran SARS-CoV, ORF8 ya kasance mai mahimmanci a cikin juyin halitta a cikin mutane, kamar yadda kwayar cutar SARS-CoV ta kasance a cikin gida amma ya kasance yana da lambar wani ORF8 mai mahimmanci.
An gano ɓarkewar nucleotide 29 mai kama da SARS-CoVs a cikin ƙwayoyin cuta na sigtototo a farkon kamuwa da cutar a cikin mutane.
Wannan ƙirar tana tura ORF8 zuwa ORF8a da ORF8b kuma ana sa ran za a iya amfani da su a matsayin sa'a ɗaya ko kuma maye gurbinsa.
Bugu da ƙari, SARS-CoV na iya ƙunsar tarihin hulɗa tare da ƙwayoyin alpha- da gamma-CoV, kuma an gano adadi mai yawa na masu haɗuwa da ƙananan ƙananan ƙwayoyin RNA a cikin RNA polymerase.
An kuma gano wuraren haɗuwa a cikin nsp9, musamman nsp10, da kuma a cikin nsp14.
Duk da haka, an gano cewa cutar MERS-CoV ta haɗa da wasu nau'o'in ƙwayoyin cuta, wanda ya faru a kan raƙuma a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an gano abubuwan da ke tattare da juna a cikin wasu HCoVs, inda HCoVs ke da alaƙa da wasu nau'ikan CoVs na al'ada a cikin kwayoyin halittarsu ba tare da an gano su ba.
Hakanan ya kamata a lura cewa zaɓin zaɓi na iya amfani da shi don canza canjin kwayar halitta, musamman waɗanda suka taso daga ƙwayoyin cuta a cikin zaɓin zaɓi na zaɓi, kamar tsarin karewa.
Wannan ya faru ne saboda wani nau'in ORF4 da ke cikin kwayar HCoV-229E, wanda ke haifar da ɓarkewar kwayar nucleotide guda biyu.
Yayinda aka gano ORF4 mai rai a cikin ƙwayoyin cuta na ƙwayoyin cuta da ƙwayoyin cuta na ƙwayoyin cuta da suka haɗa da HCoV-229E, alphanuclear alphanuclear yana nuna alamar shiga cikin kwayar nucleotide ɗaya, wanda ke haifar da canjin jiki.
A ƙarshe amma ba mafi mahimmanci ba, an hana yaduwar HCoV ta hanyar zaɓin gaggawa a cikin wuraren da aka yi garkuwa.
An gano alamun cutar a lokacin da kwari suka kamu da CoVs, wanda ba a nuna bambancin da ke tsakanin CoVs da kwari ba.
Tsuntsaye kamar tsuntsaye suna hulɗa da CoVs ta hanyar tsarin jikinsu da kuma hanyoyin da suke bi.
Misali, ana iya ganin cewa, hana samar da maganin rigakafi a cikin ƙwayoyin cuta yana rage tasirin cutar da CoV ke haifarwa.
Bugu da ƙari, ƙwayoyin cuta a cikin ƙwayoyin cuta sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun sun kasance sun sun sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun kasance sun sun kasance sun kasance sun sun kasance sun kasance sun kasance sun kasance sun kasance sun sun kasance sun sun sun sun kasance sun sun sun kasance sun sun sun kasance sun kasance sun sun sun sun sun sun sun sun sun kasance sun kasance sun kasance sun sun sun kasance sun kasance sun sun kasance sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun kasance sun sun kasance sun kasance sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun kasance sun sun kasance sun kasance sun kasance sun sun kasance sun kasance sun kasance sun sun sun sun sun kasance sun sun sun sun sun sun sun sun sun
A gefe guda, yawan iskar oxygen (ROS) da ke haifar da aikin abinci a cikin tsuntsaye na iya haifar da kwayar cutar CoV da kuma tasirin kwayar cutar ta hanyar exoribonuclease, wanda ke haifar da saurin kamuwa da kwayar cutar ta hanyar shiga cikin kwayar halitta.
Yawancin CoVs masu saurin kamuwa da cuta suna iya yin haɗuwa, wanda ke haifar da sababbin sunadarai ko sunadarai masu alaƙa da canjin yanayi.
Bugu da ƙari, ba za a iya cewa sabon nau'in HCoV guda uku sun bayyana a cikin shekaru ashirin da suka gabata ba.
CoVs ba sa cutarwa ko kuma suna nuna alamun cutar a cikin masu karɓar su kamar su tsuntsaye da dabbobin gida.
Suna da ƙarfi sosai, ba sa kuma jin wani abu marar kyau daga masu jinya.
A nan ne aka gano wani nau'i na ƙwayoyin cuta da ba su nuna alamun bayyanar cutar ba.
A mafi yawan lokuta, cututtuka na cututtuka suna haifar da amsawar rigakafi da kuma yawan ƙwayar cytokine, wanda a lokacin da rigakafi ya ɓace, ƙwayar cuta ta ƙaruwa.
Duk da haka, a cikin gwajin da aka yi kwanan nan, an gano cewa rigakafin ya kasance mai saurin rigakafin cutar ta CoV.
Irin wannan hanyar rarraba amsar rigakafi na iya zama mahimmanci a cikin maganin anti-SARS-CoV-2.
Wannan interferon yana da tasiri sosai a kan ƙwayoyin cuta.
Hakanan, bayar da maganin interferon na nau'in I a farkon lokacin SARS-CoV-2 a cikin mutane ba zai zama mai amfani ba.
Duk da haka, ba a yarda da cewa tsuntsaye suna da haɗari ga NLRP3 ba.
Bisa ga wannan, maganin NLRP3 inflammasome tare da MCC950 na iya zama mai amfani a cikin maganin COVID-19.
SARS-CoV-2 yana da alamun ƙwayar ƙwayar ƙwayar cuta kuma SARS-CoV da MERS-CoV sun fito.
Yayin da aka gano kashi 95% na kwayar nucleotide da SARS-CoV, akwai kuma kashi 96% na kwayar nucleotide da SARS-CoV-2 na CoVs.
A lokacin da aka gano cewa tururuwa da wasu dabbobi a cikin daji suna da kwayar cutar SARS-CoV a cikin jikinsu, an gano asalin kwayar cutar SARS-CoV-2.
An gano Beta-CoVs na pangolin da ke da alaƙa da SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama matsakaiciyar matattarar matattarar ko kuma beta-CoVs na iya zama ko kuma su zama tushen asalin SARS-CoV-2.
Ko da kuwa akwai alamun, ba a tabbatar da cewa SARS-CoV-2 na iya kamuwa da mutum ta hanyar cuta ko kuma ta hanyar kwari ba.
An sake samun CoVs sakamakon gano sabuwar kwayar cutar SARS-CoV-2.
Nazarin CoVs a cikin ƙwayoyin cuta da sauran dabbobi ya canza tunaninmu game da amfanin ganowa daga ƙwayoyin cuta da kuma wuraren ajiyar HCoVs a cikin maganin mutum.
Tabbacin gani ya nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga ɓeraye kuma sun kamu da mutane ta hanyar wasu ƙwayoyin cuta.
Tun da SARS-CoV ya samo asali ne daga hulɗar mutum da ƙwari a cikin gonaki, rufe gonaki da sayar da ƙwari da kuma sanya ƙwari a ciki na iya hana yaduwar SARS.
A karkashin wannan ra'ayi, ana iya cire pangolin daga cikin gida don hana su kamuwa da cutar, kamar yadda aka nuna a cikin wani bincike da aka yi game da beta-CoVs masu dauke da pangolin da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 na iya watsawa daga mutum zuwa pangolin ko wasu dabbobi kuma ya kamata a bincika a cikin bincike na gaba.
A wani ɓangare, MERS-CoV ba shi da alaƙa da ƙwayoyin cuta na asali.
Waɗannan motocin suna da amfani sosai wajen sufuri da kuma jigilar kaya, suna ba da abinci, sutura, da kuma kula da al'umma.
An rarraba su ko'ina a Gabas ta Tsakiya da Afirka.
Ba za a iya kashe dukkan raƙuman ba don kamuwa da MERS, kamar yadda aka yi a cikin dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don magance matsalar cutar MERS, an samar da wasu hanyoyin samar da rigakafin MERS-CoV na al'ada, da kuma hanyoyin hana sauran cututtukan.
Saboda ba za mu iya kamuwa da cutar ba, wasu nau'in genotypes na iya zama masu iya haifar da wasu cututtuka.
Kwayar cutar CoV ta kamuwa da cutar a cikin daji.
Mafi yawan lokuta, ana samun CoVs da ke iya haifar da kwayar cuta.
Akwai wasu hanyoyin da za a iya amfani da su don hana CoVs da ke kamuwa da ƙwayoyin cuta yin haɗuwa da juna, da kuma hana sabbin CoVs daga kamuwa da cutar da kuma/ko kashe mutane nan gaba.
Ba a cin nama a wasu sassan kasar Sin don rage hulɗar mutum da dabbobi.
Tare da SARS, MERS da COVID-19, ya zama dole a tsara da kyau kuma a sami tsarin amsawa mai dacewa.
Tabbas, yawancin ƙwayoyin cuta suna rayuwa ne a ƙasa da muka taɓa.
Suna cikin ɗakunan su lokacin da aka raba su.
Duk da cewa tsuntsaye suna da damar yada ƙwayoyin cuta, yawan lokacin da mutane ke tare da tsuntsaye da sauran dabbobi zai iya raguwa idan mutane suka saba da su.
Binciken rigakafin a cikin dabbobi zai taimaka wajen gano ƙwayoyin CoVs da kuma yanayin rayuwarsu, wanda zai iya zama mai tasiri a kan yiwuwar kamuwa da cutar daga dabbobi zuwa mutane da kuma yiwuwar kamuwa da cutar nan gaba.
A ƙarshe, hanya mafi kyau ta hana yaduwar kwayar cutar daga dabbobi zuwa mutane ita ce ta hanyar samar da wuraren da kwayar cutar ke rayuwa.
Ba a sami bayanai da yawa game da asalin asalin SARS-CoV-2 a cikin dabbobi ba.
Da farko, idan tsuntsaye sun ba da SARS-CoV-2 ga kangaye, zai zama da muhimmanci a gano yadda tsuntsaye da kangaraye suke da dangantaka ta al'ada.
Na biyu, idan dabba ta kasance mai cutarwa ga mutum, yadda mutum ya yi hulɗa da dabba ya kamata a kula da shi.
Na uku, idan akwai dabba a cikin dabba na uku, wannan dabba zai zama mai tsaro na tsakiya, kuma zai iya zama mai tsaro ga sauran dabbobi, ciki har da mutum, tsuntsaye, da kuma pangolins.
A ƙarshe, yayin da dabbobi da dabbobin gida da yawa na iya zama masu dauke da SARS-CoV-2, ya kamata a yi sa ido da bincike na cutar.
Ko dai kwari ne, ko pangolin ko wata dabba, ya kamata mu lura cewa SARS-CoV-2 ko kuma magabata ba sa yin amfani da masitin a cikin dakin ajiyar farko.
Bincike mai zurfi a cikin yankin zai tabbatar da yaduwar SARS-CoV-2 a cikin dabbobi, da kuma ƙarin hanyoyin rigakafi da gwajin COVID-19 a cikin mutane.
Samun hanyar gano "mai yiwuwa" da "tabbatacce" COVID-19 ya zama dole.
A ranar 6 ga Fabrairun 2020, ƙungiyarmu ta ba da sanarwar rashin daidaito game da takaddun shaida da maganin cutar coronavirus 2019 (2019-nCoV) kuma wannan takaddar ta bayyana ƙwarewarmu da dabarunmu na yau da kullun don magance cutar.
Koyaya, cutar coronavirus 2019 (COVID-19) sabon abu ne, kuma shirinmu da dabarunmu suna da mahimmanci don samar da sakamakon bincike da alamun da ke tattare da cututtukan asibiti; haka kuma, ana bincika hanyoyin bincike da magani akai-akai.
A cikin wannan labarin, mun amsa wasu tambayoyi game da labarinmu da kuma game da sababbin hanyoyin bincike na "mai yiwuwa" da "mai yiwuwa" kamar yadda aka bayyana a cikin Dokar Kulawa da Kulawa na COVID-19 (sake sakin layi na huɗu) da Kwamitin Lafiya na China ya fitar.
A watan Disambar 2019, sabon coronavirus 2019 (2019-nCoV) ya haifar da wata cuta, wanda a yau aka sani da cutar coronavirus 2019 (COVID-19) kuma wannan kwayar cutar ta kasance nau'in cutar respiratory coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, WHO ta ayyana COVID-19 a matsayin annoba ta duniya.
Don tabbatar da cutar SARS-CoV-2, hukumarmu ta ba da sanarwar cewa an gano wasu ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarkewar ɓarke
Wannan ya shiga cikin haƙƙin ɗan adam tun daga lokacin da aka haifi mutum.
Ko da yake cutar ta COVID-19 ba sabon abu ba ne, shirinmu da shawarwarinmu sun fi muhimmanci saboda sakamakon bincike da kuma kulawar asibiti; haka nan, hanyoyin bincike da magani sun fi dacewa.
Misali, rahoton Kula da Kula da Cutar COVID-19 da Kwamitin Lafiya na Kasa na China (http://www.nhc.gov.cn/) ya fitar, tsakanin 6 ga Janairun 2020 da 3 ga Maris 2020, ya fitar da bincike shida da kuma wasu bayanan da aka sabunta.
A halin yanzu mujallarmu ta sami amsa daga Zhou et al., suka yi amfani da kayan aiki don ba da takardun shaida ga abin da suka koya a asibiti.
Wannan aikin yana nuna sabon abu a cikin mujallarmu kuma yana nuna mahimman bayanai game da cutar.
Da godiya mai yawa muke karɓan wannan amana da aka danƙa mana.
Amma kuma aikin ya buƙaci gwaji kamar yadda aka lissafa a cikin Dokar Kulawa da Kulawa na COVID-19 (Shirin da shida na Dokar Cirewa) da kuma sababbin makarantu.
A ranar Alhamis 3 ga watan Maris na shekarar 2020, don a iya tantance mutum a matsayin wanda ke da cutar, ya kamata a hada bayanan da suka shafi tarihin cutar da kuma alamomin da ke tattare da ita don a iya yin gwajin gaba daya, ko kuma a hada bayanan alamomin guda uku idan babu wani tarihin cutar da aka gano:
Bayanan kamuwa da cutar: (1) tarihin tafiya ko zama a Wuhan da kewayenta, da kuma al'ummomin da aka samu masu dauke da COVID-19 a cikin kwanaki 14 kafin bayyanar da alamun cutar; (2) tarihin hulda da mutanen da suka kamu da SARS-CoV-2 (tare da gwajin nucleic acid mai inganci); (3) tarihin hulda da mutanen da suka kamu da cututtukan jiki ko alamun numfashi a Wuhan da kewayenta, ko kuma al'ummomin da aka samu COVID-19 a cikin kwanaki 14 kafin bayyanar da alamun cutar; (4) tarihin kamuwa da cutar da kuma gano alamun cutar (tare da samun masu dauke da COVID-19 da kuma/ko masu dauke da cutar a cikin makonni 2 kafin bayyanar da alamun cutar a makarantu, gidaje, aiki, makaranta, ko wasu wurare).
Alamomin cutar: (1) rashin lafiya/rashin lafiya na numfashi; (2) bayyanar cututtuka na COVID-19; (3) yawan jini a cikin jini, rashin jini, ko kuma yawan ƙwayar lymphocyte a farkon kamuwa da cutar.
A ƙarshe, an tabbatar da cewa an sami ƙwayoyin cuta masu cutarwa ta hanyar gwajin PCR da aka yi da ƙwayar cutar ko ƙwayar cuta ta jiki kamar haka: (1) PCR da aka gwada ya nuna cewa an sami SARS-CoV-2; (2) sashin kwayoyin halittar kwayar cutar ta nuna cewa akwai babban alaƙa da sabon coronavirus da aka sani; (3) an sami ƙwayoyin IgM da IgG na musamman don SARS-CoV-2 a cikin gwajin ƙwayar cutar jini; ko kuma an sami canjin ƙwayoyin IgG na musamman don SARS-CoV-2 ko kuma an sami canji, wanda ya ninka sau 4 a cikin ƙwayoyin cuta na yau da kullun ko na yau da kullun.
Ana iya yin gwajin PCR don nucleic acid a cikin huhu ko kuma ƙwayoyin jini na baya a cikin sashi na biyu (18 ga Janairu 2020) da na uku (22 ga Janairu 2020).
An kara yawan ƙwayar jini a cikin jini a cikin kashi na huɗu (27 ga Janairu 2020) da na shida (8 ga Fabrairu 2020); kuma an ƙara yawan jini a cikin kashi na bakwai.
Wannan ci gaba na ci gaba da aikin bincike na yau da kullum ya sa ya zama dole a sami na'urori masu amfani da nucleic acid don gwaji mai zurfi, tare da samfurori da aka dauka daga numfashi da jini, da kuma sauran kwayoyin halitta, da kuma ƙwayoyin halitta waɗanda suka zama masu amfani da kwayoyin halitta a cikin tsarin da aka tsara.
Duk da haka, akwai wasu alamun da ke nuna cewa akwai ƙarin ƙwayoyin cuta da ke haifar da su wanda ya sa ya zama dole mu kula da marasa lafiya tare da bayyanar cututtuka ko rashin bayyanar cututtuka.
Bugu da ƙari, an yi la'akari da matakin Zhou et al., wanda ya nuna cewa mutanen da ba su da alamun cutar sun kasance "masu tsufa".
Hakanan ya kamata a bincika tsarin ƙididdigar ƙididdiga a cikin ma'aikata da makarantu.
A ƙarshe, muna fatan cewa sakamakon ya kasance mai ban sha'awa kuma yana kira ga dalibai su ba da ra'ayi game da shi.
Don bincika "masu iya mallaka" da "masu iya mallaka", muna ba da shawarar shiga da kuma bin sabbin ƙa'idodin ƙasashensu.
Ƙungiyarmu za ta ci gaba da sanar da ku duk wani sabon bayani game da shirinmu na tallafi.
Bangladesh ta ba da rahoton mutuwar mutum shida sakamakon COVID-19, wanda ya yi sanadiyar mutuwar mutum shida.
Kenya da Bangladesh sun ba da rahoton sabbin mutane shida da suka mutu sakamakon COVID-19 a rana guda.
Wannan shi ne mafi yawan adadin mutanen da suka kamu da cutar a rana guda.
A cikin watan Nuwamba, Bangladesh ta Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike (IEDCR) ta ba da rahoton adadin mutanen da suka kamu da cutar wanda ya nuna cewa mutum 114 sun kamu da cutar kuma 33 daga cikin wadanda aka yi wa allurar rigakafin sun kasance a gida.
An yi rahoton kimanin mutane 17.
A cikin wani jawabi da aka yi a kafofin watsa labarai na duniya, mai kula da IEDCR, Dr Meerjady Sabrina Flora, ya ce a cikin wadanda suka mutu akwai maza hudu da mace daya.
A cewar Dr. Meerjady, biyu daga cikin marasa lafiya sun kasance shekaru bayan 60, biyu tsakanin 51 da 60 kuma daya tsakanin 41 da 50.
Ya kuma ce biyu daga cikin wadanda suka kamu da cutar sun fito ne daga Dhaka.
Kungiyar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibitin ya shaida wa Anadolu Agency, wata ƙungiyar 'yan jarida na yankin, cewa daya daga cikin wadanda aka kashe shi ne Jalal Saifur Rahman, shugaban hukumar da ke yaki da cin hanci da rashawa ta Bengali, wanda ke kwance a asibitin asibitin Kuwait Maitree.
A ranar Lahadi, a cikin wani rahoto na kasa da kasa, Babban Ministan Sufurin Jiragen Ruwa da Bridges na Bangladesh Obaidul Quader ya ba da sanarwar cewa za a dakatar da ayyukan jama'a a ranar Lahadi mai zuwa.
An fara wannan yaƙin neman 'yanci a ranar 26 ga Maris, sai kuma ya ƙare a ranar Asabar, 4 ga Afrilu.
Ana bukatar kayan abinci, magani, ruwa da abinci.
An fara samun mutum biyu da suka kamu da COVID-19 a Bangladesh a ranar 8 ga Maris, mutum biyu da suka dawo daga Italiya da mace ɗaya.
A ranar 19 ga watan Maris, dukkansu uku sun mutu.
SARS-CoV-2 ya haifar da fiye da miliyan 1 na kamuwa da cutar a duniya.
A ranar Alhamis, adadin mutanen da suka kamu da SARS-CoV-2 a duniya ya kai miliyan ɗaya, a cewar bayanan Jami'ar Johns Hopkins.
A kalla mutum dubu 52 ne suka mutu sakamakon COVID-19, cutar da ke haifar da kwayar cutar coronavirus.
An samu ci gaba sosai a wannan rana inda Malawi ta ba da rahoton bullar cutar coronavirus da kuma Zambia ta ba da rahoton cutar.
A ranar Litinin, Koriya ta Arewa ta ce tana daya daga cikin kasashen da ba su kamu da cutar coronavirus a halin yanzu a duniya.
A Kenya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da aka tabbatar da cutar, da kuma mutane 79,332 da suka kamu da cutar a ranar 4 ga Afrilu da misalin karfe 10:00 na yammacin Turai ta Tsakiya (0800 UTC).
A Amurka, an gano mutane fiye da 244 da suka kamu da cutar coronavirus, kuma an kiyasta mutuwar mutane aƙalla 5,900.
Rahoton CBS ya ce, bisa ga ayyukan Jami'ar Johns Hopkins, akwai fiye da mutane 1,000 da suka mutu a ranar Laraba sakamakon cutar coronavirus a Amurka.
A duk faɗin duniya, ƙasashe sun yi gargadin gaggawa game da yadda za a magance wannan cuta.
A ranar Alhamis, Sergei Sobyanin, wani dan kasar Moscow, ya kara da cewa ya yi barazanar barin kasar a ranar 1 ga Mayu.
A wani jawabi da ya yi wa manema labarai, Shugaban kasar Rasha Vladimir Putin ya ce mutanen Rasha za su ci gaba da karbar albashin su duk da cewa ba za su je aiki ba har sai ranar 30 ga watan Afrilu.
Majalisar dokokin Portugal ta yanke shawarar tsawaita dokar ta baci ta tsawon kwanaki 15; zaɓen ya ci nasara da mutane 215 da suka goyi bayan amincewa da shi, mutane 10 ba za su goyi bayansa ba, kuma mutum ɗaya ne kawai ya goyi bayan hakan.
Saudi Arabiya ta ba da umarnin hana zirga-zirga a cikin biranen Makka da Madina har sai an yi sallah; a baya, dokar ta fara aiki ne daga karfe 3 na safe zuwa 6 na safe.
Thailand ta kafa dokar hana fita daga ranar 10 na dare zuwa 4 na safe.
Gwamnan Ohio Mike DeWine ya sanar da gwamnati cewa jihar ta janye dokar kulle a ranar 1 ga Mayu.
Kasuwanci a Australia ya ragu saboda karuwar karamin ɗaki.
A ranar Talata da Asabar, kamfanonin Woolworths da Coles na Ostiraliya sun yi nasarar rage farashin kaya zuwa kashi biyu na kayan abinci da kuma kaya daya zuwa kashi biyu na kayan abinci a duk fadin kasar.
ALDI ya kuma samar da wani tsari na musamman, wanda ya fi dacewa da na Altine.
Wadannan hanyoyin sun kasance a matsayin bayanai a cikin shafin biya, wanda Facebook ya ɓoye.
An ba da shawarar yin amfani da kayan aikin gida don kauce wa COVID-19 idan akwai yiwuwar rashin gida.
A ranar Laraba, Woolworths ya kuma yi niyyar rage yawan kayan da ake sayar wa gidaje ta hanyar raba su da juna.
Wannan ya biyo bayan wani hari da aka kai wa wasu fakitoci hudu da aka kai Woolworths da Coles a ranar 4 da 5 ga watan Maris.
Coles, a cikin sanarwar da ta fitar a ranar 8 ga Maris, ta ce barazanar sake fasalin da aka yi a kan wasu kayayyaki huɗu, "a halin yanzu ana fama da rikice-rikice tsakanin masu cinikin guda ɗaya", kuma ta kira wannan "ba daidai ba", yayin da ALDI, ta hanyar sanarwar da ta fitar a shafinta na Facebook a ranar Talata, ta kira wannan "ba daidai ba".
Wani mai siyar da kayayyaki na Woolworths ya ce tallace-tallace sun "ƙara yawa" a makon da ya gabata.
Wani kantin sayar da abinci mai tsada da ke Canberra ya kuma rage farashin kayayyaki zuwa kashi biyu a mako mai zuwa.
Don rage jinkiri, Coles ta ba Coles kunshin kayan abinci daga masu sayen da ke ba da kayayyaki, kuma Woolworths ya ba da ƙarin kayan sayarwa, yayin da ALDI ya ba da damar shirya kayan don sayen ranar Laraba.
Russell Zimmerman, shugaban kungiyar masu sayar da kayayyaki ta Australiya, ya ce masu sayar da kayayyaki sun yi kokarin kara yawan farashin kayayyaki, amma dokokin da aka kafa na hana sayar da kayayyaki a gida sun hana hakan.
Ya yi zaton cewa samar da kayayyaki zai kara tsada, saboda mutanen da ba sa yin hakan za su iya samun kansu, kuma ba za a sayi kayayyaki da yawa ba.
A ranar Talata, ALDI ta sanar da cewa saboda matsalar samar da kayayyaki, wasu kamfanoni ba za su iya yin wannan kira ba a ranar Laraba.
A wani rahoto da News.com.au ta wallafa, Dr Gary Mortimer, wani masanin kasuwanci a Jami'ar Fasaha ta Queensland, ya ce kamfanoni suna yin amfani da na'urori masu amfani da hasken rana.
Ya bayyana cewa wani ɗan gajeren lokaci na gidan yana da wani abu mai ban mamaki, wanda ya rage yawan kaya a cikin shagon, kuma, idan lokacin ya ƙare, ya bar wani sashi marar amfani, wanda ya haifar da rashin jin dadi.
Cooes and Woolworths sun yi amanna [da] cewa idan akwai kaya masu yawa a cikin shagon, inda abubuwa kamar su kayan kwalliya da kayan wanki za su iya [samu] kuma za a iya samun wadataccen kaya, za ku iya samun wadataccen kaya, in ji Russell Zimmerman a ABC News.
Wani mai sayar da littattafai na Who Gives a Crap ya ce a ranar Laraba cewa an gama sayar da kayayyakin.
Kimberly-Clark, wanda ke yin Kayan wanka na Kleenex, da Solaris Paper wanda ke yin Sorbent, sun ce suna aiki 24/7 don kayan aiki, a cewar News.com.au.
Domain.com, wani gidan yanar gizon sayen gidaje da kuma tallace-tallace, ya ruwaito cewa masu sayar da gidaje suna ba da kyauta ga masu amfani da farko a Melbourne, yayin da kayayyaki ke da yawa saboda masu amfani ba su da lokaci a lokacin hutun hutun hutun ranar Lahadi.
Labaran Alhamis NT News, wata wasiƙa da aka aika a Darwin, da kuma wasu haruffa shida da aka aika don zuwa gidan yarin.
Kasuwanci na fama da matsalar rashin isar da sako, a cikin rahoton ABC Australia na 3 ga Maris inda suka bayyana cewa ba su da wata hanyar da za su iya hana mutane fitar da kayayyakin.
Russell Zimmerman ya kara da cewa mutane suna amfani da wasu abubuwa masu yawa, kamar su, kayan wanka, kayan hannu, kayan ado, kayan wanke hannu, da kuma kayan ado.
Amma, a wajen Australia, a ranar Talata da dare, wani dillalin Birtaniya mai suna Ocado ya sami kansa ya rage yawan kayan da ake sayarwa a gidan Andres zuwa kashi 12 cikin dari.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Lahadi, Hukumar Lafiya ta Duniya (WHO) ta bayyana cewa cutar COVID-19, wanda ke haifar da kwayar cutar SARS-CoV-2, ta zama annoba.
Yayin da kalmar "duniyar duniya" tana nufin yanayin yaduwar cutar a cikin ƙasa, ba don ta fi muni ba a wani wuri, WHO ta ba da shawarar amfanin sanar da gwamnatoci yadda yanayin cutar ke a wani wuri, WHO ta ba da shawarar cewa gwamnatoci su yi aiki:
Duk ƙasashe za su iya sauya yanayin annobar.
"Ya kamata ƙasashe su yi bincike, su ba da magani, su ba da horo, su ba da shawara, su kuma ba da umarni ga al'ummarsu su ba da amsa", in ji Tedros Adhanom Ghebreyesus, Babban Daraktan WHO.
Muna da alhakin duk wani nau'i na lalacewar lalacewa da kuma lalacewa da mutane ba sa amfani da su.
A cewar Dokta Tom Frieden, tsohon shugaban cibiyar kula da cututtuka ta Amurka, wannan ba sabon abu bane.
Ya ce, a cikin wani rahoto da CNN ta fitar a watan Fabrairu, bayan wasu shekaru, "ba a gano wata sabuwar cutar huhu ba sakamakon gaggawar da aka yi wajen ganin an ci gaba da yaduwar cutar a duniya".
Ghebreyesus ya yi magana a cikin wannan hanya, yana mai cewa, "Ba za mu taɓa fuskantar annoba ta coronavirus ba".
Ya ci gaba da cewa, "Ba mu taba fuskantar wata annoba da za mu iya warwarewa nan take ba".
Sabuwar yanayin lokacin annobar ta biyo bayan sanarwar WHO a watan Janairu cewa cutar ta zama larurar lafiya ta duniya.
A cewar wani jami'in bincike na cibiyar nazarin cututtuka ta Amurka, Dr. Anthony Fauci, "Gaskiya ba ta da kyau".
Tun daga ranar Talata, Associated Press ta ba da rahoton cewa akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duniya, wanda ya kashe mutane 4,600.
Cutar coronavirus ta 2019-20 ita ce annobar cutar coronavirus ta 2019 (COVID-19), wadda cutar sankara mai saurin yaduwa ta SARS-CoV-2 ta haifar.
Cutar ta bulla ne a Wuhan, China, a cikin Disamba 2019, kuma ta zama wata dokar ta-baci ta Majalisar Dinkin Duniya a ranar 30 ga Janairu, 2020, kuma ta zama annoba a duniya a ranar 11 ga Maris, 2020.
Tun daga 10 ga Afrilu, 2020, an yi rahoton kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a cikin ƙasashe da yankuna 210, kuma sun kashe kusan mutane 97,000.
Yawan mutanen da suka ci kuwa mutum dubu ɗari uku da dubu arbaʼin ne.
Yawan mutuwar ya ragu da kusan 4% a China, amma ya kasance tsakanin 13.04 a Algeria da 0.08 a New Zealand.
Alamar cutar ta kasance da rashin nutsuwa, rashin jin daɗi da rashin numfashi.
Matsaloli na iya haɗawa da pneumonia da kuma ciwon huhu.
Lokacin daga kamuwa zuwa bayyanar cututtuka shine kusan kwanaki shida, amma tsakanin kwanaki shida da goma sha huɗu.
Babu rigakafi ko magani da aka sani da zai iya kashe cutar.
Hanyoyin da za a iya amfani da su wajen hana kamuwa da cutar sun hada da wanke hannu, rufe baki yayin da ake shan magani, nisantar yin hulda da sauran mutane, da kuma nisantar da mutanen da ake zargi da kamuwa da cutar.
Gwamnatoci a duniya sun amsa ta hanyar hana zirga-zirga, hana fita daga gida, dokar hana fita daga gida, hana fita daga aiki, da rufe wurare.
Annobar ta shafi rayuwar jama'a da tattalin arziki, ya shafi wasanni, harkokin siyasa da wasanni, da kuma rage yawan abinci a kasuwa saboda mutane sun damu da cewa wasu za su iya kawo karshen su.
Makarantun ko jami'o'i suna buɗe a duk faɗin ƙasar ko a cikin yanki a cikin ƙasashe 193, wanda ke ɗaukar kashi 99.4 na yawan ɗaliban duniya.
Bayanai game da cutar sun yadu sosai, kuma sun haifar da matsaloli da dama da suka haɗa da rashin fahimta ko ra'ayi game da mutanen China, wasu ƙasashen Gabas ta Tsakiya da kuma mutanen da suka kamu da cutar a kudu maso gabashin Asiya, da kuma wasu daga yankunan da cutar ta fi yawa.
Saboda raguwar sufuri da kuma rufe masana'antu, an samu raguwar iska mai gurɓataccen iska da kuma gurɓataccen iska.
Jami'an kiwon lafiya a Wuhan, China (birni na farko a lardin Hubei) sun ba da sanarwar kamuwa da cutar huhu ta farko a ranar 31 ga Disamba, 2019, kuma an sake gudanar da wani bincike a farkon Janairu, 2020.
Yawancin mutane sun kamu da cutar ne a kasuwar sayar da kayan kifi ta Huanan Seafood Wholesale Market kuma ana tsammanin cewa cutar ta samo asali ne daga dabbobi.
Wannan kwayar cutar ta haifar da cutar SARS-CoV-2, sabon kwayar cutar da aka gano ya hada da coronavirus, pangolin coronavirus, da SARS-CoV. An gano mutum na farko da ke nuna alamun cutar a ranar 1 ga Disamba, 2019, kuma ba a san shi da yawa a cikin dabbobi da ƙwayoyin cuta ba.
A cikin farkon kamuwa da cutar da aka ruwaito a cikin Disamba 2019, kashi biyu bisa uku sun kamu da cutar.
A ranar 13 ga Maris, 2020, wani rahoto da muka karanta a South China Morning Post ya ce an gano wani sabon mutum a ranar 17 ga Nuwamba, 2019, wani mutum mai shekaru 55 a lardin Hubei, wanda mai yiwuwa ne farkon wanda aka gano da cutar.A ranar 26 ga Fabrairu, 2020, WHO ta ba da sanarwar cewa, yayin da aka samu sabbin kamuwa da cutar a China amma aka ci gaba da samun karuwa a Italiya, Iran, da Koriya ta Kudu, adadin wadanda aka kamu da cutar a wajen kasar Sin ya zarce na wadanda aka kamu da su a cikin kasar Sin a karon farko.
Akwai wasu kungiyoyin bayanai da ba a bayyana su ba, musamman a tsakanin wadanda ke da alamun cutar.
A ranar 26 ga Fabrairu, an ba da rahoton mutuwar mutane masu shekaru 19 zuwa sama, wanda ya kai kashi 2.4% na masu kamuwa da cutar a duniya.Shugaban masanin ilimin ilimin likitancin Birtaniya, Patrick Vallance, ya yi imanin cewa kashi 60% na Birtaniya ya kamata a kamu da cutar kafin a iya samun kariya ta al'ada.
Masu cutar sune adadin mutanen da aka gwada sun kamu da COVID-19, kuma ba a tantance su ba a matsayin masu cutar a cikin bayanan gwamnati.
A ranar 23 ga watan Maris, babu wata kasa da ta taba daukar sama da kashi uku na al'ummarta, kuma kasashen da suka samu manufofin gwamnati na kula da wadanda ke da cutar ta HIV sun hada da Italiya da Netherlands da Spain da kuma Switzerland.
A cikin rahoton da aka fitar a ranar 16 ga Maris, China ta ba da rahoton cewa, a ranar 23 ga Janairu, kashi 86% na masu cutar sun kamu da cutar COVID-19, kuma adadin wadanda aka ba da rahoton sun kasance a matsayin kashi 79% na masu cutar.
Wani rahoto da aka fitar a ranar 30 ga Maris ya ce adadin masu kamuwa da cutar a Italiya ya fi na sauran kasashen da aka ruwaito.
Sakamakon gwajin farko na farko (R0) na COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da Hukumar Kula da Cututtuka ta yi ya nuna cewa cutar na iya kaiwa 5.7.
Yawancin mutanen da ke da COVID-19 ba sa jin daɗi.
A cikin mutanen da suka kamu da cutar, tsawon lokacin bayyanar cututtuka ya kasance tsakanin kwanaki 6 zuwa 41, kuma mafi yawa a cikin kwanaki 14.
Ya zuwa 10 ga Afrilu, 2020, kusan mutane 97,000 sun mutu sakamakon COVID-19.
A China, daga ranar 5 ga watan Fabrairu, kusan kashi 80 na dukkan mutuwar yara ne 'yan ƙasa da shekara 6 da haihuwa, kuma kashi 75 na masu fama da cututtukan zuciya da na ciwon sukari. Rahotannin hukuma game da mutuwar da aka yi daga COVID-19 sun fi mayar da hankali ne kan mutanen da ba su da wata alama ta COVID kamar yadda aka lissafa a cikin takardun gwamnati.
Yawan mutuwar COVID-19 na iya zama ƙasa da ƙasa, idan ba a haɗa da mutanen da suka mutu ba tare da gwaji ba, misali, a gida, a cikin asibiti, da dai sauransu.
Bayanai daga Italiya sun nuna cewa yawan mutuwar da aka samu a lokacin annobar ya ninka wanda aka samu daga COVID-19 sau 4-5 fiye da yadda aka samu a yanzu.
Rahoton Ƙungiyar Kula da Cututtuka ta Amurka (CDC) ya lura cewa "Mun yi la'akari da cewa [haifukan mutuwa] sun kasance ƙananan ƙididdiga", kuma wasu rahotanni sun nuna cewa a Amurka an yi la'akari da cewa raguwar da yawa a cikin annobar ƙasa, kamar yadda ya faru da cutar H1N1 a 2009. An gano farkon cutar a Wuhan a ranar 9 ga Janairu, 2020.
A ranar 1 ga watan Fabrairu ne aka fara samun mutum daya da ya mutu a kasar Sin, a kasar Philippines, kuma a ranar 14 ga watan Fabrairu ne aka fara samun mutum daya da ya mutu a kasar Faransa.
A ranar 28 ga Fabrairu, bayan da aka yi a China, an yi asarar rayuka fiye da dozin biyu a Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga Maris, fiye da kasashe da yankuna 40 sun ba da sanarwar cewa za a yi wani taro na duniya a kan Antarctica.
Wadannan ƙididdigar sun bambanta dangane da yanki da lokaci, yawan gwajin da aka yi, ingancin asibitin, tsarin magani, tsawon lokacin da cutar ta fara, da kuma bambance-bambance a cikin al'umma kamar shekaru, rashin lafiya, da kuma lafiyar jiki gaba ɗaya.
Bisa ga ƙididdigar Jami'ar Johns Hopkins, yawan mace-mace a kowace shekara ya kasance 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Yawan ya bambanta dangane da yankin.
A China, yawan mutuwar mutum ya ragu daga 17.3% (a cikin waɗanda suka kamu da cutar daga 1-10 Janairu 2020) zuwa 0.07% (a cikin waɗanda suka kamu da cutar bayan 1 ga Fabrairu 2020).[1] Sauran hanyoyin sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gwada sun mutu, wanda ya danganta da cutar da yawan mutuwar mutum (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (da kuma yawan mutuwar) wanda ya danganta da cutar.
Wadannan ƙididdiga suna ci gaba da kasancewa a cikin lokaci kuma suna ci gaba da kasancewa a cikin al'umma don cutar ta hanyar maganin cutar.
Yawancin masana sunyi ƙoƙarin gano waɗannan ƙididdigar a cikin al'ummomin da aka sani.
Jami'ar Oxford ta Centre for Evidence-Based Medicine ta gano cewa yawan mace-mace daga cutar a tsakanin 0.1% da 0.39%.
Wannan ya yi daidai da sakamakon da aka samu a gwajin farko na COVID-19 a Jamus, kuma binciken da aka yi ya nuna cewa gwajin ya dogara da CFR.
WHO ta ce wannan zai iya kawo karshen cutar a wannan kasa.
Ba za a iya tantance lokacin da za a yi ba daidai ba kuma yana iya bambanta dangane da yankin.
Mace Boni a Jami'ar Jihar Penn ta ce, ya kamata a sake duba cutar da ake samu a cikin rabbit, kuma a duba ko cutar ta ƙare da cutar da ta wanzu.
Amma ba zai yiwu a yi wani shiri ba daga yanzu har gobe".
Babban jami'in kiwon lafiya na gwamnatin kasar Sin Zhong Nanshan ya ce "za a iya kawo karshen cutar Zwing" idan dukkan kasashe za su yi aiki tare don bin umarnin WHO kan hanyoyin da za a iya dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Kula da Lafiya ta London ya ce SARS-CoV-2 "za a iya kawar da shi, aƙalla a cikin shekara ɗaya ko biyu".
A cewar wani bincike na Kwalejin Imperial wanda Neil Ferguson ya gudanar, haihuwar cikin al'umma ta hanyar wasu hanyoyi ana iya ganewa "lokacin da aka samu rigakafi (aƙalla watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina tsammanin cewa coronavirus, saboda yanayin rashin lafiya, ba zai iya zama mai saurin gaske ba kuma zai iya zama kamar annoba na yanayi, kuma zai iya zama shekara-shekara".
Ƙarfin ƙwayar cuta ya dogara ne akan yadda kwayar cutar ta shiga jikin mutum kuma ta canza.
Alamun COVID-19 na iya zama na dindindin kuma mutanen da suka kamu da cutar ba za su iya nuna alamun cutar ba.
Abubuwa biyu da suka fi damun mutane shine hauka (88%) da kuma hauka mai zafi (68%).
Mafi yawan cututtukan cututtuka sun haɗa da rashin ƙarfi, ciwon shan inna (phlegm), ciwon hanci, ciwon huhu, ciwon hanci, ciwon hanci, ciwon hanci, ciwon hanci, ciwon kai, zubar da jini, ciwon huhu, ko kuma canjin yanayin jiki. WHO ta ce kusan mutum ɗaya cikin mutane takwas na fama da ciwon hanta kuma suna da haɗarin yin numfashi.
Cibiyoyin Kula da Cututtuka da Kulawa na Amurka (CDC) sun lissafa cututtuka na cututtuka kamar wahalar numfashi, ciwon zuciya ko ciwo mai tsanani, rashin lafiya, damuwa, fuska da hanci ya canza; ya kamata a tuntuɓi likitoci idan akwai alamun cutar. Hakanan, cutar na iya zuwa pneumonia, wahalar numfashi, sepsis, septic shock da mutuwa.
Wasu daga cikin mutanen da suka kamu da cutar ba su da alamun cutar ko kuma sakamakon gwajin da ya nuna cewa suna da cutar, sai dai masu bincike sun yi kira ga wadanda suka kamu da cutar su yi kokarin ganowa da kuma gano cutar.
China ta yi kiyasin cewa yawan marasa lafiyar da ke nuna alamun cutar ya ragu daga kashi kadan zuwa kashi 44 cikin dari.
Tsawon lokacin da aka sani na tsawon lokaci (lokacin tsakanin kamuwa da cutar da farawa) ya kasance daga kwanaki zuwa kwanaki 14; yawanci kwanaki shida.A matsayin misali na rashin daidaito, yawan mutanen da suka kamu da COVID-19 wadanda ba su da magani sun kasance a farkon 30% kuma a cikin 15% a baya.
Ƙarin bayani game da yadda cutar ta yadu ya bayyana a cikin wani bayani.
Cutar ta fara yaduwa ne daga haɗuwa da ƙwayoyin cuta da ke fitowa daga murya, hanci, ko kuma murya; kuma haɗuwa ta fara ne daga minti 1 zuwa 2 (kwana 3 zuwa 6).
Bincike ya nuna cewa tsuntsayen suna iya yin tafiyar kafa 4.5 (ƙafa 15) zuwa kafa 8.2 (ƙafa 27).
Wasu sun yi amannar cewa ana iya samun yaduwar cutar ta hanyar ƙananan ƙwayoyin cuta a cikin iska, wanda zai iya zama a cikin iska yayin da ake yin numfashi. Ƙwayoyin cuta da ke fitowa daga cikin numfashi na iya zama a cikin iska, kamar ƙwayoyin cuta, ko kuma a cikin iska ba tare da yaduwar cutar ba.
Tsuntsaye na iya shiga bakin ko hancin mutanen da ba su da lafiya kuma suna iya kai ga gaci.
Wasu hanyoyin kiwon lafiya kamar su gyaran zuciya da motsin zuciya na yau da kullum (CPR) na iya haifar da wani abu kamar ruwa a cikin numfashi wanda zai iya shiga cikin iska kuma ya yada zuwa sama.
Hakanan yana iya faruwa idan wani ya taɓa dabba mai ɗauke da wannan ƙirar, kamar fatar dabba, ko idanun dabba, ko hanci, ko bakinsa.
A lokacin da aka samu matsala, ana iya samun matsala ta hanyar yin amfani da magunguna, amma a yanzu ba a da yawa.
Gwamnatin kasar Sin ta yi watsi da yiwuwar watsa SARS-CoV-2 daga hanci zuwa baki.Cutar ta fi kamuwa da cutar a cikin kwanaki uku na farko na bayyanar cututtuka, kodayake ana iya yaduwa kafin bayyanar cututtuka da kuma a ƙarshen yanayin kamuwa da cutar.
Mutane da aka gwada su da cutar a cikin kwanaki uku kafin bayyanar cututtukan cutar ya nuna cewa za a iya warkar da su kafin bayyanar cututtuka.
An dai samu karamin adadi na marasa lafiya da ke nuna alamun cutar a cikin takardunsu, amma an gano cewa babu alamun cutar a wasu ƙasashe ta hanyar bincike.
Ƙungiyar Kula da Cututtuka ta Turai (ECDC) ta yi gargadin cewa idan mutum ya yi amfani da kayan wanki a lokacin da ake cutar, mutum ɗaya zai iya kamuwa da mutum biyu ko uku.
A mafi yawan lokuta, ana iya gano kwayar cutar a cikin kwanaki uku a kan polypropylene da aka rufe da 304 ƙwayoyin cuta, a cikin kwanaki ɗaya a kan takarda, da kuma a cikin kwanaki huɗu a kan takarda.
Duk da haka, yana da bambanci dangane da yanayin sanyi da zafi. Anan dabbobin gida da wasu dabbobin daji sun kamu da cutar COVID-19.
Babu wata shaida da ta nuna cewa ƙwayoyin cuta na iya haifar da cutar a cikin mutane, kodayake hukumomin Burtaniya sun ba da shawarar cewa kada a taɓa ƙwayoyin cuta, kamar ta hanyar taɓa wasu dabbobi da cutar ta kama.
Coronavirus na 2 (SARS-CoV-2) wani sabon kwayar cuta ne, wanda aka fara ganowa a cikin mutane uku da suka kamu da cutar huhu tare da cututtukan numfashi na musamman a Wuhan.
Kwayar cutar SARS-CoV-2 ta haifar da sabon kwayar cutar coronavirus a cikin daji. A waje da jikin mutum, sabulu na kashe kwayar cutar, wanda ke haifar da ci gaba da cutar. SARS-CoV-2 ba shi da alaƙa da asalin SARS-CoV.
Ina tsammanin cewa ya samo asali ne daga dabba.
Nazarin kwayoyin halitta ya nuna cewa coronavirus a cikin wannan kwayar cuta ta haɗu da Betacoronavirus, a cikin ƙananan ƙungiyar Sarbecovirus (sunan B) da kuma ƙwayoyin cuta daga kwayoyin cuta guda biyu.
An gano kashi 96% na kwayar halittar kwayoyin halittar kwayoyin halittar dabbobi da kuma kwayar cutar ta kwayar cuta ta kwayar cuta (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambancin amino acid guda daya kawai a tsakanin kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halitta.
Binciken kwayoyin halittar mutum ya nuna cewa kusan kashi 92% na abubuwan da ke tattare da kwayar halittar mutum sun kasance tsakanin kwayar cutar pangolin da SARS-CoV-2, wanda ya isa ya tabbatar da cewa pangolin na da matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar mats mats matsakaiciyar matsakaici matsakaici
Ana iya gano cutar ta hanyar bayyanar cututtukan cututtukan cututtuka, ko da yake ganewar asali ya kamata a yi ta hanyar bincike na rRT-PCR na ruwan jiki.
Binciken da aka yi na PCR da CT a Wuhan ya nuna cewa CT ya fi PCR ƙarfi, ko da yake a ƙasa, kuma mafi yawan alamun hoto sun fi dacewa da hanyoyin cutar huhu da cututtuka.
A watan Maris na 2020, Kwalejin Ilimin Radiology ta Amurka ta ba da shawarar cewa "a ɗauki CT sau uku don a gwada ko a gwada COVID-19".
WHO ta samar da jerin gwaje-gwajen RNA da yawa don SARS-CoV-2, wanda aka fara fitar da shi a ranar 17 ga Janairu.
Wannan gwajin ya yi amfani da gwajin rRT-PCR (polymerase chain reaction).
Ana iya yin wannan gwajin ta hanyar maganin numfashi da na jini.
Ana samun alamun cutar a cikin 'yan sa'o'i a rana.
Wannan gwajin yawanci ana ɗauka ta hannu ko kuma ta hannu za a iya ɗauka. Da yawa daga cikin masana'antun gwajin da masana'antun ƙwayoyin cuta suna fafatawa don samar da kayan aikin gwajin jini, wanda ke ba da lafiya ga masu haƙuri.
Tun daga 6 ga Afrilu, 2020, babu wanda ya tabbatar da cewa an yi amfani da shi a duniya.
A Amurka, Cellex ya samar da wani tsari na gwajin jini wanda aka amince da shi don amfani a dakunan gwaje-gwaje na musamman.
Hanyoyin daukar hoto na rediyo da na tomography (CT) na mutanen da ba su da alamun cutar sun hada da yin amfani da allurar rigakafi a cikin gida da kuma rashin yawan kumburi a cikin huhu.
Ƙungiyar Rayuwa ta Italiya ta tattara bayanai daga ƙasashe daban-daban a kan hanyoyin sadarwa na hoton da aka gano marasa lafiya da suka kamu da cutar.
Saboda wasu cututtuka kamar adenoviruses, hoto ba tare da PCR ba yana da iyakance ga ganewar COVID-19.
Wani binciken da aka yi a China ya gwada sakamakon CT na zuciya da PCR kuma ya nuna cewa ko da yake ba a iya gano cutar ba, yana da saurin kamuwa da cutar, wanda ya nuna muhimmancinsa a matsayin kayan bincike a wuraren da aka kamu da cutar.
An kuma kirkiro wasu na'urori masu amfani da na'urorin kwakwalwa don gano alamun hoto na hoto na hoto da kuma na'urorin CT.
Hanyoyin da za a bi don hana yaduwar cutar sun hada da hana shan taba, wanke hannu, daina taba idanu, hanci, ko baki da hannaye masu laushi, da kuma wanke ko wanke cikin kwanon rufi da kuma ajiye shi a cikin wanki mai tsabta.
An shawarci mutanen da ke da mummunar cutar su yi amfani da abin rufe fuska a cikin jama'a.
An kuma ba da shawarar hanyoyin hana yaduwar cutar. Gwamnatoci sun ba da shawarar ko kuma sun ba da shawarar dakatar da zirga-zirgar jiragen sama zuwa ko daga ƙasashe da yankuna da cutar ta shafa.
Koyaya, cutar ta kai matakin yaduwar jama'a a cikin ƙananan yankuna na duniya.
Ba wai kawai cewa kwayar cutar tana yaduwa a cikin al'umma ba, har ma da cewa wasu mutane ba su san inda ko yadda za su iya kamuwa da cutar ba. Ma'aikatan kiwon lafiya da ke kula da duk wanda ke da damar kamuwa da cutar an shawarce su da su yi amfani da hanyoyin da suka dace na rigakafi, rigakafi, da rufe ido.
Amfani da bayanan wayar hannu ta hanyar hukuma don wannan aikin ya haifar da rikice-rikice na tsaro, ciki har da Amnesty International da fiye da 100 sauran kungiyoyi.
Akwai aikace-aikacen hannu da yawa da ake da su ko aka biya don yin hulɗa kai tsaye, kuma tun daga 7 ga Afrilu, 2020, fiye da dozin kungiyoyin masu bincike suna aiki da hanyoyin da suka dace, kamar Bluetooth don yin hulɗa da wasu mutane ta hanyar wayoyi.
Masu garkuwa suna aika da takardar shaida idan sun kasance tare da wani wanda aka tabbatar yana da COVID-19.Sauran bayanai da aka ba da izini game da yadda za a hana kamuwa da cutar; alal misali, wanke wanka da wanke wanka ba su da amfani.
Babu rigakafin COVID-19, duk da cewa masana kimiyya da yawa suna aiki kan gano shi.
An yi amfani da maganin hana yaduwar cutar don hana yaduwar cutar.
CDC ta ba da shawarar cewa a wanke hannuwanku da sabulu da ruwa na aƙalla aƙalla aƙalla aƙalla sakan ashirin, musamman bayan kun fita daga ɗaki ko kuma bayan an wanke hannuwanku; kafin ku yi wanka; da kuma bayan kun sha ruwa, kuka, ko hancinku.
Saboda a waje da jikin mutum, sabulun na kashe ƙwayoyin cuta, wanda ke ɓoye ɓoyayyen ɓoye.
CDC ta kuma ba da shawarar yin amfani da ruwan wanke hannu mai ƙarancin kashi 60% na giya idan sabulu da ruwa ba su da kyau.
WHO ta ba da shawarar a guji taɓa idanu, hanci, baki da hannayen da suka kamu da cutar.
Za a iya tsabtace farfajiyar ta hanyoyi da yawa (a cikin minti daya lokacin da aka canza kayan da aka gyara a cikin farfajiyar), kamar 62-72% ethanol, 50-100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Wasu sunadarai, kamar su benzalkonium chloride da chryohexidine gluconate, ba su da ƙarfi sosai.
CDC ta ba da shawarar cewa idan wani ya kamu da COVID ko kuma an gano shi a wani wuri kamar ma'aikata ko asibiti, duk wuraren aiki, wuraren shan ruwa, wuraren sayar da abinci, wuraren sayar da abinci, wuraren sayar da abinci, wuraren sayar da abinci, wuraren sayar da abinci, wuraren sayar da abinci, wuraren sayar da abinci, wuraren sayar da abinci, wuraren sayar da abinci, wuraren sayar da abinci, da ATM da aka yi amfani da su da kuma wuraren da aka yi amfani da su.
Ma'aikatan lafiya sun ba da shawarar cewa a rufe baki da hanci da hannu ko kuma a rufe fuska da hannu yayin da ake wanka da wanka, kuma a guji yin amfani da duk wani irin wannan abu.
Ba a ba da shawarar yin amfani da abin rufe fuska ga mutanen da za su iya kamuwa da cutar, domin sanya abin rufe fuska zai iya hana yin amo da kuma yin ɓari yayin da muke numfashi, yin magana, yin cough, ko kuma yin fitsari.
WHO ta fitar da wasu bayanai game da yadda za a sanya takunkumin fuska.
A cewar Stephen Griffin, malamin ƙwayoyin cuta a Jami'ar Leeds, "sa tufafin rufe fuska zai iya hana mutane daga taɓa fuskokinsu, wanda shine matakin farko na kamuwa da cuta ba tare da an wanke shi da kyau ba". Ana kuma ba da shawarar sanya tufafin rufe fuska ga masu kula da marasa lafiya waɗanda ke iya kamuwa da cutar.
WHO ta ba da shawarar sanya abin rufe fuska ga mutanen da ba su da cutar ko kuma waɗanda za su iya kamuwa da cutar, kamar waɗanda ke kula da wani da ke da COVID-19, duk da cewa an yi la'akari da cewa sanya abin rufe fuska na iya hana mutane yin mu'amala da fuskarsu.
Ƙasashe da dama sun fara haramta saka mayafi a gaban jama'a.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska da aka yi da rigar.A China, an ba da shawarar sanya abin rufe fuska da aka yi da rigar da aka yi amfani da shi a baya daga mutanen da ba su da cutar, yayin da suke kusa (mita 1 (kwana 3) ko kusa) da sauran mutane.
Hong Kong ta ba da shawarar saka abin rufe fuska yayin da ake hira a cikin mota da wasu mutane ko kuma a cikin jama'a.
Hukumomin Thailand sun yi kira ga jama'a da su yi amfani da abin rufe fuska a gida kuma su yi yaki da cutar.
An hana 'yan Czech Republic da Slovakia fita ba tare da rufe fuska ko hanci ko baki ba.
A ranar 16 ga watan Maris, an umarci dukkan mutanen Vietnam da su sanya abin rufe fuska a lokacin da suke fitowa a cikin jama'a don kare kansu da sauran jama'a.
Gwamnatin Austria ta ba da shawarar cewa duk wanda ya shiga shagon sayar da kayayyaki ya rufe fuskarsa.
Isra'ilawa suka umarci dukan mutane su sa riguna a fuskokinsu a fili.
Taiwan, wacce za ta yi amfani da allon rufe fuska sau miliyan goma kafin tsakiyar watan Maris, ta ba da umarnin cewa duk masu zirga-zirga da motoci da ke tafiya daga birni zuwa birni su sanya abin rufe fuska daga ranar 1 ga Afrilu.
Panama ta ba da izinin sanya abin rufe fuska a duk lokacin da kake fita, kuma an bada shawarar sanya abin rufe fuska a gida ga waɗanda ba za su iya biyan kuɗin abin rufe fuska ba.
Ana amfani da takalma mai laushi a Zapong, Koriya ta Kudu, Malaysia, da Singapore.
Gudanar da cuta (wanda aka fi sani da guje wa jama'a) ya ƙunshi matakan rigakafin cutar don rage yaduwar cutar ta hanyar hulɗa da mutane.
Matakan sun hada da yin dokar kulle; hana zirga-zirga; da rufe makarantu, wuraren aiki, wuraren wasanni, gidajen kallo, ko wuraren kasuwanci.
Mutane za su iya yin amfani da hanyoyin da aka tsara na keɓewa ta wurin zama a gida, rage yawan tafiya, guje wa wuraren da mutane ke da yawa, yin wanka da hannu da ƙafa, da kuma yin wanka a jiki.
Yawancin gwamnatoci sun yi kira ko sun ba da shawarar a daina yin jima'i a cikin yankunan da cutar ta shafa.
Adadin mutanen da za su iya haduwa a wani taron jama'a da hukumomin gwamnati da na kiwon lafiya na Amurka suka kafa ya ragu daga mutane 250 (ba tare da yaduwar COVID-19) zuwa mutane 50, daga baya zuwa mutane 10.
Bayan 22 ga Maris, 2020, Jamus ta hana yin rajistar fiye da mutane biyu.Mutanen da suka tsufa da kuma waɗanda ke da wasu cututtuka kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, cututtukan jini, da kuma tsarin rigakafin da ba su da ƙarfi suna da ƙarancin iya jure wa cututtuka masu tsanani da kuma matsaloli kuma CDC ta ba da shawarar cewa su zauna a gida kamar yadda za su iya a wuraren da jama'a ke da haɗari.A ƙarshen Maris 2020, WHO da sauran cibiyoyin kiwon lafiya sun canza kalmar "ranar jama'a" da "ranar lafiya", don daidaita wannan haɗin don rage haɗarin kamuwa da cuta ta hanyar kasancewa cikin jama'a, ta hanyar yin amfani da umarnin yau da kullun.
Maganar "ba da lafiya" ta sa mutane su kasance masu zaman kansu a cikin gidajensu, amma sun kasance masu ƙarfafawa don yin hulɗa da wasu ta wasu hanyoyi. Wasu gwamnatoci sun ba da wasu hanyoyin da za su iya magance cutar a cikin annoba.
Wannan ya haɗa da yiwuwar yin hulɗa da wanda ba shi da cutar ko alamun cutar.
Ba a bada shawarar keɓewa daga sauran mutane ba ga mutanen da suka kamu da COVID-19 da kuma waɗanda ake tsammanin sun kamu da cutar.
Ma'aikatar kiwon lafiya ta ba da sanarwar cewa dole ne a yi zaman kadaici, kuma gwamnatoci sun ba da umarni ko ba da shawarar yin hakan ga mutanen da ke zaune a yankunan da cutar ta fi kamari.
Bayanai kan zaman lafiya da kansa ya fito ne daga kungiyoyin da ke da damar yin amfani da maganin.
Duk wanda ya yi hulda da wani da ya kamu da cutar COVID-19 ko kuma ya yi tafiya mai tsawo zuwa wata ƙasa ko yanki da cutar ta yadu, dole ne ya keɓe kansa na tsawon kwanaki 14 daga lokacin da ya shiga yankin da cutar ta bazu.
Matakan don magance wannan cuta shine hana ko rage yawan ciwon kai, da kuma rage shi.
Nisa yana da amfani a farkon lokaci kuma yana da kyau a bincika mutanen da suka kamu da cutar da kuma samar da wasu hanyoyin rigakafi da alluran rigakafi don hana yaduwar cutar zuwa sauran al'umma.
Idan ba za a iya hana yaduwar cutar ba, to sai a mayar da hankali ga matakan da za a dauka: a dauki matakan da za su iya hana yaduwar cutar da kuma rage tasirinsa a kan manufofin kiwon lafiya da kuma jama'a.
Ana iya ɗaukar haɗuwa da hanyoyi biyu na tsaftacewa da ragewa a lokaci guda.
Yin rigakafi ya zama hanya mafi mahimmanci don magance cutar ta hanyar rage yawan cutar zuwa kashi 1%. Wani zaɓi na musamman don cututtuka masu saurin kamuwa da cuta ya haɗa da rage yawan cutar, wanda aka sani da rage yawan cutar.
Wannan yana rage saurin masu aikin kiwon lafiya kuma yana ba su lokaci mai yawa don samun allurar rigakafi da magani.
Abubuwan da ba a sani ba da likitocin da za su iya magance cutar sun haɗa da matakan kariya na kai, kamar wanke hannu, sanya abin rufe fuska, da kuma nisantar jama'a; hanyoyin kare lafiyar jama'a kamar rufe makarantu da hana zirga-zirgar jama'a; ka'idojin jama'a don hana yin amfani da waɗannan hanyoyin; da kuma hanyoyin kare muhalli kamar wanke motoci. An dauki wasu matakai masu mahimmanci don hana yaduwar cutar a China bayan barkewar cutar, kamar hana garuruwa da kewaye da birane da kuma hana zirga-zirgar jiragen sama.
Wasu ƙasashe sun ɗauki wasu matakai don rage yaduwar cutar a cikin birni.
Koriya ta Kudu ta gabatar da gwajin jama'a da kuma keɓewar jama'a, tare da sanya takunkumi kan bayyanar cututtuka.
Singapore ta ba da gudummawar kuɗi don tallafa wa waɗanda suka kamu da cutar da waɗanda suka yi aiki da kansu a cikin ɓoye kuma sun ba da damar waɗanda ba su yi haka ba tare da ƙarin kuɗi.
Taiwan ta ƙaddamar da allurar rigakafi kuma ta hana hana kayan aikin likita.Kwatanta Ingila da Amurka sun nuna cewa hanawa (hanawa amma ba hana yaduwar cutar) da hanawa (hana cutar) suna da illa ga lafiyar jiki.
Ka'idodin rage yawan magungunan ƙwayoyin cuta sun rage yawan adadin masu kiwon lafiya da ke cikin asibiti da kashi biyu bisa uku, amma duk da haka dubban mutane sun mutu sakamakon shan miyagun ƙwayoyi ba tare da sun ji rauni ba.
Zai yiwu kuma ya kamata a yi rigakafi a lokacin da cutar ta riga ta bazu a cikin al'umma (ko kuma lokacin da aka gano rigakafin, idan wannan shine farkon zuwan), don hana yaduwar cutar.
Tsarin rigakafi na yau da kullun yana haifar da asarar kuɗi ga jama'a da ƙasa.
Babu wani magani da aka riga aka gano da zai iya kashe COVID-19, amma akwai wasu da dama da aka yi amfani da su, ciki har da gwajin da aka kammala.
Shan magani, shan gishiri, da kuma hutawa na iya rage alamun cutar.
A cikin yanayin da aka samu, magani da ruwa, maganin jini, da kuma taimakon numfashi na iya taimakawa.
Yin amfani da steroid zai iya zama alamar.
Yawancin magungunan da suka dace da maganin wasu cututtukan ƙwayar cuta suna cikin bincike don gano ko za su iya zama masu amfani wajen maganin COVID-19.
WHO ta ce akwai " magungunan gida da na gida " da za su iya rage alamun cutar SARS-CoV-19.
WHO ta amince da maganin rigakafin COVID-19 a matsayin maganin rigakafin cutar.
ECDC da WHO ta ƙasashen Turai sun ba da shawarwari ga asibitoci da cibiyoyin kiwon lafiya don rage yawan kayan aiki, da kuma rage yawan cibiyoyin bincike ta hanyar gwajin COVID-19, da kuma rage matakan zaɓuɓɓuka idan ya yiwu, da kuma warewa da kuma ware mutanen da ke da COVID-19 a cikin gida, da kuma inganta tsarin kula da lafiya ta hanyar horar da ma'aikata da kuma ƙara yawan adadin asibitocin da ke da asibitocin asibitoci.
Akwai maganganu daban-daban game da inda mai haƙuri na farko (wanda aka sani da mai haƙuri na farko) zai iya tashi.
An fara gano sabon nau'in coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin watan, yawan mutanen da suka kamu da cutar coronavirus a Hubei ya karu da hankali.
An gano cutar ne a wani wuri a cikin ruwa mai zurfi na Huan, wanda ya yi kama da ruwan tabarau, kuma a wasu kalmomin, cutar ta samo asali ne daga ɗayan waɗannan tabarau: , ko kuma a wasu kalmomin, ya samo asali ne daga ruwan tabarau. An gano cutar a cikin ruwan tabarau mai zurfi a ranar 26 ga Disamba kuma an yi ta ne ta hanyar likita Zhang Jixian a asibitin lardin Hubei, wanda ya ba da rahoton Wuhan CDC Jianghan a ranar 27 ga Disamba.
A ranar 30 ga Disamba, ƙungiyar likitocin asibitin Wuhan ta sanar da abokan aikinta game da " nau'in SARS na coronavirus ".
Wasu 'yan sanda sun ce Li Wenliang da wani mai suna Ai Fen sun yi garkuwa da mutane don su yi gargadin jama'a.
Hukumar Lafiya ta lardin Wuhan ta fitar da wata sanarwa ga jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An sanar da wasu mutane masu dauke da cutar sankara ga jami'an kiwon lafiya a Wuhan don fara gwajin a farkon Janairu.A lokacin da cutar ta bulla, adadin masu dauke da cutar ya ninka bayan mutum takwas da rabi da suka kamu da ita.
A farkon da tsakiyar watan Janairu, cutar ta bulla a wasu lardunan China, tare da yin amfani da tashar jirgin sama ta China ta Wuhan a matsayin cibiyar zirga-zirga da kuma mafi yawan hanyoyin sufuri.
A ranar 20 ga watan Janairu, China ta ba da rahoton sabbin mutane 140 da suka kamu da cutar a cikin mutum ɗaya, mutum biyu a Beijing da kuma mutum ɗaya a Shenzhen.
Rahotannin da hukumomi suka fitar a ranar 26 ga watan Maris, sun nuna cewa Amurka ta fi China da Italiya yawan masu dauke da cutar a duniya, inda ta kai mutane 6,174 da suka kamu da cutar a ranar 20 ga watan Janairun 2020. Ya zuwa 9 ga watan Afrilun 2020, an samu mutum fiye da miliyan 1.63 da suka kamu da cutar a duniya, inda mutum fiye da 97,000 suka mutu, kuma fiye da 364,000 suka kamu.
Kusan kasashe da yankuna 200 sun kamu da cutar aƙalla sau ɗaya.
A sakamakon barkewar cutar a Turai, ƙasashe da yawa a yankin na Schengen sun yi watsi da kasancewarsu a cikin Turai kuma sun sanya takunkumi kan iyakokin.
Tsarin ƙasa ya haɗa da matakan kariya kamar su keɓewa (wanda aka fi sani da dokar keɓewa, dokar hutu na kwana ɗaya, ko dokar hana fita) da kuma dokar hana fita.Kisa ga 2 ga Afrilu, kimanin mutane miliyan 300, ko kuma kusan kashi 90% na yawan jama'a, suna cikin kurkuku a Amurka, fiye da mutane miliyan 50 ba a hana su fita ba a Philippines, fiye da mutane miliyan 50 ne a kurkuku a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun kasance a cikin gida, wanda ya karu daga nan zuwa mutane biliyan 2.6 a rana guda, kusan kashi ɗaya bisa uku na yawan jama'ar duniya.
An fara gano cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a amsa ba ya ce an fara gano cutar a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya duba mutanen da ke dauke da cutar huhu a ranar 26 ga Disamba, bayan da asibitin ya sanar da CDC Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwajin farko da aka yi a kan wani mutum a ranar 29 ga Disamba, 2019 ya nuna cewa kwayar cutar coronavirus ta SARS ce.
An fitar da wata sanarwa ga jama'a daga Hukumar Lafiya ta lardin Wuhan a ranar 31 ga Disamba.
An sanar da WHO a ranar.
Bayan samun rahotannin, likitoci a Wuhan sun sanar da 'yan sanda cewa suna "tsorata" game da cutar.
Jami'an lafiya na China sun fara da cewa babu wani "tabbaci mai inganci" game da yaduwar cutar daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani sabon tsari mai muhimmanci wanda a baya Sakatare Janar na Jam'iyyar Kwaminis ta Sin Xi Jinping ya yi amfani da shi a matsayin "kayan aikin jama'a" don dakile yaduwar cutar.
A cikin abin da aka bayyana a matsayin "babbar barkewar cutar a tarihin ɗan adam", an ba da sanarwar cutar a ranar 23 ga Janairu, wanda ya hana zirga-zirgar jiragen sama daga Wuhan, ya kuma bazu zuwa wasu birane 15 a Hubei, wanda ya shafi kusan mutane miliyan 57.
Motarka mai kyau ta yi hadari.
A wasu wurare, ana yin bukukuwan da ke nuna ranar 25 ga Janairu a matsayin ranar hutun shekara ta kasar Sin.
Jami'an gwamnati sun kuma sanar da gina asibitin farko, asibitin Huoshenshan, wanda aka kammala a cikin kwanaki 10.
Daga baya an gina asibiti, asibitin Leishenshan, don karɓar ƙarin marasa lafiya.
Baya ga sabon asibitin da aka gina, China ta sake gina wasu wurare 14 a Wuhan, kamar wuraren taro, dakunan shan magani, da wuraren shan magani. A ranar 26 ga Janairu, gwamnati ta ba da wasu matakan hana yaduwar COVID-19, kamar samar da bayanai ga masu yawon bude ido da kuma inganta bikin bikin bazara.
An rufe makarantu da jami'o'i a duk fadin kasar.
Yankunan Hong Kong da Macau sun kafa wasu dokoki, musamman ma game da makarantu da jami'o'i.
An kuma yi amfani da wannan hanyar a wasu sassan kasar Sin.
Akwai karancin zirga-zirga a cikin da kuma wajen Hubei.
An dakatar da tattaunawar jama'a, kuma an rufe dukkan gidajen tarihi a kasar Sin.
An yi gargadin cewa an hana yaduwar cutar a birane da dama, kuma mutane miliyan 760 (kimanin yawan jama'a) sun yi a gida. Bayan annobar ta bazu a duniya a watan Maris, hukumomin kasar Sin sun yi kokari wajen hana masu kamuwa da cutar daga kasashen waje.
Misali, Beijing ta ba da keɓewa na kwanaki 14 ga duk wanda ya yi tafiya daga wata ƙasa kuma ya yi niyyar shiga cikin birni.A ranar 23 ga Maris, babban yankin China ya sami mutum ɗaya da ya kamu da cutar a cikin ƙasar kafin wani mutum ya kamu da cutar a cikin kwanaki shida, wani mutum ya dawo Guangzhou daga Istanbul.
A ranar 24 ga watan Maris na shekarar 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an dakatar da yaduwar cutar a cikin birni kuma an kawo karshen annobar a kasar Sin.
Ba za a sake yin balaguro ba a yayin annobar, musamman a Wuhan, bayan kwanaki biyu da aka yi a cikin gida.Hukumar China ta hana yin balaguro a cikin gida.A ranar 26 ga Maris, 2020 ta ce an dakatar da neman takardar izinin shiga kasar, daga ranar 28 ga Maris, kuma za ta ba da ƙarin bayani game da lokacin da za a kammala.
Duk wanda ke son shiga kasar Sin dole ne ya nemi takardar izinin shiga ta daga ofishin jakadancin kasar Sin da ke wata kasa.
Gwamnatin kasar Sin ta ba da umarnin sake bude dukkan kamfanoni da masana'antu a ranar 30 ga Maris, kuma ta ba da kudaden tallafi ga masana'antun.Sakamakon haka, Ministan Harkokin Wajen kasar ya ba da sanarwar cewa cutar ta fara ne daga karfe 10:00 na safe zuwa karfe 3:00 na yamma a ranar 4 ga Afrilu, wanda ya yi daidai da lokacin bikin Qingming, duk da cewa gwamnatin ta tsakiya ta bukaci kamfanoni da su tabbatar da cewa sun yi allurar rigakafi da kuma yin gwajin rigakafi don kaucewa kamuwa da cutar COVID-19.
An gano cewa COVID-19 ya bazu a Koriya ta Kudu tun 20 ga Janairu, 2020 daga China.
Ma'aikatar lafiya ta kasar ta ruwaito cewa adadin masu kamuwa da cutar ya karu a ranar 20 ga Fabrairu, yayin da mutane suka yi tururuwa zuwa Daegu don sabon masallacin da aka gina da ake kira Shincheonji Church of Jesus.
Shincheonji da ke daure a Daegu daga Wuhan ya zama wanda ya kamu da cutar.
A ranar 22 ga watan Fabrairu, daga cikin mutane 9,336 da aka yi wa allurar rigakafi, 1,261 ko kashi 13 cikin 100 na cikinsu ba su da alamun cutar. Koriya ta Kudu ta ba da rahoton mafi yawan kamuwa da cutar a ranar 23 ga watan Fabrairu 2020.
Ya zuwa ranar 28 ga watan Fabrairu, an samu mutane sama da 2,000 da suka kamu da cutar a Koriya, wanda ya kai 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sojojin Koriya ta Kudu bayan an gano cewa sojoji uku sun kamu da cutar.
An dakatar da shirye-shiryen jiragen sama kuma an rage yawan masu kamuwa da cutar.Koriya ta Kudu ta kafa abin da ake ɗauka a matsayin mafi mahimmanci da kuma mafi mahimmanci a duniya don magance cutar ta al'umma, ta hanyar barin waɗanda suka kamu da cutar da kuma kula da waɗanda suka kamu da cutar.
Hanyoyin bincike sun haɗa da bayar da rahoton rahoton kai tsaye na cutar daga masu balaguro da suka dawo daga ƙasashen waje ta hanyar aikace-aikacen hannu, gwajin kwayar cutar tare da sakamakon da aka samu a cikin kwanaki masu zuwa, da kuma inganta tsarin bincike don samun masu balaguro 20,000 da za a bincika duk sakamakon.
Shirin Koriya ta Kudu ya kasance mai ban mamaki a cikin magance matsalar ko da yake an rufe garuruwan da yawa. Jama'ar Koriya ta Kudu sun kasance masu zaman kansu a farkon lokacin da Shugaba Moon Jae-in ya amsa wannan matsala.
Yawancin 'yan Koriya sun sanya hannu a takardar neman a fitar da Moon saboda suna ganin gwamnati za ta iya magance matsalar, ko kuma a ce za a yi watsi da ita.
A ranar 23 ga Maris, an ruwaito cewa Koriya ta Kudu ta yi rashin lafiya na tsawon mako huɗu.
A ranar 29 ga Maris an sanar da cewa daga ranar 1 ga Afrilu, duk wanda ya yi kutse a kasar zai yi zaman gidan yari na tsawon makonni biyu.
Kamar yadda kafofin watsa labarai suka ruwaito a ranar 1 ga Afrilu, Koriya ta Kudu ta sami buƙatun taimako da gwajin cutar daga ƙasashe 121 daban-daban.
Iran ta ba da sanarwar farko game da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda, a cewar Ma'aikatar Kiwon Lafiya da Cibiyar Kiwon Lafiya, mutane biyu sun mutu daga baya a wannan rana.
Matakan farko da gwamnati ta dauka sun hada da dakatar da bukukuwa da wasannin motsa jiki, da ayyukan wasanni, da dakatar da karatun Lahadi, da rufe majami'u, da makarantun sakandare, da makarantu.
Iran ta kashe rials tiriliyan shida don magance wannan cutar.
Shugaban kasar Hassan Rouhani ya bayyana a ranar 26 ga Fabrairun 2020 cewa babu wani shiri na kebewa daga wuraren da cutar ta bulla, kuma mutane za su iya kebewa ne kawai.
An yi niyyar rage zirga-zirgar jiragen sama tsakanin biranen a watan Maris, duk da cewa akwai zirga-zirgar jiragen sama tsakanin biranen kafin bikin sabuwar shekara ta Farisa.
An sake bude masallacin Shia a Qom ga masu yawon bude ido a ranar 16 ga Maris, 2020. Iran ta kasance cibiyar da cutar ta fi yaduwa bayan China a watan Fabrairu.
A yayin da ake kokarin ganin an shawo kan yaduwar cutar a Iran, sama da kasashe goma sun mayar da martani kan adadin wadanda suka kamu da cutar a Iran a ranar 28 ga Fabrairu, inda suka ce adadin wadanda suka kamu da cutar ya zarce adadin mutane 388 da gwamnatin Iran ta sanar.
An rufe asibitocin Iran, inda aka gano 23 daga cikin 290 da ke dauke da cutar a ranar 3 ga Maris.
A ranar 12 ga Maris, Human Rights Watch ta yi kira ga hukumomin tsaro na Iran da su saki duk wanda aka kama da laifi da kuma wadanda ba su da laifi.
An lura cewa cutar na iya yaduwa a wurare masu zaman gida kamar gidajen yara, inda ba a kula da lafiyarsu.
A ranar 15 ga Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda shi ne mafi girma tun lokacin da cutar ta bulla.
An kashe mutane biyar daga cikin manyan 'yan siyasa da kuma jami'an gwamnati a Iran a ranar 17 ga Maris.
A ranar 23 ga Maris, Iran ta ba da rahoton sabbin masu kamuwa da cutar korona 50 a kowace awa da kuma mutuwar mutum daya a kowane minti goma.
A cewar wani jami'in WHO, ana iya samun adadin masu kamuwa da cutar fiye da sau biyar a Iran.
Haka kuma, Amurka ta ce matakin da Iran ta dauka zai iya shafar tattalin arzikin kasar a sakamakon barkewar cutar.
Babban Kwamishinan Kare Hakkin Dan Adam na Majalisar Dinkin Duniya ya yi gargadin rage tattalin arzikin kasashen da cutar ta fi shafa.
An san cewa cutar ta isa Italiya a ranar 31 ga Janairu, lokacin da aka gwada wasu mata biyu 'yan ƙasar Sin da ke Roma da cutar SARS-CoV-2 a cikin su.
An yi ta fama da annobar, wanda ya sa gwamnatin Italiya ta dakatar da duk wani zirga-zirgar jiragen sama zuwa ko daga China kuma ta ayyana dokar ta baci.
An gano karin mutum 16 da suka kamu da COVID-19 a Lombardy a ranar 21 ga Fabrairu.A ranar 22 ga Fabrairu, hukumomin kasar suka sanar da sabon matakin dakile cutar, tare da kebe mutane sama da 50,000 a larduna 11 daban-daban na arewacin Italiya.
Shugaban ma'aikatar kula da lafiyar jama'a Giuseppe Conte ya ce, a lokacin cutar, shiga da fita ba zai yiwu ba.
A ranar 4 ga Maris, gwamnatin Italiya ta rufe makarantu da kuma jami'o'i a duk fadin kasar har sai da aka kai adadin mutanen da suka mutu a Italiya ya kai 100.
Yawancin wasannin motsa jiki, kamar kowane rukuni na Serie A, dole ne su faru a cikin yankin da aka rufe a watan Afrilu, amma a ranar 9 ga Maris, an dakatar da wasanni na akalla wata guda.
A ranar 11 ga Maris, Shugaba Conte ya ba da sanarwar dakatar da yawancin shagunan sayar da magunguna da kantin magani. A ranar 6 ga Maris, Kwalejin Italiya ta Anaesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta ba da shawarar shawarwari ga likitoci kan zaɓin manufofin da za su iya amfani da su.
A ranar 19 ga Maris, Italiya ta zarce China a matsayin kasa da ta fi kowa yawan masu kamuwa da cutar coronavirus bayan da ta yi rahoton mutuwar mutane 3,405.
A ranar 22 ga Maris, an ba da rahoton cewa Rasha ta aika da jiragen saman soja guda shida da ke dauke da kwayoyi zuwa Italiya.
Tun daga ranar 5 ga Afrilu, an sami mutane 128,948 da suka kamu da cutar, an kashe 15,887, kuma an warkar da 21,815 a Italiya, kuma an gano yawancin waɗannan cututtukan a yankin Lombardy.
Wani rahoto na CNN ya ce cewa Italiyanci na da dangantaka mai tsawo da kuma rashin kula da marasa lafiya na iya haifar da mutuwar mutane da yawa.
Amsar da Burtaniya ta bayar game da cutar ta zama ɗaya daga cikin mafi munin a tsakanin ƙasashe, kuma a ranar 18 ga Maris, 2020, gwamnatin Burtaniya ta ba da umarnin hana yin aiki da jama'a ko kuma hana yin aikin jinya ga jama'a.
Bugu da ƙari, an yi imanin cewa gwamnati za ta magance cutar da kyau kuma ta amsa matsalolin jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ta ba da shawarar rage yawan zirga-zirgar jiragen sama da ke da tasiri a kan rayuwar jama'a, kuma ya ba da shawarar cewa jama'a su yi aiki daga gida idan za su iya kuma su yi amfani da wuraren shakatawa kamar gidajen shan giya, gidajen cin abinci, da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa duk wuraren shakatawa da wuraren shan giya da wuraren wasanni za su rufe, kuma ta ce za ta biya ma'aikata kashi 80 cikin 100 na albashin su amma ba za ta biya fiye da £2,500 a wata ba idan mutane uku suka rasa aikinsu a lokacin rikicin. A ranar 23 ga watan Maris, Gwamnatin ta sanar da cewa za a yi wa jama'a hutun da suka fi na yau da kullum tsanani, ta rage yawan jama'a zuwa kashi biyu kuma ta rage yawan tafiye-tafiye da kuma yawan aiki zuwa wani wuri da ya fi dacewa.
A cikin wannan yanayin, 'yan sanda suna amfani da 'yan sanda don su yi amfani da su wajen yin gargadi da kuma yada jita-jita.
Yawancin kasuwancin sun rufe saboda wannan yanayin, tare da wasu "mafi yawan" kasuwancin, kamar kantin sayar da abinci, kantin sayar da magani, kantin sayar da kaya, kantin sayar da kayan aiki, kantin sayar da man fetur, da kuma motar mota.
A ranar 20 ga Janairu, an gano mutum na farko da ke dauke da cutar COVID-19 a jihar Pacific Northeast na Washington a jikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
Kwamitin Bincike na Fadar White House kan cutar Korona zai bayyana ne a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kasa, inda ta hana duk wani dan kasar Sin shiga kasar.
A ranar 28 ga watan Janairu, 2020, Hukumar Kula da Cututtuka, babbar hukumar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta ƙaddamar da sabon gwajin ta.
Duk da haka, Amurka ta yi nasara wajen gudanar da gwajin, wanda ya rage yaduwar cutar a cikin lokaci.
Aikin bincike ya nuna damuwa game da ingancin kayan aikin gwaji da gwamnatin tarayya ta fitar a watan Fabrairu, saboda gwamnatin tarayya za ta amince da sayen kayan gwaji na gwamnati (na kiwon lafiya, bincike da asibitoci) a ƙarshen Fabrairu, da kuma shirin da za a ba wa mutane don samun damar yin gwajin a farkon Maris (wanda ba shi da izinin likita).
A ranar 27 ga Fabrairu, The Washington Post ta ba da rahoton cewa an yi wa mutane fiye da 4,000 allurar rigakafi a Amurka.
A ranar 13 ga watan Maris, The Atlantic ta ruwaito cewa za a yi gwajin cutar fiye da 14,000.
A ranar 22 ga Maris, Associated Press ta ba da rahoton cewa: "Yawancin mata masu ciwon hauka da ke fama da rashin lafiya sun yi kwanaki ko kuma makonni da yin gwajin cutar".Bayan da aka samu mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamnan Jay Inslee ya ba da sanarwar gaggawar lafiya, wanda wasu jihohi suka bi a hankali.
Makarantun da ke kewayen Seattle sun dakatar da karatu a ranar 3 ga Maris, kuma tun daga tsakiyar Maris, makarantu a cikin ƙasar za su rufe makarantu.A ranar 6 ga Maris, an ba da sanarwar cewa Amurka na fuskantar sabon kamuwa da kwayar cutar coronavirus a cikin gida ta hanyar ƙungiyar masu binciken cutar a Imperial College London.
A ranar Talata, Shugaba Trump ya ba da umarnin dokar Coronavirus Preparedness and Response Supplemental Appropriations Act, wanda ya ba da dala biliyan 8.3 a matsayin taimakon gaggawa ga cibiyoyin gwamnati don amsa cutar.
Kamfanoni sun ba da umarnin tafiye-tafiye ga ma'aikatansu, sun hana tarurruka, kuma sun hana ma'aikata yin aiki daga gida.
A ranar 11 ga Maris, Trump ya sanar da dakatar da zirga-zirgar jiragen sama zuwa ga mafi yawan kasashen Turai, ban da Birtaniya, na tsawon kwanaki 30, daga ranar 13 ga Maris.
A cikin shekara ta gaba, ya fadada wannan ra'ayi a Ingila da Ireland.
A ranar 13 ga Maris, an sanar da gaggawa na kasa, wanda ya haifar da kudaden da aka adana a cikin asusun tallafi don amsawa.
Tun daga ranar 15 ga Maris, yawancin kamfanoni a Amurka sun rufe ko kuma sun sake yin jirage a wani mataki na rage yaduwar cutar.
A ranar 17 ga watan Maris, an samu rahotannin cutar a jihohi 50 da kuma cikin Columbia. A ranar 23 ga watan Maris, an ruwaito cewa birnin New York yana da mutum 10,700 da suka kamu da cutar coronavirus, wanda ya fi na Koriya ta Kudu.
A ranar 5 ga Maris, gwamnati ta ce dokar hana fita ta yi tasiri, kuma adadin mutanen da ke da lafiya ya ragu daga kwanaki 2.0 zuwa 4.7.
Ya zuwa 28 ga watan Maris, akwai mutane 32,308 da aka tabbatar sun kamu da cutar a New York City, da kuma mutum 672 da suka mutu sakamakon cutar. Ya zuwa 26 ga watan Maris, Amurka ta sami karin mutane da suka kamu da cutar fiye da kowace kasa a duniya, ciki har da China da Italiya. Ya zuwa 8 ga watan Afrilu, an samu mutum 400,335 da suka kamu da cutar a Amurka, da kuma mutum 12,841 da suka mutu.
A cewar wani rahoto da aka bayar a ranar 30 ga watan Maris, Shugaba Trump na Amurka ya yi niyyar tsawaita dokar hana fita daga kasar har zuwa ranar 30 ga watan Afrilu.
A cikin wannan, USNS Comfort, wani asibiti mai girman gado da ke da asibiti mai ɗauke da gado 1,000, ya tsaya a New York.
A ranar 3 ga watan Afrilu, Amurka ta yi kiyasin mutuwar mutum 884 da suka mutu sakamakon cutar korona a cikin kwanaki 24.
A jihar New York an kiyasta adadin masu kamuwa da cutar ya zarce 100,000 a ranar 3 ga Afrilu.Fadar White House ta gano cewa cutar ta haifar da cutar kuma tana sa ido kan al'amuran ta hanyar tura jami'an kiwon lafiya da masana don ba da shawara ga al'ummomin da ke fuskantar al'amuran da suka shafi cutar da kuma al'amuran da suka shafi shugaban kasa Mike Pence na biyu.
Duk da haka, Trump ya yi amfani da wasu hanyoyin da mutane ke ganin sun yi tasiri a kan cutar.
Wasu shugabannin Amurka da masu yawon bude ido sun soki Amurka saboda rashin amincewa da kayayyakin da ba su da daraja a kasashen waje, kamar maganin gargajiya, a China.
Wani bincike kan iskar gas da aka dauka don tantancewa da kuma tantance yadda iskar ke sauka ya fito ne a Journal of Travel Medicine a tsakiyar watan Janairun 2020.
A cewar wani rahoto na shekara ta 2018 daga kungiyar sufurin jiragen sama ta kasa da kasa, Bangkok, Hong Kong, Tokyo, da Taipei sun fi yawan wadanda suka yi tafiya daga Wuhan.
Dubai, Sydney, da Melbourne sun kuma bayyana a matsayin wuraren da ake samun karuwar matafiya daga Wuhan.
Bali an bayar da rahoton a matsayin mafi ƙarancin yawon shakatawa a cikin birane 20 da suka fi yawan yawon buɗe ido ko yawon shakatawa, yayin da birane a Ostiraliya suka fi yawan balaguro. Ostiraliya ta ba da sanarwar Karin Magani game da Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
An ba da ƙarin haske game da cutar COVID-19, kuma Ostiraliya za ta ƙara ƙuntatawa da kuma nuna bambanci a cikin martanin da ta bayar game da cutar.
A ranar 21 ga Maris, an yi gargadin gaggawa game da cutar shan inna a Ostiraliya.
Don magance matsalar rashin lafiyar da ke tattare da cutar a Wuhan da Hubei, ƙasashe da yawa sun shirya don kwashe 'yan ƙasarsu da jami'an tsaro daga yankin, da farko ta jirgin sama da ke da alhakin kai tsaye, tare da taimakon gwamnatin China.
Kasashen da suka fara aiwatar da shirin sun hada da Canada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand.
Pakistan ta ce ba za ta kori 'yan kasarta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta fitar da 'yan Brazil 34 da aka yi wa yan gudun hijira da kuma wasu 'yan Poland hudu, da wani dan China daya, da kuma wani dan China daya.
Jiragen sama daga Poland, China, da Indiya sun sauka a Poland, inda jiragen Brazil suka sauka kafin a iya amfani da su a Brazil.
An keɓe 'yan Brazil da suka ziyarci Wuhan a sansanin sojoji da ke Brasilia.
A wannan rana, 215 'yan Canada (176 a jirgin farko, da 39 a jirgin na biyu da gwamnatin Amurka ta yi) suka tashi daga Wuhan zuwa CFB Trenton, inda aka tsare su a cikin dakuna biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai saukar da mutane 185 daga Wuhan ya sauka a CFB Trenton.
Gwamnatin Australia ta kwashe 'yan kasarta 277 a ranar 3 da 4 ga watan Fabrairu zuwa tsibirin Kirsimeti, wanda aka yi la'akari da wani wuri mai zaman kansa, inda suka zauna har tsawon kwanaki 14.
Wani jirgin saman jirgin saman New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojin (da wasu daga Australia da Pacific) an tsare su a wani yanki a tashar jiragen ruwa ta Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta ba da izinin zama 'yar Amurka ga mataimakinsa, Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin saman Kanada mai dauke da fasinjoji 129 ya yi hadari a cikin jirgin Diamond Princess a garin Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara dawo da 'yan kasarta daga Iran. A ranar 14 ga watan Maris, jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta shirya ya dawo da 'yan kasar Afirka ta Kudu 112.
An yi gwajin lafiya kafin a yi rigakafin, kuma duk wani mutumin Afirka ta Kudu da ke da alamun cutar coronavirus ya kamata a yi shi nan da nan don rage kamuwa da cutar.
Ba a maida mazauna Afirka ta Kudu da suka kamu da cutar ba a matsayin 'yan kasarsu.
Rahoton ya nuna cewa dukkan 'yan kasar Afirka ta Kudu, ciki har da hukumar kula da zirga-zirgar jiragen sama, ma'aikatan jirgin sama, masu kula da otel, 'yan sanda da kuma sojoji masu ba da agaji, sun kasance a karkashin tsare-tsare kuma sun kasance ba su da izinin shiga cikin kwanaki 14 a Ranch Resort.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda cutar.
A ranar 5 ga watan Fabrairu, Ofishin Jakadancin China ya sanar da cewa kasashe 21 (har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun ba da tallafi ga kasar Sin.
Wasu ma'aikatan likitancin kasar Sin a cibiyoyin kiwon lafiya na Amurka sun yi kira da a tura taimako zuwa yankunan da cutar ta shafa a China, tare da wasu kungiyoyi a yankin Chicago da ke da iyaka wadanda suka yi gwagwarmaya don ba da kyautar N95 50,000 ga wasu asibitocin lardin Hubei a ranar 30 ga Janairu.Kungiyar ba da agaji ta Direct Relief, tare da taimakon FedEx, ta tura kayan rufe fuska 200,000 da sauran kayayyaki, kamar kayan aikin hannu da kayan aiki, ta jirgin saman gaggawa zuwa Wuhan Union Hospital a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun ba da sanarwar bayar da tallafin dala miliyan 100 ga WHO don binciken magungunan cutar da kuma hanyoyin magance ta da kuma hana "ƙananan ƙasashe na Afirka da Kudancin Asiya kamuwa da cutar".
An ba da rahoton cewa gwamnatin China ta ba da kyautar abin rufe fuska 200,000 ga Filipinos a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya ba da kyautar abin rufe fuska miliyan 3.16 a Wuhan.
A ranar 19 ga Fabrairu, Ƙungiyar agaji ta Singapore ta sanar da cewa za ta aika da dala miliyan 2.26 domin taimaka wa ƙasar Sin.
Japan ta ba da rigunan rigakafi a Wuhan, Turkiyya ta ba da umarnin asibiti, Rasha ta ba da kayan aikin likita da kayan aiki sama da tan 13 a Wuhan, Malaysia ta ba da rahoton ba da kayan aikin hannu miliyan 18 ga China, Jamus ta ba da kayan aikin likita da kayan aikin kiwon lafiya 10,000, kuma Amurka ta ba da asibiti da kayan aikin likita tan 17.8 ga China kuma ta ba da ƙarin dala miliyan 100 a matsayin tallafi da kuɗi ga ƙasashe masu tasowa.Bayan an ba da rahoton cewa cutar ta ragu a China, kasar ta fara ba da tallafi ga sauran ƙasashe da ke fama da cutar.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da likitoci don taimakawa Italiya yaƙi da annobar coronavirus.
Kamfanin Jack Ma ya aika da umarni na gwaji miliyan 1.1, da takardar rufe baki miliyan 6, da takardar rufe baki 60,000 zuwa Addis Ababa, Habasha don rarraba ta Ƙungiyar Tarayyar Afirka.
Daga baya ya aika kayan gwaje-gwaje 5,000, rigunan rufe fuska 100,000 da kuma jirgin saman jirgin sama 5 zuwa Panama.
Haka kuma, an ba da kyautar kayayyakin kiwon lafiya ga kasar Canada. Netherlands, Spain, Turkey, Georgia, da Czech Republic sun nuna damuwa game da rigakafin rigakafin da aka yi a China da kuma kayayyakin gwaji.
Misali, Spain ta fitar da kayan gwajin cutar Sin 58 000 wadanda suka nuna ingancin cutar ta 30%, yayin da Netherlands ta fitar da kayan aikin kashe gobara na kasar Sin 600 000 wadanda suka nuna ingancin cutar.
Belgium ta yi watsi da takunkumin rufe fuska 100,000, bayan da aka gano cewa sun fito ne daga Colombia.
A wani lokaci, an ba da taimakon taimakon agaji na kasar Sin a wasu yankuna na Latin Amurka da Afirka.A ranar 2 ga Afrilu, Hukumar Lafiya ta Duniya ta kaddamar da ayyukan agaji na gaggawa ga kasashen da ke fama da talauci.
Hukumar ta WHO ta yi tir da kokarin da gwamnatin kasar Sin ke yi na hana yaduwar cutar.
WHO ta lura da bambanci tsakanin barkewar cutar SARS a 2002-2004, wadda aka zargi gwamnatin China da aikata ta'asa da kuma rashin bin ka'idojin hana yaduwa da kuma dakile cutar, da kuma barkewar cutar da gwamnatin China ta "ba da rahoton mutane uku da suka kamu da cutar kafin a fara sabuwar shekara".
A ranar 23 ga watan Janairu, a cikin martani ga kiran da gwamnatin tsakiya ta yi na hana barazanar cutar a Wuhan, wakilin WHO Gauden Galea ya ce "ba a taba samun wani mataki na WHO ba", yana mai cewa "yana da muhimmanci gwamnati ta yi kokari wajen hana wannan annoba daga barkewa a cikin wani lokaci mafi muni" kuma ya ce "ba a taba samun irin wannan a tarihin kiwon lafiya ba". A ranar 30 ga watan Janairu, bayan an tabbatar da kamuwa da cutar daga mutum zuwa mutum a wajen kasar Sin da kuma samun karuwar masu kamuwa da cutar a wasu ƙasashe, WHO ta sanar da cewa cutar ta kamu da cutar ta cutar ta duniya (PHEIC), kuma ita ce ta farko da PHEIC ta yi tun bayan da aka fara gudanar da shirin kamuwa da cutar a shekarar 2009.
Babban sakataren WHO Tedros Adhanom ya ce cutar PHEIC na iya "zama da saurin yaduwa a duniya, musamman a kasashe masu karancin lafiya da ke da karancin hanyoyin kiwon lafiya masu inganci".
Dangane da koma bayan da aka samu a kan tafiye-tafiye, Tedros ya ce "babu wani canji ga matakan da ke hana tafiye-tafiye zuwa wasu ƙasashe da kasuwanci" kuma "WHO ta ba da shawarar rage kasuwanci ko rashin lafiya".
A ranar 5 ga watan Fabrairun, WHO ta yi kira ga al'umman duniya da su yi amfani da matakan da suka dace don samar da tallafin da ya kai dala miliyan 675 ga ƙasashe masu ƙarancin ci gaba, ta hanyar yin kira ga ƙasashen da "ba su da tsarin kula da lafiyar jama'a, ko da kuwa sun shiga cikin wani yanayi na rashin lafiya".
Tedros ya kara da cewa "mu masu karfi ne kamar kashin jikinmu" kuma ya yi kira ga al'ummar duniya da su "yi kokarin magance wannan cuta yanzu ko kuma a kara tsanantawa nan gaba".A ranar 11 ga Fabrairu, WHO a taron manema labarai ta ayyana COVID-19 a matsayin cutar.
A wannan ranar, Tedros ya ce Babban Sakataren Majalisar Dinkin Duniya António Guterres ya amince da "dakatar da duk wata manufa ta Majalisar Dinkin Duniya a cikin wannan martani".
Ƙungiyar ta Majalisar Ɗinkin Duniya ta World Health Organization ta ba da amsa, ta ba da umarni ga Majalisar Dinkin Duniya, wadda WHO ta ba da shawara cewa "a ba da shawara ga al'umma a kan lafiyar lafiyar jama'a a lokaci guda, kuma sauran kungiyoyi za su iya yin amfani da su don magance matsalolin da suka shafi al'umma, da kuma al'ummominmu".
A ranar 14 ga watan Fabrairu, Hukumar Kula da Kula da Kula da Kula da China ta yi kira ga wakilan kasashen waje da na WHO a China da su taimaka wajen yin bincike da kuma gano "aukuwar cutar da kuma yadda za a iya yada ta" a cikin kasar ta hanyar tuntuɓar manyan cibiyoyin bincike da cibiyoyin bincike na kasashen waje don "ƙaddamar da ayyukan da za a yi a lardin da ƙauyuka, birane da garuruwa". A ranar 25 ga watan Fabrairu, WHO ta ce "a yanzu duniya tana yin shirye-shiryen da za a yi game da yiwuwar kamuwa da cutar coronavirus", kuma ta sanar da cewa a cikin wani lokaci za a iya gano da kuma kawar da cutar, kuma dole ne ƙasashe su kasance "a matakin farko".
A sakamakon sakamakon cutar da ke ci gaba a Iran, WHO ta tura wani rukunin bincike na musamman don yin bincike kan cutar.A ranar 28 ga Fabrairu, jami'an WHO sun ce za a fara gudanar da binciken cutar coronavirus a duniya daga "babban" zuwa "ƙananan", wanda zai zama matakin ƙarshe na binciken cutar.
Mike Ryan, mai kula da shirin gaggawa na kiwon lafiya na WHO, ya ce a cikin wata sanarwa cewa "Wannan ya zama babban abin mamaki ga kowace gwamnati a duniya: Muna da lafiya.
Wannan kwayar cutar za ta iya zama mai zaman kanta kuma dole ne a kawar da ita", ta hanyar samar da hanyoyin da za a iya samun mafita wanda zai iya hana duniya "ta hanyar yin amfani da ita".
Ryan ya kuma kara da cewa wannan bayanai na yanzu zai ba da tabbaci ga jami'an kiwon lafiya game da yadda cutar ta barke, yana mai cewa sakamakon ya nuna cewa "muna da babban tabbaci cewa kowane mutum a duniya zai iya kamuwa da cutar".
A watan Maris, WHO ta ayyana coronavirus a matsayin annoba.
Babban Daraktan ya ce WHO ta "ƙware sosai kan lamuran cutar da kuma yadda cutar ke yaduwa, da kuma yadda ake samun ci gaba". WHO ta yi la'akari da muhimmancin da ke tattare da abubuwan da ke faruwa a duniya kamar yadda ake kula da cutar, da kuma muhimmancin da ke tattare da al'amuran da suka shafi lafiyar jama'a da kuma shigar da cutar a cikin kungiyoyin cutar.
Har ila yau, an yi watsi da sanarwar da aka ba wa Shugaban WHO Tedros Adhanom na dakatar da aikinsa, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, Kwamitin Kula da Lafiya na Majalisar Dinkin Duniya ya yi wa'adi kan wasu shawarwari 10 da za a yi don ci gaba da kula da lafiyar dan Adam a yayin annobar COVID-19.
Kungiyar ta ce duk abin da aka yi ya shafi shirin satar mutane, kuma gwamnati na da hannu a ciki.
Ƙungiyar ta yi jayayya cewa rashin samun tsarin kiwon lafiya mai inganci ba zai iya zama hanyar warkar da sauran jama'a ba.
Masu bincike sun kuma yi la'akari da duk wanda ke da matsalar rashin lafiya, ciki har da mutanen da ke da cututtukan haihuwa, da kuma wadanda ke cikin kungiyoyi masu zaman kansu, da tsofaffi, da mutanen da suka yi canje-canje a rayuwarsu a kasar, da marasa gida, da marasa lafiya, da fursunoni, da masu neman taimako da sauran kungiyoyin da ke bukatar taimakon gwamnati.
Hukumomin duniya suna ta gwagwarmaya don magance matsalolin tattalin arziki da zamantakewa da COVID-19 ya haifar.
Kwamitin Ci Gaban Majalisar Dinkin Duniya ya ba da tabbacin bayar da bayanai a kan lokaci game da manufofin siyasa na ƙasashen duniya, da kuma abubuwan da suka shafi siyasa.
Daga manufofin da suka shafi kiwon lafiya da tsaro na duniya zuwa rage yawan zaman gida da kuma rage zirga-zirgar ababen hawa, daga cikin manufofin da suka shafi harkokin waje na Majalisar Dinkin Duniya, ya haɗa da ƙoƙarin taimakawa ƙasashe su koyi yadda za su yi aiki da kuma shirya don sake fashewa na coronavirus.
Gwamnatin China ta yi kira ga Amurka, da Ministan Ma'aikatar Burtaniya Michael Gove, da Firayim Ministan Brazil Jair Bolsonaro da kuma dan Eduardo Bolsonaro da su yi aiki tare don magance annobar, wacce ta fara a lardin Hubei na China.
An yi wa shugabannin wasu yankuna na Jam'iyyar Kwaminis ta Sin (CPC) horo saboda rashin iya kula da harkar cin zarafin al'umma a Jamhuriyar Sin, da kuma rashin samun ingantacciyar hanyar magance matsalar a yankuna masu tasowa.
Wasu masu sharhi sun yi amannar cewa matakin ya yi daidai da na babban sakataren jam'iyyar kwaminis na China Xi Jinping don ya yi wa jama'a jaje game da cutar korona.
Wasu masana masana na kasar Sin, kamar Zhao Lijan sun musanta da'awar cewa an gano cutar coronavirus a Wuhan, bisa ga tsarin kwayar cutar COVID-19 da aka samo asali a Amurka ko Italiya.
Gwamnan Amurka Donald Trump ya yi watsi da coronavirus a matsayin "kwayar cutar China" ko "kwayar cutar Wuhan" kuma ya ce China "ta gano wata cuta da ta zama annoba a yanzu", wanda wasu masu sukar suka yi da'awar cewa ba ta da tushe kuma "ba za a iya zargi hukuma ba saboda rashin kulawar da ta yi".
The Daily Beast ta sami wata sanarwa daga gwamnatin Amurka da ke nuna irin yadda ake samun ta'aziyyar da aka samu daga Kwamitin Tsaro na Kasa, kuma an kira wannan shirin "Duk abin da ya shafi kasar Sin.
An kuma bayyana cewa za a iya yin la'akari da irin wannan tallafi a wasu hanyoyi, ciki har da a kafofin watsa labarai da kuma a shafukan yanar gizo".Kasuwancin kasuwanci kamar Politico, Foreign Policy, da Bloomberg sun nuna cewa duk wani yunƙurin da China ke yi na neman tallafin ƙasashen waje na nuna rashin amincewa da ƙasashen duniya.
Shugaban harkokin wajen Josep Borrell ya ce akwai "wani tsarin siyasa da ke ci gaba da kasancewa a nan gaba a matsayin wata hanya ta samun ci gaba ta hanyar siyasa da kuma "samar da taimako".
Borrell ya kuma ce "China tana ƙin wannan bayanin da ƙarfi, ba kamar Amurka ba, wadda abokin ciniki ne mai mutunci da aminci".
China ta kuma yi kira ga Amurka da ta janye takunkumin da ta dauka kan Syria da Venezuela da Iran, ta kuma ba da taimako ga kasashen biyu da aka ambata a baya.
An dakatar da ziyarar Jack Ma da ke rufe 100,000 a Cuba saboda tashin Amurka daga ranar 3 ga Afrilu.
Gwamnatin Amurka ta yi tir da sauya kudaden tallafi da aka ba wa kasashen waje.
Akwai kuma wasu batutuwan da aka ruwaito na rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria, Switzerland; da Czech Republic da kuma Italiya.
Bugu da kari, Turkiyya ta ba da umarnin yin amfani da makamai masu linzami a kan makamai masu linzami da aka harba a Spain.
A farkon Maris, gwamnatin Italiya ta yi tir da Tarayyar Turai saboda rashin samun tallafi daga Italiya ga masu fama da cutar korona.
Maurizio Massari, wakilin Italiya a EU, ya ce "China ta yi watsi da duk wani mataki da aka dauka.
Wannan zai zama babban abin damuwa ga Tarayyar Turai. "
A ranar 22 ga watan Maris, bayan wani tattaunawa ta waya da Firaministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya ba da umarnin sojojin Rasha su kwashe magungunan soja, motocin share fage na musamman, da wasu umarnin magani daga Italiya.
Jaridar La Stampa ta Italiya ta ba da rahoton "kwarin gwiwar siyasa" amma ba ta ce ba cewa kashi 80% na taimakon da Rasha ke bayarwa "ba shi da amfani ko kuma ba shi da wani amfani ga Italiya".
Wannan labarin ya ce Rasha ta shiga cikin "rikice na siyasa da na siyasa" da wata ƙasa.
Shugaban Lombardy Attilio Fontana da kuma shugaban kungiyar Luigi Di Maio sun yi musayar ra'ayoyi da kuma bayyana rashin amincewarsu.
Rasha ta kuma aika da jirgin sama da ke jigilar kayayyaki da kayan kiwon lafiya zuwa Amurka.
Babban jami'in Kremlin Dmitry Peskov ya ce "a lokacin da aka ba da taimako ga abokan Amurka, [Putin] ya yi imanin cewa masu samar da kayayyakin kiwon lafiya na Amurka za su sami damar yin hakan idan suka sami damar".
NATO ta shirya wani sabon shirin soja mai suna "Defender 2020" a Jamus, Poland da kuma kasashen Baltic, wanda shine shirin soja mafi muhimmanci da NATO ta yi tun bayan da aka kafa Ƙungiyar Soji ta Tarayya, amma ba a kammala shi ba.
Shugaban Hukumar Kula da Harkokin Kasuwanci ta Tarayyar Turai Kate Hudson ta yi tsokaci game da shirin Defender 2020: "Game da cutar ta yau da kullun, za ta iya shafar sojoji daga Amurka da sauran ƙasashen Turai da ke aiki a can da kuma mutanen ƙasashen da wannan cutar ke aiki a can. "A Iran an sami kusan mutane ashirin da suka kamu da cutar, kuma an yi rahoton cewa fiye da mutane ashirin da biyu sun kamu da cutar tare da wasu 'yan siyasa goma sha shida.
Shugaban kasar Iran Hassan Rouhani ya rubuta wata wasikar budewa ga shugabannin duniya inda ya nemi taimako a ranar 14 ga Maris, 2020, inda ya ce kasarsa tana yaki da cutar saboda ba za ta iya shiga wasu kasashe ba saboda takunkumin da Amurka ta yi wa Iran.Wannan annoba ta haifar da zanga-zangar a Amurka don kawar da manufofin da ba a yarda da su a kasashe masu tasowa, da kuma kula da lafiyar duniya, kula da yara, kula da gida mai zaman kansa, da kuma taimakon likita da kudi da kuma sauran manufofi.
Masana siyasa sun yi gargadin cewa hakan na iya haifar da rikici a lokacin zaben Donald Trump a zaben shugaban kasa na 2020.
Koriya ta Kudu ta yi watsi da "shirin keɓewa da tsabtace tsabtace" bayan da Japan ta ba da umarnin cewa duk wanda ya tashi daga Koriya ta Kudu ya keɓe kansa na tsawon makonni biyu a wani wurin da gwamnati ta tsara.
Koriya ta Kudu ta yi kira ga shugaban kasar Moon Jae-In da ya yi murabus a kan lamarin.
Koriya ta sa hannu a takardar da ke nuna cewa Moon ya yi watsi da shawarar da ta bayar na cewa gwamnati za ta iya magance cutar ko kuma ta yi watsi da ita. Wannan annoba ta haifar da gaggawa a matsayin amsar.
Wasu masu kallo sun yi imanin cewa zai iya ba da damar gwamnatoci su yi amfani da ikon su a cikin sararin samaniya.
A Hungary, majalisar ta yanke shawarar ba da lissafi ga Firayim Minista, Viktor Orbán, don magance matsalar ta hanyar ci gaba da gudanar da zabe, da dakatar da majalisar da kuma zabar wadanda aka tabbatar da sun bayar da bayanan da ba daidai ba game da cutar da kuma yadda gwamnati ke kokarin magance matsalar tsaro.
Cutar koronaviris ta haifar da matsaloli da yawa kamar ƙonewa, rashin lafiyar da ke haifar da ƙonewa a cikin asibitoci don kula da cutar a duniya, barazanar rashin lafiya, ƙuntatawa na masana'antu da kuma zirga-zirga.
Hukumar Abinci da Magunguna ta Amurka ta ba da sanarwar cewa za a yi bincike kan magungunan da aka sayar a kantin magani da kuma umarnin likita domin an samu karin takardun shaida daga masana'antun da suka yi watsi da su.
Yawancin yankuna kuma suna fuskantar barazanar lalacewar da ke haifar da lalacewar abubuwa kamar abinci, da shara, da ruwan sanyi, wanda ke haifar da lalacewar abubuwa.
A mafi yawan lokuta, tsarin fasaha yana dogara ne akan tsari a cikin tsarin abubuwa kamar tsari.
A cewar Babban Daraktan WHO Tedros Adhanom, bukatar kayayyakin kariya ta jiki ta karu da kashi 100.
Wannan ya haifar da abubuwa masu ban sha'awa da yawa kuma ya haifar da wani abu mai ban sha'awa kamar itace a cikin hudu zuwa shida dabbobi.
A duk duniya, ana samun ƙwayoyin cuta da wuya a samu, kuma WHO ta yi gargadin cewa wannan na iya zama barazana ga masu kiwon lafiya.
A Ostiraliya, cutar ta ba da dama ga masu sayar da kayayyaki su sayi kayayyakin Australiya daga China.
Wannan ya sa aka hana sayar da kayayyakin jarirai a manyan kantunan sayar da kayayyaki kuma gwamnatin Ostiraliya ta hana su.Kodayake akwai karuwar masu kamuwa da cutar COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma tashin hankali kan kayayyakin abinci da yawa, amma har yanzu ba a sami matsalar abinci ba a yankuna biyu.
A cikin tsarin sarrafa kayayyaki na China da Italiya, da kuma tsarin kasuwanci na kayayyaki masu inganci, ana samun raguwar abinci mai gina jiki a Turai da Arewacin Amurka.
A cikin Italiyanci, an yi amfani da ita a matsayin hanyar da za ta iya magance matsalar rashin tsaro, amma farashin ya karu a cikin al'ummomin da ke da'awar.
An samu karancin abinci na ɗan lokaci a Wuhan, yayin da gwamnatin China ta kafa wata hanya ta samar da abinci ga jama'a.
Irin wannan doka a Italiya ta hana masu samar da abinci daga yin hakan.
An ba da rahoton fargabar cutar a China: a cikin rahoton rahoton kafofin watsa labarai na 16 ga Maris, an ba da rahoton cewa an yi wa masana'antar kasar Sin mummunan rauni a farkon watanni biyu na 2020 saboda matakan da gwamnati ta ɗauka don hana yaduwar cutar, tare da raguwar tallace-tallace na ƙananan kayayyaki da kashi 20.5%.
Kasar Sin dai cibiyar tattalin arziki ce ta duniya, inda cutar ta yi sanadiyyar mutuwar mutane da dama.
Agathe Demarais ta Economist Intelligence Unit ta ce, "Dole ne a yi hasken rana kafin a iya ganin ko wane abu da ke cikinta".
A cikin watan Janairun 2020, wasu masana sun yi amannar cewa cutar ta mutu a lokacin da ta yi yawa fiye da SARS a 2002-2004.
Wani masanin kimiyyar halittu a Jami'ar Washington a St. Louis ya ce sama da dala biliyan 300 ne aka kashe a wannan yunkurin na kawar da cutar da zai dauki tsawon shekaru biyu.
Kungiyar Kasashen Da Ke Fitar Da Man Fetur ta OPEC ta ce "an yi tashin gwauron zabi" bayan farashin man ya yi kasa sosai sakamakon matakin da China ta dauka na hana ta shigowa da man fetur.
Kasashen duniya sun yi addu'a a ranar 24 ga Fabrairu saboda yawan masu kamuwa da COVID-19 a kasashen waje da China.
A ranar 27 ga Fabrairu, saboda karuwar damuwa da annobar coronavirus, farashin kayayyakin Amurka da NASDAQ-100, S&P 500 Index, da kuma Dow Jones Industrial Average sun fadi a mafi girma tun daga 2007-08.
Dukkanin jihohin uku sun yi nasara da kashi 10 cikin 100 a makon da ya gabata.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta ba da rahoton ƙididdigar Sin, amma ta yi watsi da ita a matsayin mai ba da shawara ga kasar Sin.
Farashin ya sake raguwa saboda tsoron cutar coronavirus, dangane da farashin da aka samu a ranar 16 ga Maris.
Mutane da yawa sun yi tunanin cewa zai iya zama mai kyau.
Shugaban kungiyar Mohamed El-Erian ya yi godiya ga matakan gaggawa da aka dauka na gaggawar kai ga cibiyoyin tsaro na tsakiya da na kasa da suka isa a kan lokaci.
Kamfanonin ajiyar kuɗi sun yi watsi da kudaden shiga da aka ba su a cikin 2008.
Balaguron ya kasance wani yanki na aiki wanda ke da matukar damuwa saboda takunkumin hana zirga-zirga, rufe hanyoyin sufuri na jama'a da zirga-zirgar jiragen sama, da kuma hana gwamnatocin uku daga kowa yin balaguro a duniya.
A sakamakon haka, an dakatar da zirga-zirgar jiragen sama da yawa don masu zirga-zirgar jiragen sama, kamar British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin saman yankin Burtaniya na yankin Flybe ya tsaya.
Ƙungiya da kuma ma'aikata ma sun san da addu'o'in da ba su taɓa ƙarewa ba.
Wasu kamfanonin jiragen ruwa da na jiragen ruwa sun rufe kofofinsu.
Wannan ya haɗa da Chunyun, lokacin balaguro na bazara da kuma bikin Sabuwar Shekara na China.
Yawancin ayyukan da aka yi da jama'a sun haɗa da gwamnatocin jihohi da jihohi, bikin Sabuwar Shekara, da kuma haɗin gwiwar da aka yi da gidaje da wuraren shakatawa na musamman kamar Hong Kong Disneyland da Shanghai Disneyland.
Abubuwan da aka gano a cikin Sabuwar Shekara sun hada da abubuwa uku da aka gano a cikin al'ummomin da aka gano, da kuma Ƙaƙƙarfan Ƙasar a Beijing da kuma wasu wuraren da aka gano a gidajen tarihi.
A cikin larduna 24 zuwa 31 na kasar Sin, birane da yankuna, jami'an tsaro sun yi bikin bikin sabuwar shekara a ranar 10 ga watan Fabrairu, kuma an yi gargadin cewa za a bude wasu gidajen cin abinci a lokacin da ya dace.
Wannan bangare yana da kusan kashi 80% na GDP na ƙasar da kuma kashi 90% na yawan amfanin ƙasa.
Hong Kong ta tsawaita matakanta na dakile cutar zuwa na yau da kullum da kuma sanar da dokar ta-baci, ta rufe makarantu a watan Maris, ta dakatar da bukukuwan sabuwar shekara. An kuma dakatar da kananan kantunan duniya, tare da rage lokutan shiga cikin manyan kantuna ko rufe su gaba ɗaya.
Ƙananan masu sayen kayayyaki a Turai da Latin Amurka sun karu da 40%.
Ƙananan ƙasashe a Arewacin Amurka da Gabas ta Tsakiya sun ragu da kashi 50-60.
Wannan ya sa yawan cinikin da ake yi a shagunan ya ragu da kashi 33-43% a watan Maris idan aka kwatanta da na watan Fabrairu.
Shugabannin masana'antun duniya sun ba da ƙarin shawarwari, ciki har da haɓaka kula da lafiya, samar da kayan aikin jin dadi don magance matsalar rashin lafiyar abokan ciniki, da kuma dakatar da ayyukan.Kwamitin Tattalin Arzikin Majalisar Dinkin Duniya na Latin Amurka ya yi hasashen cewa cutar da ta haifar da lalacewar kayan aiki na iya barin mutane tsakanin miliyan 14 da 22 a cikin matsananciyar cutar a Latin Amurka a lokacin da babu wata annoba.
A watan Janairu da Fabrairun 2020, lokacin da annobar ta ɓarke a Wuhan, mutane miliyan 5 a China sun rasa ayyukansu.
Kimanin ma'aikatan kasar Sin da ke zaune a kasashen waje sun kai kimanin miliyan 300 wadanda ke zaune a gidajen da ke lardin Hubei.Kamar yadda aka kiyasta a watan Maris na shekarar 2020, fiye da miliyan 5 na Amurkawa a kasar Sin sun rasa ayyukansu kuma suna neman tallafi daga gwamnati.
Coronavirus zai iya haifar da asarar ayyuka miliyan 47 a Amurka kuma rashin aikin yi na iya kaiwa 32%, a cewar Bankin Tsaro na Tarayyar St Louis. Kasancewa a gida a Indiya ya sa ma'aikatan kasashen waje a Indiya su yi aiki da miliyoyin (wanda aka biya daidai gwargwado). Wani rahoto daga Cibiyar Angus Reid ya gano cewa kashi 44% na iyalan Kanada suna cikin irin wannan rashin aikin yi. Kimanin ma'aikata 900,000 sun rasa ayyukansu a Spain kuma an kore su daga gida a tsakiyar Maris 2020.
A cikin watan Maris, ma'aikatan Faransa miliyan 4 sun yi ritaya daga aikin yi saboda rashin aikin yi, yayin da ma'aikatan Burtaniya miliyan 1 suka yi ritaya daga aikin yi. Kusan rabin miliyan na masana'antun Jamus sun bar ma'aikatansu bisa ga umarnin gwamnati a cikin wani ɗan gajeren lokaci da aka sani da Kurzarbeit.
Ba a yi nasara ba a cikin aikin ba da daɗewa ba a Jamus kuma an yi nasara da Faransa da Ingila.
Aukuwa kamar aikin hannu ko aikin gida na iya samun mummunan tasiri a yayin da cutar ta mamaye, wanda ke haifar da mummunan tasiri ga tsarin aiki da kuma al'ummomin da aka dauka duka ma'aikata ne da kuma masu zaman kansu a duniya.
Hukumomi kamar su kantin sayar da kayayyaki ko gidajen tarihi na iya yin amfani da ayyukanta (mafi yawa ana samun kuɗin gwamnati) don buɗe gidajen tarihi ga jama'a, kiyaye lafiyar ma'aikatansu da na jama'a, da kuma kula da masu yawon buɗe ido idan ya yiwu.
A cikin watan Maris na 2020, a yayin da ake fama da cutar a duniya, gidajen tarihi, gidajen karatu, wuraren baje kolin, da sauran wuraren jama'a da dama sun rufe kofofinsu, an dakatar da ayyukansu, ko kuma an dakatar da ayyukansu.
An kuma yi kokarin hana wasu daga cikin masu garkuwa da mutane ta hanyar yin amfani da umarni.Wani abin da ya faru da wannan annoba ya zama sanadin dakatar da ayyukan addini, wasanni, da sauran ayyukan jama'a, kamar bukukuwan kiɗa da rawa, taron fasaha, da kuma zanga-zanga.
An kuma dakatar da samar da bidiyo. Vatican ta sanar da cewa za a dakatar da gudanar da bukukuwan ranar Asabar mai tsarki a Roma, wanda ke gudana a karshen mako na Juma'a.
Yawancin gidaje sun ba da izinin tsofaffi su yi wa'azi a gida daga haikalin zuwa Haikali da kuma Alfarma; wasu kuma suna yin wa'azi ta hanyar rediyo, talabijin ko kuma ta wasu hanyoyi da wasu mutane suke yi a cikin mota.
A cikin watan Maris, Roman Katolika ta rufe wasu majami'u da wuraren ibada a Babila da St. Peter's, kuma ba a ba da izinin Masons ba, kuma wasu addinai sun dakatar da yin ibada da kuma hana jama'a daga masallatai, Majami'un Mohammed, gidajen ibada da gurdwaras.
Hukumomin Iran sun sanar da dakatar da ziyarar ranar Juma'a a yankunan da cutar ta shafa kuma daga baya sun rufe wuraren ibada, yayin da Saudi Arabia ta dakatar da shigowar matafiya daga kasashen waje da na cikin gida zuwa wuraren da ke kusa da Makka da Madina.
Annobar ta haifar da gagarumar sauyi a fagen wasanni a duniya tun bayan Yaƙin Duniya na Biyu.
Yawancin wasannin wasannin wasanni za a dakatar ko kuma a soke su, kamar 2019-20 UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, 2019-20 NBA Season, da kuma 2019-20 NHL Season.
A watan Maris, Hukumar Olympic ta Duniya ta sanar da cewa "za a yi wasan ne a tsakiyar shekarar 2020 ba a tsakiyar shekarar 2021 ba".
Wannan ya sa 'yan wasa suka tafi da iska, kuma gidajen caca da yawa sun ba da rahoton ƙaruwar yawan masu halarta. An dakatar da filin wasan da kiɗa, kuma ƙungiyoyin kiɗa sun dakatar ko hana ayyukansu.
Yawancin gidajen wasan kwaikwayo, ciki har da na Broadway, sun dakatar da ayyukansu.
Wasu masu wasan kwaikwayo sun nemi wasu hanyoyi don ci gaba da yin aiki da kuma rarraba ayyukansu a duniya kamar su shiga cikin jama'a, kamar su shiga cikin jama'a ko samar da "ƙungiyoyi" na duniya, aikawa, da kuma nuna aikin su.
A cewar rahotanni, masu bincike na duniya da dama sun yi la'akari da coronavirus a matsayin wata cuta da ke fama da ita a cikin tsakiyar shekara.
Tun bayan barkewar COVID-19, ana nuna nuna ƙiyayya, wariya, da nuna bambanci tsakanin Sinawa da waɗanda ke da asalin yankin Asiya ta Gabas, da kuma waɗanda suka fito daga yankunan da cutar ta fi kamari a Turai, Amurka, da sauran ƙasashe.
A cikin ƙasashe da yawa muna fuskantar ƙuntatawa, rashin kulawa, da kuma rashin jin daɗi, musamman a Turai, Gabashin Asiya, Arewacin Amurka, da yankin Asiya-Pacific.
Wasikun da aka fitar a watan Fabrairu (lokacin da yawancin masu kamuwa da cutar suka kamu a kasar Sin) sun nuna rashin amincewa da ra'ayoyi daga bangarori daban-daban na al'ummar kasar Sin game da ko cutar ta same su ko kuma sun yarda da cewa Allah ne ya yi hakan.
Sauran kasashen Afirka ma sun nuna damuwa kan batun da ya shafi 'yan China da ke fuskantar matsanancin talauci.
Yawancin mazauna Wuhan da Hubei sun yi iƙirarin cewa za a yi zaben ne bisa ga asalin su.
Mutanen kasar Sin sun sami kariya ta musamman, ta hanyar rigakafin cutar baki daya, da kuma ta hanyar samun damar shiga wuraren da cutar ta fi kamari.
Saboda yadda cutar ta yadu a kasashe da suka kamu da cutar, mutane daga Italiya, kasar da ta fara ba da rahoton kamuwa da cutar COVID-19 a Turai, za su iya zama masu laifi ko kuma a yi musu hukunci. 'Yan ƙasa daga ƙasashe kamar Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu a kan takardun da ke neman hana shigo da Sinawa zuwa ƙasashensu don magance cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama ruwan dare a Twitter.
Ƙungiyoyin Sinawa da sauran mutanen Asiya a Birtaniya da Amurka sun yi rahoton cewa an sami karuwar rashin jituwa na asali, da kuma wasu matsaloli.
An yi wa shugaban Amurka Donald Trump alhakin kiran cutar coronavirus da "Chinese virus", wani furucin da ya zama abin ba'a da ba'a a idanun masu sauraronsa.
Kungiyar 'yan ta'adda a Ukraine ta dakatar da motocin da ke dauke da 'yan Ukraine da wasu 'yan kasashen waje daga Wuhan zuwa Novy Sanzhary.
Dalibai da suka dawo daga Arewa maso gabashin Indiya, wanda ke da iyaka da China, kuma ke zaune a yawancin biranen Indiya an ba da rahoton cewa sun kamu da cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata Party na jihar West Bengal Dilip Ghosh ya ce China ita ce duniya kuma "Allah ya albarkace su saboda hakan".
Wannan al'amari ya sami karɓuwa daga wani jami'in al'ummar Sin da ke Kolkata a baya, wanda ya kira shi "ba daidai ba". A China, nuna bambanci da nuna bambanci ga al'ummar da ba ta fito daga China ba ya ƙaru a yayin da cutar ta zama ruwan dare, kuma baƙi sun zama "kayan da aka ba da kyauta" wanda dole ne a "bace".
An cire wasu haruffa da rubutu da aka yi amfani da su don ƙarin bayani ko kuma don ƙarin bayani game da coronavirus.
Yawancin masu bincike na ilimin harshe sun yi magana game da wannan cuta ba tare da sun nuna wani abu ba.
Wasu masu bincike sun zabi su rarraba sakamakon binciken su ta hanyar oda kafin a buga su a shafukan yanar gizo kamar su bioRxiv.
Cutar da aka samu ta hanyar sabon kwayar cuta, cuta ce da aka kamu da ita ta hanyar sabon kwayar cuta, musamman ma da sabon kamuwa da cuta na yau da kullum ko kuma na yau da kullum.
Duniya ta kamu da cutar - bincike na duniya da kuma maganin cutar
Yawan kamuwa da cutar - Yawan mutuwar cutar da ba ta da kamuwa da cutar
Magungunan dabbobin da ke dauke da kwayoyi - Abubuwan da ke haifar da rashin lafiyar da ba su da alaƙa da cinikin kwayoyi da aka shigo da su.
Gwajin gwaji na coronavirus na 2019 (COVID-19) a cikin dakin gwaje-gwaje tare da kwayar cuta ba tare da SARS-CoV-2 ba ya haɗa da tsarin rigakafin cutar da masu bincike na rigakafin rigakafin rigakafin rigakafin da aka samo don magance cutar.
Ana iya tabbatar da bayyanar cutar a cikin ƙwayoyin cuta ta hanyar RT-PCR, wanda ke nuna RNA na coronavirus.
Wannan gwajin na musamman ya shafi RNA na SARS-CoV-2 virus.
Yana da amfani wajen gano sababbin cututtuka ko cututtuka masu aiki.
Gwajin jini na iya zama da amfani ga bincike da kuma kare jama'a.
Gwajin likitancin jiki yana nuna yadda mutane suke da cutar, kamar waɗanda ba su da alamun bayyanar cututtuka da yawa ko kuma ba su da alamun bayyanar cututtuka.
Za a iya tantance yawan mace-macen da ke da cutar da kuma inda al'ummar ke da lafiya ta hanyar sakamakon gwajin.
A sakamakon binciken da aka gudanar, a watan Maris na shekarar 2020 babu wata ƙasa da ta samu cikakken bayani kan yawan masu cutar a cikin al'umma.
A ranar 23 ga watan Maris, babu wata kasa da ta samu sama da kashi uku cikin dari na yawan masu cutar, kuma akwai matukar damuwa game da yadda cutar ke yaduwa a cikin kasashe.
Wannan bambancin ya shafi yawan adadin mutuwar da aka ruwaito, wanda yawanci ana yin ta bakin mutane a wasu ƙasashe.
Yin amfani da gwajin gwajin ƙwayar cuta na polymerase (rRT-PCR) na gaba zai iya zama da sauƙi dangane da samfurin ƙwayoyin cuta da aka samo ta hanyoyi daban-daban, ciki har da ƙwayoyin cuta ko ƙwayoyin cuta.
Yawancin lokuta ana samun alamun cutar a cikin 'yan sa'o'i ko kuma cikin kwana biyu.
Gwajin RT-PCR da aka yi a kan ƙwayar hanci ba shi da inganci sai a cikin makon farko na kamuwa da cutar.
Bayan haka, kwayar cutar za ta iya zama a cikin hanci yayin da take cikin huhu.
A cikin mutanen da aka gwada a cikin makonni biyu, za a iya ɗaukar wasu kayan ji na numfashi ta hanyar numfashi ta hanyar yin amfani da catheter ko kayan numfashi (na'urar numfashi).
Daya daga cikin gwajin PCR na farko da aka fitar a Charité a Berlin a ranar 20 ga Janairu 2020 ta amfani da bincike na jerin polymerase (rRT-PCR) na baya-bayan nan, kuma ya samar da kimanin 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
A ranar 23 ga watan Janairun 2020 ne Birtaniya ta sanar da cewa za a iya gwada cutar.Koginebiotech na Koriya ta Kudu ya sanar da cewa za a iya gwada cutar ta SARS-CoV-2 ta hanyar PCR (PowerChek Coronavirus) a ranar 28 ga watan Janairun 2020.
Yana bincika kwayar "E" da kowane kwayar cutar beta ke dauke da ita, da kwayar RdRp da ke da illa ga SARS-CoV-2.A China, BGI Group ya kasance ɗaya daga cikin cibiyoyin bincike na farko da suka karɓi takardar izinin gaggawa daga Hukumar Kula da Magunguna ta China don kayan gwajin PCR na SARS-CoV-2.A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) suna ba da shawarar sabon kwayar cutar Coronavirus 2019 (2019-nCoV) RT-PCR a halin yanzu ga cibiyoyin bincike na gwamnati ta hanyar Reagent International Resource.
Ɗaya daga cikin uku daga cikin gwaje-gwajen kwayar halitta a cikin tsarin kayan gwajin da aka yi a baya ya nuna alamun rashin lafiya saboda ƙwayoyin cuta, tare da ƙwarewar gwaji a CDC a Atlanta; wannan ya ba da damar ƙididdigar ƙwayoyin cuta da ke ƙasa da 100 a cikin kwanaki don a gwada su da kyau a cikin watan Fabrairu 2020.
Gwajin gwaji guda biyu ya nuna cewa akwai tabbataccen shaida a ranar 28 ga Janairu, 2020, kuma daga baya duk cibiyoyin bincike na tarayya da na jihohi sun amince da fara gwajin.
An amince da gwajin a Hukumar Abinci da Magunguna ta Amurka a karkashin wani izinin gaggawa na amfani da shi. Cibiyar bincike ta kasuwanci ta fara gwajin a farkon Maris 2020.
Tun daga ranar 5 ga Maris, 2020 LabCorp ya sanar da cewa a duk faɗin ƙasar akwai gwajin COVID-19 na RT-PCR.
Quest Diagnostics ya kuma sanar da cewa a duk fadin kasar akwai gwajin COVID-19 daga 9 ga Maris, 2020.
Babu wani abu da ya rage yawan adadin da aka rubuta; an yi amfani da gwajin gwaji da kuma gwaji bisa ga shawarar CDC.
A Rasha, gwajin COVID-19 ya samo asali ne daga Cibiyar Bincike ta Jihar Virology da Biotechnology VECTOR.
A ranar 11 ga Fabrairun 2020 Hukumar Kula da Kula da Lafiya ta Tarayya ta amince da gwajin.A ranar 12 ga Maris 2020, Mayo Clinic ta bayar da rahoton cewa ta samar da gwajin gano cutar COVID-19.A ranar 13 ga Maris 2020, Roche Diagnostics ta karɓi FDA ta ba da izini don ƙarin gwajin da zai iya wucewa cikin sa'o'i 3.5 da rabi, yana ba da izini don yin gwaje-gwaje 4 128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa na EUA ga Abbott Laboratories don gwaji bisa tsarin Abbott m2000; FDA ta ba da izinin irin wannan izinin ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ya sami izinin FDA don gwajin gwajin gwajin wanda ya ɗauki minti 45.
FDA ta amince da wani gwaji wanda ya yi amfani da isothermal nucleic acid amplification technology maimakon PCR.
Don ƙayyade canje-canje a cikin zafin jiki da kuma yawan zafin jiki, wannan tsari zai iya ɗaukar sakamako mai kyau a cikin minti biyar kuma mummunan sakamako a cikin minti goma sha uku.
Akwai kimanin umarni 18,000 a Amurka kuma Abbott yana da niyyar taimakawa wajen samar da gwajin 50,000 a kowace rana.Bayan wannan, an yi amfani da gwajin likitanci tare da ƙwayoyin cuta guda ɗaya wanda ke da alaƙa da kwayar cutar kwayar cutar (N protein) a cikin Taiwan, tare da tsammanin samar da sakamako a cikin minti 15 zuwa 20 a matsayin gwajin bazara kawai.
Wani bincike da aka yi a watan Maris ya nuna cewa "radio na zuciya ya zama kamar ƙaramin gwaji ne a farkon matakan, amma sakamakon CT [saman hoton da aka zana a cikin hoto] zai iya kasancewa kafin a fara samun matsala.
Wasu cututtuka na CT sun haɗa da bilateral multilobar ground-glass opacificities da kuma kusurwoyi a baki, baya, da kuma gaba.
Duk da haka, yana da saurin yaduwa a cikin ƙananan ƙananan, kuma yana da haɗuwa da haɗuwa da haɗuwa idan cutar ta ci gaba.
Wani bincike da aka yi na PCR da CT a Wuhan a farkon barkewar cutar ya nuna cewa CT ya fi PCR ƙarfi, ko da yake ba a iya dogara da shi ba, kuma an yi amfani da shi a wasu nau'o'in ciwon huhu da kuma hanyoyin kamuwa da cuta.
A watan Maris na 2020, Kwalejin Rediology ta Amurka ta ba da shawarar cewa "ba za a iya amfani da CT don bincike ba ko a matsayin hanyar farko don magance COVID-19". A watan Maris na 2020, CDC ta ba da shawarar PCR don gwaji na farko.
A cewarsa, matakin farko na rigakafi shine samar da rigakafin rigakafi irin su IgM da IgG.
Wannan zai iya zama da amfani wajen gano cutar a cikin mutane tun daga farkon kwana 7 ko kuma bayan bayyanar da alamomin, don nuna rashin lafiyar jiki, da kuma a cikin kulawar al'umma. Ana iya gudanar da bincike a cikin dakunan gwaje-gwaje na cibiyar (CLT) ko ta hanyar gwajin asibiti (PoCT).
Hanyoyin gwaji na yau da kullun a yawancin dakunan gwaje-gwaje na iya magance waɗannan matsalolin amma suna da iyakance dangane da yawan fitowar kowane tsari.
A cikin CLT, an fi ɗaukar nau'in jini wanda yake auna yawanci, ko da yake ana iya ɗaukar nau'in jini mai yawa don auna ƙarfin rigakafin jiki.
A cikin yanayin PoCT, an dauki mafi yawan masu cutar jini guda ɗaya ta hanyar allurar rigakafi.
Ba kamar sauran hanyoyin PCR ba, ba a buƙatar a yi amfani da ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa kafin a yi amfani da gwajin.A ranar 26 ga Maris, 2020, FDA ta lissafa nau'ikan 29 waɗanda ke ba da bayanan asibiti kamar masu karɓa kuma suna iya buƙatar gwajin likita.
A ranar 7 ga Afrilu, 2020, an ba da izinin gwajin gwaji guda ɗaya na FDA don gaggawa na gaggawa. A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun ba da izini.
Yawan gwajin ya yi daidai da yawan gwajin da aka yi a cikin ƙwayoyin cuta kuma ya fi rikitarwa fiye da gwajin RNA na kwayar cutar PCR da aka sani.
Ba a tantance likitanci ba har sai bayan kwanaki 14 da fara cutar.A watan Afrilu, Ingila ta gano cewa tana cikin jerin wuraren da likitancin ke amfani da shi a matsayin hanyar da ta fi dacewa ta amfani da shi.
Hong Kong ta ba da wani sabon tsarin inda duk wanda ake zargin yana da cutar a gida, "ma'aikatan kiwon lafiya za su ba da maganin ga wanda ake zargi", a yi masa allurar rigakafi, a duba shi, sannan a gano sakamakon. NHS Ingila ta sanar da cewa tana ba da umarnin yin gwajin cutar a gida ga duk wanda ake zargi, wanda ke kawar da yiwuwar kamuwa da cutar daga wasu mutane lokacin da suka isa asibiti, ko kuma wanke motar da ke dauke da cutar. A cikin gwajin cutar COVID-19 na cikin gida ga mutanen da ke da cutar, ma'aikacin kiwon lafiya yana ɗaukar allurar rigakafi da magunguna.
A cikin Jamus, National Association of Statutory Health Insurance Physicians ya ce a ranar 2 ga Maris, zai iya samar da 12 000 gwaje-gwaje da aka yi a cikin yankunan da za a iya amfani da shi kuma a cikin mota da 10 700 aka yi a cikin makonni na farko.
Likita ba zai iya yin wannan binciken ba idan likita ya ba da shawara.
A cewar wani bincike da Robert Koch ya yi, Jamus na iya daukar mutum 160,000 a mako.
A ranar 19 ga Maris, an gudanar da gwaje-gwaje a cikin motoci a birane da yawa.
A ranar 26 ga Maris, 2020 ba a kammala dukkan gwaje-gwajen da aka gudanar a Jamus ba, saboda kawai an bayar da rahoton sakamako mai kyau.
Wani jami'in asibiti ya ba da rahoton cewa daga makon 12/2020 an gwada 483 295 gwaje-gwaje kuma daga 12/2020 an gwada 33 491 (6.9%) na SARS-CoV-2.[1] A Isra'ila, masu bincike a Technion da kuma Rambam Hospital sun gabatar da kuma gwada wani sabon tsarin gwajin gwaji a kan mutane 64 a cikin wani asibiti, ta hanyar yin amfani da magani a cikin wani asibiti kuma bi da gwaji idan haɗuwa da magani ya haifar da kamuwa da cutar.[2] Wuhan Cibiyar bincike ta gaggawa ta farko ta 2000 da ake kira "Huo-Yan" (Chinese: 火眼, "G wuta") da aka rufe a ranar 5 ga Fabrairu 2020 ta BGI, ta yi gwajin gwaje-gwaje 10,000 a kowace rana.
Tare da wani gini wanda shugaban BGGI Wang Jian ya gina kuma ya ɗauki kwanaki 5, sakamakon ya nuna cewa adadin marasa lafiya a Hubei zai iya zama kusan 47% kuma farashin magani na gida zai ninka sau biyu idan yawan gwajin ya kasance daidai.
Wuhan Laboratory ya kasance a cikin jerin cibiyoyin bincike na Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, da kuma cibiyoyin bincike a birane 12 na kasar Sin.
A watan Maris 2020 yawan adadin gwaje-gwaje ya kai 50 000 a rana. A cikin tsari mai budewa, an samar da nau'ikan gwaje-gwajen Origami da za su iya magance cutar COVID-19 1122 da kuma gwaje-gwaje 93.
A watan Maris, yawan reagent ya ƙare kuma ya zama matsala ga gwaji da yawa a cikin EU da Ingila da Amurka.
Wannan ya sa wasu masana suka kirkiro wata hanyar tsara maganin da ta hada da hada miyagun kwayoyi a 98 °C (208 °F) cikin minti 5 don cire RNA genome don wasu kwayoyin.A ranar 31 ga Maris an ba da rahoton a Hadaddiyar Daular Larabawa cewa suna gwada yawancin al'ummarsu don coronavirus daban da na kowace ƙasa, kuma yana da alhakin gudanar da gwaje-gwaje har zuwa mafi yawan jama'a.
Wannan ya zo ne ta hanyar hada tsarin gwajin a cikin mota, da kuma samar da dakunan gwaje-gwaje masu amfani da motoci a cikin Group 42 da BGI (gwargwadon dakin gwaje-gwaje na gaggawa na "Huo Yan" a China).
An gina shi cikin kwanaki 14, wannan dakin gwaje-gwaje na iya karɓar dubban gwaje-gwajen RT-PCR sau goma a kowace cuta kuma ya zama na farko irin sa a wajen kasar Sin.
An yi amfani da hanyoyi daban-daban na gwaji don nazarin kwayoyin halittar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta amince da shirin Jamus na fitar da kayayyakin da aka yi niyya a ƙasashen da ba su da talauci da yawa da ba za su iya fitar da nasu ba.
Ba a fitar da samfurin Jamus ba har zuwa 17 ga Janairu, 2020; ba a fitar da samfurin Cibiyar Nazarin Amurka ba har zuwa 28 ga Janairu, wanda zai iya tabbatar da gwajin da aka yi a Amurka. Kasar Sin da Amurka sun fuskanci kalubale kan amincin gwajin gwaji a farkon barkewar cutar, yayin da kasashen Turai da Ostiraliya ba su iya samar da kayan gwajin da suka dace da gwajin jijiyoyin jiki da na jijiyoyin jiki na marasa lafiya ba.
A wani lokaci, masana sun yi iƙirarin cewa gwajin da aka gudanar a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
Tsarin gwaji, musamman a dakunan gwaje-gwaje na kasuwanci, an tsara shi ne shekaru da yawa da gwamnatin Koriya ta Kudu.
A ranar 16 ga watan Maris, Ƙungiyar Lafiya ta Duniya ta yi kira ga gaggauta samar da tsarin gwaji a matsayin muhimmin mataki na rage yaduwar cutar COVID-19.Abubuwan da suka shafi gwaji sun yi yawa saboda yaduwar kwayar cutar ta hana gwajin kwayar cutar a cibiyoyin gwaji na kasuwanci a Amurka, kuma kayan aikin adanawa da reagents sun yi yawa.
A watan Maris na 2020, Cayenne ya ba da sanarwar cewa akwai matsaloli tare da amintacce a cikin binciken da aka gudanar.
A Amurka, gwajin da aka yi a Sin da CDC ta yi ya nuna cewa akwai "rashin tabbaci", kuma gwamnati ta kafa wasu takunkumi da suka hana yin gwajin a wasu dakunan gwaje-gwaje na gwamnati. Spain ta sayi gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na China, amma ta ga cewa sakamakon ba shi da tabbas.
Cibiyar ta yi amannar cewa sakamakon da ba a tabbatar ba na iya zama sanadiyar wata matsala a cikin kula da magani ko kuma rashin amfani da kayan gwajin.
A cikin wata sanarwa da aka fitar, kungiyar ta Spain ta ce za ta fitar da kayan gwajin da suka nuna cewa ba su da gaskiya, kuma za ta maye gurbin su da wasu kayan gwajin na Shenzhen Bioeasy. 80% daga cikin kayan gwajin da Jamhuriyar Czech ta saya daga China sun ba da shaidar cewa ba su da gaskiya. Slovakia ta sayi kayan gwaji miliyan 1.2 daga China da aka gano cewa ba su da gaskiya.
Shugaban Hukumar Matovič ya ce ya kamata a bar shi a cikin ruwan Danube. Ateş Kara na Hukumar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta shigo da su China suna da "ƙimar ƙimar gaske" kuma "ba su da kyau". "Kasar Ingila ta sayi kayan gwajin miliyan 3.5 daga China amma a farkon Afrilu ta ba da sanarwar cewa ba za su yi amfani ba.
Gwaje-gwaje, tare da keɓe mutanen da aka gano sun kamu da cutar daga waje da kuma bincika waɗanda suka yi hulɗa da waɗanda ke da SARS-CoV-2 masu cutar, sun yi tasiri sosai.
Masu bincike da ke aiki a garin Vò na Italiya, wanda shine farkon inda aka gano COVID-19 a Italiya, sun yi hasashen cewa ƙungiyar ta yi bincike kan yawan mutanen da suka mutu a cikin kwanaki goma.
Kusan rabin mutanen da ake zargin suna da cutar sun kamu da cutar a duniya, kuma duk wadanda aka gano da cutar ana killace su.
Tare da hana zirga-zirgar ababen hawa a cikin birni, an hana sabon kamuwa da cuta.
Tare da hanawa ga masu hulda da jama'a, hana zirga-zirgar baƙi, gwaji, da keɓewa, cutar sankara ta 2020 a Singapore ta fi dacewa da ƙasashe masu haɗari, amma ba tare da manyan haɗari kamar buɗe gidajen abinci ko shagunan sayayya ba.
A sakamakon wannan, a Singapore dokar hana fita ta fara aiki a ranar 28 ga Maris, amma an sake bude makarantu a ranar 23 ga Maris.
Yawancin ƙasashe sun yi maganin cutar ta hanyar ba da izinin shiga, hana zirga-zirgar baƙi, gwaji, da kuma keɓewa, amma tare da ƙa'idodin tsare-tsare masu ƙarfi kamar Iceland da Koriya.
Nazarin kididdiga ya gano cewa kasashe masu yawan gaske, dangane da yawan mutanen da suka mutu, suna da karancin mutuwar mutane, musamman ma idan aka yi amfani da su don gano alamun da ke da wuya ko kuma babu su.
WHO ta ba da shawarar cewa ƙasashe da ba su da cikakken tsarin gwaji da kuma dakunan gwaje-gwaje na ƙasa da ke da ƙwarewa a kan COVID-19 su ba da takardar shaidar asibiti shida da suka ba da rahoton cutar COVID-19 da kuma goma da suka ba da rahoton cutar COVID-19 a ɗaya daga cikin 16 dakunan gwaje-gwaje na WHO a matsayin tushen don tabbatar da gwajin.
Daga cikin 16 dakunan gwaje-gwaje, 7 suna cikin Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Ostiraliya.
A cikin wannan labarin, ƙungiyar "Kamar kashi na gwajin" ba ta da tasiri a kan manufofin gwajin ƙasa.
Kasashen da suka fi yawan wadanda aka killace a asibiti suna da yawan masu cutar fiye da kashi daya bisa dari na wadanda suka yi gwajin cutar a kasashe da suka fi yawan jama'arsu, ko da kuwa sun nuna alamun cutar ko babu, wasu daga cikin wadannan dalilai na iya zama masu amfani.
Wanke hannu, wanda aka fi sani da wanke hannu, yana nufin wanke hannaye don cire datti, ƙazanta, datti, ko wasu abubuwa marasa amfani.
Yin amfani da sabulu a "kowane lokaci" a lokacin da ake fama da cutar yana hana yaduwar cututtuka da dama, kamar su kwalara da cutar amai, wanda yawanci ana samunsa ta hanyar hanci da baki.
Mutane na iya kamuwa da cututtuka na numfashi kamar mura ko mura idan sun wanke hannayensu kafin su taɓa idanunsu, hancinsu ko bakinsu (kamar su taɓa wani abu mai zafi).
Muhimman lokuta guda shida a rana da suke buƙatar wanke hannu da sabulu sune: kafin da kuma bayan haihuwa, bayan wanke jaririn jariri ko kuma gyara jariri, kafin haihuwa da kuma bayan wankewa ko kuma tausa, cuku, ko kuma kaza.
Idan babu ruwa da sabulu, to ku wanke hannuwanku da hannuwanku. Ƙungiyar lafiya ta duniya ta ba da shawarar wanke hannu.
Kafin, lokacin, da kuma bayan abinci.
Kafin kula da mara lafiya da kuma bayan kula da shi.
Bayan an canja kwalban ko an wanke jaririn da ya yi ciki.
Bayan ka dafa kaza, sai ka dafa shi da ruwan sanyi ko ruwan sanyi.
Bayan ka shuka dabba, ka wanke dabbar, ko kuma kaɗabbun dabba.
Tsabtace hannu ya zama wani ɓangare na tsarin kiwon lafiya.
Wanke hannu kafin a ba da magani ko kula da lafiya zai iya hana ko hana yaduwar cutar.
Wanke hannu yana da muhimmanci musamman domin yana kare hannu daga ƙwayoyin cuta (bacteria, ƙwayoyin cuta, ko kwayoyin da za su iya haifar da cuta) da sauran abubuwa da za su iya haifar da ciwo ko cuta.
Wannan yana da mahimmanci ga mutanen da ba su da lafiya ko kuma suna aiki a cikin kiwon lafiya, amma yana da mahimmanci ga al'umma.
Yin wanka da hannu yana da fa'idodi masu yawa, kamar hana yaduwar cutar mura, coronavirus, da sauran cututtukan cututtuka; hana kamuwa da cutar sankara; rage cututtukan numfashi;
kuma rage yawan mutuwar jarirai da aka haifa a gida.
Wani bincike na 2013 ya nuna cewa yin wanka da hannu a kai a kai yana da tasiri mai kyau a kan ci gaban yara har zuwa shekara shida.
A ƙasashe masu talauci, ana iya rage yawan mutuwar yara daga cututtukan numfashi da kuma mura ta hanyar sauya halayyarsu, kamar wanke hannu da sabulu.
Wannan zai iya rage yawan mutuwar da cutar ke haifarwa da kashi 50%.
Hanyoyin da ke hana wanke hannuwan mutum zai iya rage yawan cututtuka da ke faruwa a cikin gida sau uku, wanda hakan ya haɗa da samar da ruwan sha mai tsabta a wuraren da mutane ke wanka.
48% na cututtukan da aka samu sun danganci wanke hannu da sabulu. wanke hannu da sabulu ya zama hanya mafi inganci da kuma mafi sauki wajen kaucewa kamuwa da cututtukan da suka shafi cututtukan hanta da kuma cututtukan hanta (ARI), kuma ya zama al'ada a gida, a makarantu, da kuma a cikin al'ummomi a duniya.
Pneumonia, wata cuta ta yara, ita ce babbar sanadin mutuwar yara a duniya 'yan kasa da shekaru biyar, inda take kashe yara miliyan 1.8 a shekara.
Cutar sankara da kuma cutar huhu tare suna kashe yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, tsaftace hannuwanmu da sabulu kafin mu ci abinci ko kuma bayan mun cire wani abu daga cikin jikinmu zai iya ceton rayuka fiye da allurar rigakafi ko magunguna, rage mutuwar mutum da rabi, da kuma mutuwar mutum hudu daga cutar huhu.
A yawancin lokuta ana haɗa wanke hannu da sauran ayyukan kiwon lafiya kamar wanke hannu da wanke aljihu (WASH) da sauran shirye-shirye.
Rashin lafiya na hannu yana haifar da ciwon kai wanda ya haifar da rashin lafiya.
Wani abin da zai iya haifar da rashin lafiya shi ne wanke hannu akai-akai zai iya sa mutum ya ji rauni.
Wani bincike na Danish ya nuna cewa yawan wanke hannu a 2012 na iya haifar da cututtukan fata kamar eczema ko dermatitis na hannu, wanda ya fi dacewa da masu kula da lafiya.
Rashin ƙarfi yana da alaƙa da rashin ƙarfi da rashin ƙarfi.
Akwai lokuta guda hudu da ya kamata a wanke hannu da sabulu domin a rage yaduwar cutar daga bakin zuwa baki: bayan an fitar da jariri daga cikin daki (duka, wanka), bayan wanke jaririn da hanci (kafin wanke hanci), kafin a yaye jariri, kafin a yi wanka/ bayan an yi wanka da abinci ko kuma bayan an taba wani abu da ba a wanke ba, ko bayan an yi wanka da wani abu da ba a wanke ba.
Wasu lokutan da za a iya amfani da wanke hannu don hana yaduwar cututtuka sun hada da kafin ko bayan kula da dabbobi; bayan an yi wanka, wanka, ko kuma yin wanka; bayan an taɓa ƙashin dabba ko dabba; da kuma bayan an taɓa gida.
A ƙasashe da yawa, yawan mutanen da ke yin sallama da saɓo ya ragu.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya nuna cewa, kashi 38.7% na yara suna wanke hannayensu da sabulu. Wani bincike a shekarar 2014 ya nuna cewa Saudi Arabiya na da mafi yawan adadin da ya kai kashi 97%; Amurka na kusa da matsakaici da kashi 77%; China da kasa da kashi 23%. Tsarin gyaran hali na zamani yana kara fadada don daukar nauyin wanke hannu da sabulu a wasu lokuta masu mahimmanci. Ƙungiyar wanke hannu ta yara a makaranta a lokacin da aka yi a cikin kwanaki na yau da kullum tana zama kamar wata hanya a cikin ƙasashe masu tasowa don sanya kayan wanke hannu a cikin yara.
Shirin Kula da Kiwon Lafiya na Musamman wanda Hukumar Ilimi ta samar a Philippines ya zama misali na mai da hankali kan lafiyar jiki da tunani na yara.
A wanke ƙura sau biyu a shekara da sabulu, a wanke ƙura da gurɓataccen ruwa da kuma amfani da sinadarin fluoride, yana tsakiyar shirin ƙasa.
Ana kuma ganin shi a matsayin mai kyau a Indonesia.
Ana iya cire ɓarkewar jiki ta wajen amfani da sabulu ko ruwan wanka.
Da farko, sabulu da ruwa suna da amfani wajen rage hadarin da ke tattare da tsarin, kuma suna kara saurin lalacewa.
Ruwa yana da mahimmanci ga ƙwayoyin halitta da sunadarai, abubuwa ne da suka samo asali daga ƙasa, kuma ba za a iya kawar da su ba kawai da ruwa.
A wanke shi da ruwa mai tsabta da kuma tsabta.
Sabulu mai tsabta, saboda ana iya sake amfani dashi, ba zai iya ƙunsar ƙwayoyin cuta da ke zaune a wurin ba yayin da aka yi amfani da shi a cikin tsabta.
Wasu bincike da aka yi a kan ƙwayoyin cuta daga sabulu sun nuna cewa ba za a iya yin amfani da su ba don kawar da ƙwayoyin cuta daga iska.
CDC ta kuma ce "sabon ruwa mai tsabta wanda hannayensa ba sa taɓa taɓa yaduwar cuta".
Ana ba da shawarar sabulun kashe kwayoyin cuta ga mutanen da ke damuwa da lafiyarsu.
A halin yanzu, babu wani tabbacin da ya nuna cewa amfani da maganin antiseptic ko maganin rigakafi yana magance ƙwayoyin cuta masu haɗari ga ƙwayoyin cuta.
Duk da haka, wasu sabulu na aljihu na aljihu sun ƙunshi wasu abubuwa masu guba kamar triclosan, wanda ke da yawan adadin abubuwa masu guba.
Bugu da ƙari, kodayake ƙwayoyin cuta masu ƙwayoyin cuta sun fi dacewa da sabulu masu kashe ƙwayoyin cuta, ba za su iya zama marasa ƙarfi kamar yadda aka kwatanta a cikin lambun su ba.
Bugu da ƙari ga surfactants da sauran abubuwan da ke kare lafiyar jiki, wasu sinadaran sun hada da acid mai narkewa (acetic acid, ascorbic acid, lactic acid) a matsayin mai hana PH, benzoic acid a matsayin mai kashe ƙwayoyin cuta da kuma abubuwan da ke kare lafiyar jiki (aloe vera, bitamin, menthol, maganin hana shan magani).[1] Bincike daga Jami'ar Oregon School of Public Health ya gano cewa sabulu mai tsabta yana da inganci iri ɗaya da sabulu da aka saba amfani da shi a cikin masana'antar da ke dauke da tricloser don hana cututtuka da kuma kawar da ƙwayoyin cuta a hannu.[2]
Ruwa mai ɗumi da aka yi amfani da shi don wanke hannu bai da kyau wajen kashe ƙwayoyin cuta.
Kwayoyin ba sa iya jurewa da zafin jiki (37 °C).
Duk da haka, ruwan sanyi da sabulu sun fi ruwan sanyi da aka sha amfani da shi wajen cire ƙwayoyin cuta da ƙwayoyin cuta.
Akasin yadda mutane suke zato, wasu bincike sun nuna cewa wanke hannu da ruwan zafi ko ruwan sanyi bai taimaka wajen rage ciwon kai ba.
Sanitic na hannu ko antiseptic na hannu shine maganin wanke hannu amma ba ruwa ba.
A ƙarshen 1990s da farkon karni na 21, maganin hana ruwa da barasa don wanke hannu (wanda aka fi sani da maganin hana ƙwayoyin cuta, maganin antiseptic, ko maganin wanke hannu) ya zama ruwan dare.
Mafi yawanci ana amfani da isopropyl alcohol ko ethanol wanda aka haɗa da wani abu mai guba kamar Carbomer (polymer acrylic acid) a cikin gel, ko wani abu mai guba kamar glycerin a cikin ruwa, ko kuma iska don samun sauƙin amfani da shi kuma rage yawan guba a hannu.
Bugu da ƙari, hydrogen-peroxide yana da tasiri mai yawa a kan ƙwayoyin cuta. Abin da ke da alaka da 60 zuwa 95% na barasa yana da tasiri mai yawa a kan ƙwayoyin cuta.
Abubuwan da aka yi da giya da kuma ruwan da aka sha da hannu suna kashe ƙwayoyin cuta, ƙwayoyin cuta masu saurin kamuwa da cuta (MRSA da VRE), cutar sankara, da wasu ƙwayoyin cuta (kamar HIV, herpes, RSV, cinnavirus, vaccinia, mura, da cutar sanyin cizon sauro) da kuma fungi.
Abubuwan da aka yi amfani da su na wanke hannu da ke dauke da kashi 70% na barasa suna kashe 99.97% (aƙalla log 3.5 a cikin 35 decibel) na kwayoyin dake jikin hannu a cikin dakika 30 bayan an wanke su da kuma 99.99% zuwa 99.999% (aƙalla log 4 zuwa 5) na kwayoyin dake jikin hannu a cikin minti daya bayan an wanke su. Abubuwan da aka yi amfani da su na wanke hannu sun fi tasiri ga kwayoyin cuta kuma sun kasa tasiri ga wasu ƙwayoyin cuta.
Abincin da aka sha da giya yana da tasiri kadan kan kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar.
Kafin a gama, sai a wanke hannuwan da hannayen a cikin ruwa, ruwa mai sanyi ko kuma gel na tsawon minti 30.
Dole ne a wanke hannuwan da hannu sosai, ta hanyar wanke su da hannu biyu. Hukumar Kula da Cututtuka ta Amurka ta ba da shawarar wanke hannu a kan allurar hannu, musamman idan hannaye suna da ruwa.
An yi amfani da wannan kayan don wanke hannu saboda yana da sauƙin amfani kuma yana hana ƙwayoyin cuta; duk da haka, ba za a iya amfani da shi a matsayin hanyar wanke hannu ba idan babu sabulu da ruwa.
Yin amfani da sabulu a kai a kai da kuma shan giya na iya haifar da rashin lafiyar jiki idan aka ƙara sabulu a cikin abin da aka haɗa.
Ana iya rage ko kuma dakatar da maye gurbin giya ta hanyar ƙara glycerin da/ko wasu abubuwan da ke rage zafin jiki a cikin mahaɗin.
Gwaje-gwaje a dakin gwaje-gwaje sun nuna cewa masu wanke hannu da ke dauke da sinadarin da ke hana mutum wanke hannunsa daga sabulu ko wasu kayan wanki.
Allergic contact dermatitis, contact urticaria ko hypersensitivity to alcohol or to additives a hannun wanki da kuma alcohol-containing hand sanitizers sun kai ga rashin lafiya.
Aikace-aikacen da aka saba amfani da shi don magance cututtukan da ke da illa ga hanci kamar wanke hannu da sabulu da ruwa.
Ko da yake akwai ƙwayoyin cuta, masu wanke hannu ba sa iya wanke hannuwan mutum, amma suna kashe ƙwayoyin cuta ne kawai.
Saboda haka, tsabtace hannu ba shi da ƙarfi fiye da sabulu da ruwa don hana yaduwar cututtuka, saboda cututtuka suna nan a hannu.
Ingancin maganin wanke hannu ba tare da barasa ya dogara da abin da aka haɗa da shi, kuma tarihi ya nuna cewa zai iya daidaita ƙarfin maganin wanke hannu.
A wannan lokacin, wasu kwayoyin da ke dauke da sinadarin benzalkonium chloride sun nuna cewa suna da karfin da ke da karfi da kuma karfi bayan amfani da su, ba kamar yadda yake da barasa ba, wanda hakan ya nuna cewa sun yi rashin nauyi bayan an ci gaba da amfani da su a matsayin maganin cutar kansa.
Yawancin mutane a cikin al'ummomin da ke da tsabta ba za su iya samun sabulu ba kuma suna aiki ba tare da samun ƙasa ba.
Gida ko ƙasa na iya zama mafi kyau fiye da ruwa, amma ba zai iya zama sabulu ba.
Wani matsalar kuma ita ce idan aka yi amfani da gurbatacciyar ƙasa ko ƙasa da aka yi amfani da ita, za a iya samun ƙarin yaduwar cutar maimakon ragewa.
Kamar sabulu, ƙwai na iya zama mai kashe ƙwari domin idan ya yi haɗuwa da ruwa, zai zama kamar ƙura.
WHO ta ba da shawarar a yi amfani da kayan wanki kamar sabulu ko kuma ruwan wanka.
A cikin Amurka, Cibiyar Kula da Cututtuka da Kula da Cututtuka ta ba da shawarar wanke hannu a cikin wadannan hanyoyin:
Wanke hannuwanku da ruwan sha ko kuma wanka mai sanyi.
Ana bada shawarar a yi amfani da ruwa mai tsabta domin mai riƙe da ruwa zai iya kamuwa da cutar, kuma ba za a iya canza ruwan ba.
Wanke hannuwanku da sabulu mai tsabta don kada su fita daga tufafi, da bayan hannu, tsakanin hannaye, da kuma cikin gidajenku.
Sabulu yana kawar da cututtukan da ke cikin jiki, kuma bincike ya nuna cewa mutane ba sa wanke hannayensu idan sabulu ko ruwan wanki ya taɓa su.
Ka yi tafiya a cikin minti ashirin.
Yin gyaran hannu yana da alaƙa da hannu, wanda ke kawar da ƙwayoyin jikin mutum kuma yin gyaran hannu sau da yawa yana haifar da ƙwayoyin jiki da yawa.
Ka yi wanka da ruwa mai tsabta.
Sa'an nan kuma, a cikin takalma, za a iya yin amfani da hannayen hannu don sake sakewa.
Yi wanka da tufafi masu tsabta ko kuma iska.
Hannun da aka ɗora ya kamata ya zama mai laushi kuma. Abubuwan da mutane suke da kyau a ciki su ne hannayen hannu, yatsun hannu, tsakanin yatsun hannu, da kuma cikin ciki.
Ƙananan dabbobi masu shayarwa ko masu shayarwa na iya zama marasa lafiya.
An ba da shawarar yin wanka sau uku a kowace rana; yin wanka na yau da kullum zai iya zama mai kyau kuma zai iya kara yawan kamuwa da cuta.
Sauran hanyoyin da ba su da sauki na iya zama dole don wanke hannu a wuraren da ruwa da/ko sabulun ruwa suke, kamar su wanke ruwa a cikin ruwa ko kuma wankewa ta hanyar wanka da/ko kuma ɗaukar wanka idan ba a yi amfani da su kamar a ƙasashe masu tsabta.A lokacin da babu ruwa sosai (kamar a makarantu ko gidajen abinci a ƙasashe masu tsabta), akwai hanyoyin da za a iya adana ruwa, kamar "ti-taps" da sauran hanyoyin da ba su da sauki.
Tippy tap wani zaɓi ne wanda zai iya zama a cikin wani wuri mai nisa daga cikin ɗakin da aka yi da wani abu da za a iya ɗorawa daga ƙasa don yin amfani da ƙananan ƙwayoyin hannu da ƙananan sabulu.
Yin wanka da hannu a kai a kai yana da kyau a cikin tsabtace hannu, amma akwai wasu matsaloli game da tsabtace hannu a cikin gidajen jama'a.
Yawancin bincike da ake yi a yanzu sun nuna cewa yin amfani da takardar izinin shiga asibiti ya fi dacewa da yin amfani da takardar izinin shiga asibiti.
A shekara ta 2008, wani bincike da aka yi a University of Westminster, London, tare da taimakon European Tissue Symposium, ya gwada tasirin da ke tattare da tsabtace jiki, ƙwayoyin hannu, da kuma na'urorin da ke hana numfashi.
Bayan an wanke hannu da hannu da kuma wanke hannu, an gano cewa adadin kwayoyin dake jikin mutum sun karu da kashi 194 cikin dari da kuma na hannaye da kashi 254 cikin dari.
Yin amfani da maganin hana hayaki ya haifar da karuwar kwayoyin cuta a kan gashin ido da kashi 42% da kuma a kan hannu da kashi 15%.
Bayan an wanke hannuwa da hannu, an sami raguwar ƙwayoyin cuta a jikin fata da kashi 76% sannan a hannu an sami raguwar kashi 77%.[1] Masu bincike sun gudanar da gwaje-gwajen don gano yiwuwar kamuwa da cuta daga masu amfani da hannuwa da sauran sassan jikin mutum kamar yadda aka nuna a cikin wani gwaji.
Jirgin da ke yin iska mai saurin gaske, wanda ke yin iska a cikin iska mai saurin 180m/s (650 km/h; 400 mph), zai iya sa ƙwayoyin cuta su yi tsalle daga hannaye zuwa ga ƙafa kuma zai iya kaiwa ga mutane da ke zaune a cikin wani gida mai nisan mita 2.
Aikin sa ya yi daidai da yadda aka rarraba hannayen da suka kai 0.25 m.
Aikin wanka a gida zai iya nuna yadda ciwon ya yadu. A shekara ta 2005, a wani binciken da TÜV Pordukt und Umwelt ya yi, an gano hanyoyin wanka da hannu.
Ga yadda aka gano adadin ƙwayoyin cuta a bayan wanke hannu:
Akwai masu yin allurar rigakafin hannu iri-iri, da kuma allurar rigakafin hannu a kan allon da ke kusa da gidan.
Wanke hannu da wanke hannu a wanke hannu ya zama wani zaɓi na musamman a lokacin da ba a da sabulu da ruwa.
Maganin tsabtace hannu dole ne ya kasance yana da aƙalla kashi 60% na giya.
Ana bukatar wanke hannu tun bayan da wani likitan kasar Hungary Ignaz Semmelweis ya gano (a 1846) cewa yana da amfani wajen hana yaduwar cutar a asibiti.
Akwai wasu umarni da ke tunatar da ma'aikatan kiwon lafiya su wanke hannayensu bayan sun dawo.
Wani bincike ya nuna cewa an samu raguwar cututtuka a sakamakon amfani da wannan maganin.
Wanke hannuwanka ya kamata ya ɗauki aƙalla 15 seconds, kuma aƙalla saƙa da ruwa ko gel zai sa wanka ya zama mai daɗi da kuma tsabta.
Ku yi kuka da farin ciki tare da 'yan'uwa masu bi.
Idan akwai wani abu mai laushi a cikin kayan, za a iya amfani da shi don yin gyare-gyare.
Saboda ana iya samun ƙwayoyin cuta a hannu, yana da kyau a wanke su da kyau kuma a wanke su da tufafi masu tsabta.
Bayan an gama, sai a ɗauki ɗan ƙaramin murfi a cikin ɗakin don a hana ruwa fita (kuma a buɗe ƙofar idan akwai).
Don kare hannayenka, ɗauki wasu takalma.
Amfanin wanke hannu a wurare masu lafiya a jiki shi ne kawar da kuraje ("gills") da kuma hana yaduwar cutar ga wasu.
The New England Journal of Medicine ya ruwaito cewa rashin wanke hannu ya zama dole a cikin mafi yawan wuraren kiwon lafiya, kuma likitoci da ma'aikatan kiwon lafiya da ke riƙe da hannuwan wanke kafin su taɓa marasa lafiya, ba za su iya yada cutar ba ga sauran mutane.
Wani bincike ya nuna cewa wanke hannu da hannu da kuma wasu hanyoyin da suka dace na iya rage cututtukan da ake samu ta hanyar jini da kashi 66%, kuma Hukumar Lafiya ta Duniya ta wallafa wata takarda da ke nuna yadda za a wanke hannu da kuma wanke hannuwa a wuraren da ake samun rashin lafiya.
An kuma sanya takardar shaidar wanke hannu a shafin yanar gizon don jama'a su amsa.
An yi amfani da wannan ra'ayi na musamman ta hanyar Whitby et al.
Dokokin kasuwanci na iya ƙuntata kuma ƙyale cin hanci, idan akwai tabbacin da ya nuna cewa an bi wannan dokar.
Hukumar Lafiya ta Duniya ta tsara "Abubuwa Bakwai" don wanke hannu:
bayan an sha ruwa ko ruwa
kafin a yi masa magani, da
bayan kula da mai haƙuri. Ƙara maganin kashe ƙwari a sabulu (sabon "sabon lafiya" ko "sabon ƙwari") yana ƙarfafa tsabta a cikin kayan wanke hannu.
Irin wannan aikin kashewa yana iya zama da amfani kafin a duba mai haƙuri ko a wurin da ƙwayoyin cuta masu cutarwa suke.Domin 'ɓoye' hannaye a duba mai haƙuri, yana da muhimmanci a sami ruwa mai tsabta wanda mutum zai iya buɗewa ko rufewa ba tare da taɓa hannaye ba, wanke da chlorhexidine ko iodine, goge gashi wanda ba a taɓa amfani da shi ba, da kuma goge gashi da kayan wanka don wanke gashi.
Ka cire dukan kuɗin.
Wannan tsari ya haɗa da wanke hannu daga ƙasa zuwa sama, sau da yawa a cikin minti 2-6.
Ba a amfani da sautin kuka da yawa (minti 10).
A lokacin da aka yi ruwa, an sake cika ruwa a cikin hannayensu.
Bayan wanke hannu, ya kamata a wanke hannu da tufafi masu tsabta kuma a sanya takalma mai tsabta.
Don rage yaduwar cututtukan cututtukan fata, yana da muhimmanci a wanke hannu ko wanke kayan wanke hannu kafin da kuma bayan kula da marasa lafiya.
Don rigakafin cututtukan staph a cikin asibiti, an nuna cewa amfanin yau da kullun na wanke hannu ya kai kashi 20% na farko na wanka, kuma ƙaramin ƙaruwa ya faru yayin da yawan wanke hannu ya karu da sauri zuwa kashi 35%.
Aika da sabulu mara amfani ya nuna sau uku na kamuwa da cututtukan da ke tattare da abinci fiye da amfani da sabulu mai kashe kwayoyin cuta. Gwada wanke hannu da kayan maye da sabulu mai kashe kwayoyin cuta a cikin 30 seconds ya nuna cewa wanke hannu da kayan maye ya rage kamuwa da kwayoyin cuta da kashi 26% fiye da wanke hannu da sabulu mai kashe kwayoyin cuta.
Amma sabulu da ruwa sun fi dacewa da na'urar tsabtace hannu da ke dauke da barasa don rage yaduwar cutar H1N1 A da Clostridium difficile spores a hannu. Hanyoyin da za a bi don inganta wanke hannu a wuraren kiwon lafiya na iya hada da sanar da ma'aikata game da tsabtace hannu, wanda ke ƙara yawan amfani da na'urar wanke hannu mai dauke da barasa, da kuma sanya takardun shaida da takardun shaida ga ma'aikata.
Ana buƙatar ƙarin bincike don gano ko waɗannan hanyoyin suna da amfani a wasu fannonin kiwon lafiya.
A cikin ƙasashe masu tsabta, wanke hannu da sabulu an san shi da tsabta, muhimmiyar hanya ta kiwon lafiya, da kuma abinci mai kyau.
Duk da haka, rashin ingantattun ruwa, sabulu da kuma wuraren wanke hannu a gida, makaranta da kuma wurin aiki, ya zama matsala ga tsabtar da wanke hannu.
Alal misali, a yawancin al'ummomin Afirka, samun isasshen ruwa don wanke hannu ba shi da sauƙi a cikin gidaje masu zaman kansu ko na jama'a, ko da yake akwai hanyoyin da za a iya gina wuraren wanke hannu masu tsabta.
Duk da haka, ana iya rage yawan saurin wanka ta hanyar rage yawan saurin wanka da rashin sabulu da ruwa.
Amincewa da rashin amincewa da wanke hannu da sabulu na iya shafar manufofin al'umma, ya nuna amfanin wanke hannu da kuma canza halayyar al'umma a nan gaba.
Domin wannan tsarin ya yi aiki da kyau, kulawa da gwaji suna da muhimmanci.
A cikin bincike sama da 70 an gano cewa hanyoyin da jama'a ke amfani da su suna da muhimmanci wajen inganta tsaftace hannu a LMIC, a wasu lokuta kuma suna da laifi ga jama'a wajen sayen abinci da kuma ciyar da yara. Wani bincike na musamman da aka yi kan hanyoyin da ake amfani da su wajen tsaftace hannu a makarantu shi ne wani shiri da ake kira "Third Star Plan" da UNICEF ta yi na hana makarantu yin amfani da rigakafin cutar da ke hana dalibai wanke hannuwansu da sabulu, a tsakanin sauran hanyoyin tsaftace hannu.
Idan an sami matsala ta farko, za a iya gina makaranta daga ɗaya zuwa uku.
Yin wanka da hannu ba tare da wanke hannu ba zai iya zama wani ɓangare na dabarun wanke hannu da aka tsara don rage cututtukan yara da kuma mutuwar yara.
Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar Ranar R Ranar R Ranar Ranar Ranar Ranar R R Ranar R R R R R Ranar Ranar R R R R R R Ranar R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R
Wasu bincike sun nuna cewa wanke hannu yana da matukar hadari a ƙasashen da ke ƙarƙashin dokar DALY.
Duk da haka, wasu bincike sun nuna cewa wanke hannu da sabulu ya fi zama da sauƙi fiye da sauran hanyoyin wanke hannu da ruwa ko magani.
Amfanin wanke hannu a rayuwar mutum, musamman ga al'ummomi masu wahala kamar tsofaffin ma'aikata ko sojoji da ke fama da rashin lafiya a asibiti, ya samo asali ne a tsakiyar 1900s ta hanyar masu gwagwarmayar tsabtace jiki: Ignaz Semmelweis na Hungary wanda ya yi aiki a Vienna, Austria da Florence Nightingale, "mahaifiyar likitancin" na Ingila.
A lokacin da mutane suka yi tunanin cewa cututtuka ne ke haifar da cututtuka, an yi amfani da wasu maganganu na musamman da ake kira miasma.
A cikin shekarun 1980, ci gaba da yaduwar cututtukan cututtukan abinci da cututtukan cututtukan cututtukan jiki sun sa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar cewa wanke hannu yana da mahimmanci wajen hana yaduwar cututtuka.
Barkewar annobar zazzabin cizon sauro a 2009 da kuma barkewar annobar COVID-19 a 2020 sun sa an ƙara yin amfani da tsabta a ƙasashe da dama domin amfanin wanke hannu da sabulu wajen kare kai daga irin wannan cuta.
Alal misali, hotuna da "takarda na wanke hannu" sun bayyana a bangon wanke hannu a cikin dakunan dakunan jama'a da dakunan ofisoshin da kuma tashoshin jiragen sama a Jamus.
A cikin wannan misali, "ba da hannunsa" yana nufin cewa ba za ka iya ba da kanka ba ko kuma ka zama mai taimako.
A cikin littafin Matta, an ambaci Pontius Pilate yana ɗora hannunsa a kan Yesu Kristi, amma wannan ba wani abu ne da ya shafi jama'ar Ingila ba.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannunta don neman hujja da ke cikin zuciyarta, wanda ya nuna cewa ta aikata laifin kisan kai da ta sa mijinta ya shiga cikin al'amarin.
An kuma gano cewa mutane, bayan sun ji ko sun ga wani abu da ya faru, suna wanke hannayensu sau da yawa fiye da sauran mutane, kuma suna da ra'ayin da ya dace game da wanke hannu.
Duk da haka, mutanen da suka yi wanka bayan wannan za su iya ba da damar yin "wanka" a matsayin taimako.
Yin wanka da hannu don tsaftacewa da kuma nunawa yana da muhimmanci a addinai. Yin wanka da hannu, wanda ya ƙunshi wankewa da ruwa ba tare da sabulu ba, ya kasance yana da mahimmanci a cikin addinai daban-daban, kamar addinin Bahá'í, Hindu, Tevilah da Netilat yadayim a cikin addinin Yahudanci, Lavabo a cikin addinin Mahabbanci, da Wudhu a cikin Islama.
Addinan Hindu, Yahudanci da Islama sun haramta wanke hannu bayan an fita daga gida.
Addinan Hindu, Buddha, Sikh, Islama, da Yahudanci sun yi wa'azi da cewa a wanke hannu kafin a ci abinci da kuma bayan an ci abinci.
Gargadi game da haɗarin COVID-19 a wurin aiki
Binciken haɗarin COVID-19 a wurin aiki shine tsarin kula da lafiyar jiki da na muhalli don rigakafin cutar coronavirus 2019 (COVID-19).
Ka'idojin haɗarin wurin aiki sun bambanta dangane da wurin aiki da kuma irin aikin, dangane da ƙimar haɗarin zama, haɗarin kamuwa da cuta a cikin al'umma, da kuma abubuwan da ke haifar da yiwuwar kamuwa da COVID-19 ga ma'aikata.
Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA) ta ce, yin aiki a gida yana da haɗari ga lafiyar jama'a da kuma sauran ma'aikata, wanda ya ƙunshi kiyaye matakan kariya na farko, kamar wanke hannu, keɓe ma'aikata a gida idan sun kamu da cuta, tsabtace numfashi, da tsabtace kayan aiki.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da mutanen da ba su da alaƙa ko kuma ba su da wata alama ta COVID-19, amma za su iya kamuwa da cutar ta hanyar yaduwar al'umma ta yanzu ko ta hanyar balaguro zuwa ƙasashen waje.
Wannan ya haɗa da ma'aikata waɗanda ke da ƙwarewar hulɗa da jama'a a cikin ɗakunan karatu, wuraren aiki da ke da yawan jama'a, da kuma wuraren da aka tara kayan kasuwanci da yawa.
Ƙididdigar haɗarin ƙungiyar, ban da matakan rigakafin cutar ta farko, sun haɗa da hana amfani da rigakafin cutar, rigakafin rigakafin rigakafi, da kuma sanya rigunan kariya na mutum idan kana tare da wani da ke da COVID-19.
OSHA ta yi wa ma'aikatan kiwon lafiya da ma'aikatan asibiti da kansu da kansu da kuma wasu ma'aikatan asibiti da suka gano ko wani da ke da COVID-19 na iya zama masu haɗari, wanda ke ƙara haɗarin kamuwa da cutar idan ma'aikatan suka yi aiki a wuraren da ke fitar da iskar aerosol, ko suka yi aiki, ko kuma suka taɓa wani da ke da COVID-19 ko kuma wanda ke da yiwuwar kamuwa da cutar.
Hanyoyin haɗari masu mahimmanci ga masu aiki sun haɗa da matakan injiniya kamar su ɗakunan da aka sanya su da kyau, da kuma kayan aikin da suka dace da aikin.
COVID-19 na iya haifar da haɗarin gaske a wurin aiki.
Ma'aikata na iya yin rashin aiki saboda kamuwa da cutar, don kula da wasu, ko don tsoron kamuwa da cutar.
Kasuwancin kasuwanci na iya bambanta, dangane da irin kayan da ake buƙata, da kuma hanyoyin da ake amfani da su don samun waɗannan kayan (kamar yin amfani da su a lokacin da ake buƙatar kayan aiki, ko ta hanyar masu amfani da su a gida ko a cikin zirga-zirgar motoci).
A ƙarshe, za a iya dakatar da jigilar kayayyaki daga wuraren da COVID-19 ya fi tasiri. Tsarin shiri ko amsawa ga annoba na iya zama da amfani don kare ayyukan.
Shirye-shiryen sun rage haɗarin haɗarin da ba a haɗa su da kowane irin aiki ba, kamar su ciwon kai, abubuwan da ke haifar da haɗarin haɗari a gida da kuma a cikin al'umma, da kuma abubuwan da ke haifar da haɗarin haɗarin haɗari na mutum kamar kamuwa da cutar ko kuma wani ci gaba da cutar.
An kuma tsara matakan kariya don rage haɗarin, tare da shirye-shiryen keɓewa don abubuwan da ke iya haifar da alamun cutar.
Shirye-shiryen da shirye-shiryen maganin cututtukan cututtuka na iya zama cikin kasa ko na gida.
Hanyoyin da za a bi don magance wannan cuta sun hada da hana yaduwar cutar daga ma'aikata, masu kula da marasa lafiya da kuma wasu da ke da hadarin kamuwa da wasu cututtuka, ci gaba da kasuwanci, da kuma rage hadarin a wasu sassa na rayuwarsu.
Rashin lafiya a cikin al'umma da ke da kasuwanci yana shafar matakan da aka ɗauka.
Tsarin kula da haɗari shine tsarin da aka yi amfani da shi a cikin lafiyar jiki da kuma kiwon lafiya don samar da matakan kariya ga ƙungiyar da kuma yadda ya kamata.
A wuraren da ba za a iya kawar da cutar COVID-19 ba, matakan kariya mafi mahimmanci sune matakan kariya na injiniya, sannan kulawar aiki, sannan kuma kayan aikin rufewa.
Kula da injiniya ya ƙunshi hana ma'aikata haɗari da haɗari na aikin ba tare da la'akari da halayyar ma'aikaci ba, kuma yana iya zama hanya mafi dacewa.
Aikace-aikacen aiki sauye-sauye ne a cikin manufofin aiki ko al'amuran da ke buƙatar haƙƙin ma'aikaci ko mai gudanarwa.
Kayan aikin kare lafiyar mutum (PPE) na da matukar muhimmanci ga aikin injiniya da kuma aikin da ake yi, amma kuma yana da matukar muhimmanci ga aikin injiniya a wasu wurare.
Duk wani nau'in PPE dole ne a zaba bisa la'akari da haɗarin da ke tattare da shi ga ma'aikaci, wanda ya ƙunshi muhimmancinsa (misali umarnin yin numfashi), an sa shi da kyau kuma an ba shi izini, an bincika shi, an tsabtace shi, an canza shi idan ya dace da lokacin da ya dace, an cire shi da kyau, an bushe shi, an cire shi ko an ajiye shi don kada ya lalace.
A cewar Hukumar Kula da Lafiya da Tsaro ta Amurka (OSHA), ayyukan da ba su da illa ba suna iya haifar da matsala tsakanin ma'aikata da jama'a.
Matakan farko na rigakafin cutar da aka ba da shawara a wurin aiki sun haɗa da wanke hannu daidai da kuma a kan kari, hana ma'aikata zama a gida idan sun kamu da rashin lafiya, kula da numfashi ta hanyar rufe fuska da wankewa, ba da sutura da kayan aiki don kawar da cuta, shirya don canza yanayin rayuwa ko kuma ƙaura idan ya cancanta, hana masu aiki yin amfani da kayan aiki ko umarnin wasu, da tsaftace da tsabtace wurin aiki.
Bayyana da kuma nisantar da mutanen da ke dauke da cutar a matsayin masu cutarwa na da muhimmanci wajen kare ma'aikata, abokan ciniki, masu kiwon lafiya, da sauran masu cutar a wurin aiki.
Hukumar Kula da Kula da Lafiya ta Amurka (CDC) ta ba da shawarar cewa ma'aikatan da ke da alamun cutar numfashi mai tsanani su zauna a gida sai dai idan sun sake kamuwa da cutar, cutar ta kamuwa da cutar, ko kuma alamun cutar sun sake bayyana bayan awanni 24 ba tare da an ba su maganin rage kamuwa da cutar ba ko kuma wasu alamun cutar, kuma an ba da izinin kamuwa da cutar, ba da izinin barin ma'aikatan da ke gida don kula da wanda ya kamu da cutar a gida, kuma ma'aikaci ya yi la'akari da manufofin.
A cewar OSHA, ayyukan da ke da haɗari sun haɗa da waɗanda ke buƙatar nisantar mutane a ƙafafun ƙafafu (1.8 m) waɗanda aka tabbatar ko kuma waɗanda ke da yiwuwar kamuwa da COVID-19, amma waɗanda ke iya kamuwa da SARS-CoV-2 saboda watsawa ta al'umma a cikin yankin kasuwanci, ko kuma saboda baƙon da ya dawo daga wata ƙasa tare da COVID-19 ya kamu.
Wannan ya haɗa da ma'aikatan da ke da alaƙa da jama'a kamar makarantu, wuraren aiki da yawa, da wuraren kasuwanci inda kayan aiki ke da yawa. Ka'idodin injiniya don ƙarancin iska da kuma ƙungiyoyi masu haɗarin haɗari sun haɗa da ƙarancin aikin tsabtace iska, haɓaka iska, rage buƙatun kamar jinkirin aiki, da kuma ƙarancin ƙofar mai siyarwa. Ka'idodin aikin gida da ƙungiyoyi masu haɗari don kamuwa da cutar sun haɗa da ba da izinin ma'aikata su kula da wasu marasa lafiya a gida, sauya tarurruka a cikin gida da kuma a cikin gida, yin amfani da ɗakunan gwaji, ƙuntatawa na gida, ƙuntata ƙuntataccen COVID-19, rage haɗarin COVID-19 a wuraren aiki, rage yawan aiki, rage haɗarin COVID-19, kula da yanayin aiki, da kuma inganta ayyukan tsaro, da kuma kula da wuraren aiki, da kuma kula da lafiya, da kuma kula da wuraren aiki, da kuma kula da lafiyar jiki, da kuma kula da yanayin aiki, da kuma kula da lafiyar jiki.
Ma'aikatan kungiyar suna bukatar umarnin budewa.
Idan mutum ya kamu da cutar a cikin jirgin sama, wasu matakan kariya da ake bukata don hana ma'aikata da sauran masu ba da izini su haɗa da hana mai cutar shiga tare da wasu mutane, yin wanka na tsawon ƙafa 6, sanya wani daga cikin su don kula da mai cutar, da ba mai cutar wani abin rufe fuska ko kuma sanya mai cutar ya rufe baki da hanci da kuma hanci yayin da yake yin fitsari ko shaƙar baki.
Ma'aikatan jirgin za su iya amfani da kayan wanke hannu da aka tanada bayan kula da mai tafiya ko taɓa wani tsoka ko tsoka da aka kamu da ita, in ba haka ba za su iya amfani da wasu kayan kariya idan mai tafiya yana da zazzabi, ciwon huhu ko kuma matsalar numfashi.
Ya kamata a ajiye kayan wanke hannu a cikin akwatin da aka ajiye su, kuma a tsabtace da kuma tsabtace wuraren da aka kamu da cutar. Idan akwai haɗari daga haɗarin haɗarin kayan kasuwanci, kamar jirgin sama da sauran jiragen da ke haɗuwa da mutane, matakan rigakafin cutar sun haɗa da hana zirga-zirga zuwa wurin mutumin da ke da cutar, warewa da kuma sanar da ma'aikatan kiwon lafiya idan akwai cutar.
A wasu lokuta, ana iya yin wannan aikin a cikin ɗakin da ke keɓewa.Dangane da makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace ko tsabtace yayin da wani wanda ke da cutar ya kasance a cikin ɗakin makarantar ba tare da damuwa game da yaduwar cutar ba.
Idan akwai karancin iskar a cikin al'umma, tsarin hana yaduwar jama'a zai iya zama da amfani, kamar hana zirga-zirgar garken dabbobi, da kuma hana wasu nau'ikan haɗuwa kamar yin jima'i, da kuma yin wanka ko shan ruwa a cikin abincin dare, da kuma kara yawan mutane a tsakanin garken dabbobi, da rage lokutan isowa da tashi, da hana garken dabbobi daga yin amfani da su, da kuma hana asibiti daga kai jarirai zuwa asibiti.
Idan akwai kamuwa da cuta a cikin al'umma, bayan an yi amfani da hanyoyin hana yaduwar cutar, za a iya tsawaita lokacin rufewa.
An shawarci ma'aikatan kiwon lafiya da ke hulɗa da mutanen da ke da ko za su iya samun COVID-19 su bi ƙa'idodin kiwon lafiya, kamar su sanya kayan kariya.
Idan sun haɗu da haɗari, ma'aikata ya kamata su wanke da kuma tsabtace kayan aiki da kayan aiki kafin su yi aiki kuma suyi amfani da kayan wanka na gida ko na gida, kuma su bi ka'idodin aiki waɗanda suka haɗa da adanawa da kuma kawar da PPE da kayan wanka ko tufafi masu lalacewa.
OSHA ta ɗauki ma'aikatan kiwon lafiya da ma'aikatan asibiti a matsayin ƙungiyoyi masu haɗari ko masu haɗari.
Ayyukan da ke da haɗari sun haɗa da ma'aikatan kiwon lafiya, masu ba da taimako, ma'aikatan asibiti, da masu kula da lafiya waɗanda ke hulɗa da marasa lafiya waɗanda ke da ko kuma za su iya samun COVID-19.
Akwai haɗarin haɗari sosai idan ma'aikata suka yi amfani da hanyar yin amfani da aerosol a kan, ko kuma riƙe ko taɓa, mutane da aka sani ko kuma za a iya kamuwa da su da COVID-19.
Aerosol spraying procedures sun hada da allurar rigakafi, allurar farfadowa, bronchoscopy, gyaran jiki da sauran gwaje-gwaje, ko kuma gyaran fata.
Ayyukan jami'an asibiti sun haɗa da tsara makomar mutanen da aka sani ko kuma za su iya kamuwa da COVID-19 a lokacin mutuwarsu; wannan ya haɗa da haɗarin haɗarin haɗarin haɗari yayin da ake bincika abin da ya kashe shi. Ƙarin binciken injiniya ya haɗa da haɗarin haɗarin haɗari kamar keɓewa ga mutanen da aka sani ko kuma za su iya kamuwa da COVID-19, kamar yadda hanyoyin aerosol ke haɗawa.
Ana iya amfani da iskar gas na musamman a wasu wuraren kiwon lafiya da kuma kula da marasa lafiya.
Dole ne a kula da dabbobi bisa ga matakan tsaro na Biosafety Level 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa masu shiga da suka kamu da cutar su ware kansu a wuraren da za a iya samun COVID-19. baya ga PPE, OSHA ta ba da shawarar cewa a sanya takunkumin hana iska a kan mutanen da ke aiki a kusa da wadanda aka san ko ake zargin suna dauke da SARS-CoV-2, da kuma waɗanda ke gudanar da gwajin numfashi na aerosol.
A Amurka, N95 respirator wanda NIOSH ta amince da shi ko mafi girma dole ne a yi amfani da shi a cikin kowane shirin kariya na numfashi, wanda aka tsara a matsayin gwaji na gwaji, horo, da kuma gwaji.
Sauran umarnin numfashi na iya ba da ƙarin kariya da kariya ga ma'aikaci. WHO ta ba da shawarar suturar rigakafi saboda COVID-19 wata cuta ce ta numfashi da ke da alaƙa da rashin lafiya.
WHO ta ba da shawarar sanya rigar rufe fuska ga ma'aikatan asibiti.
Ya haɗa da mutanen da ba su da wani abin da ya shafi numfashi, kulawa, ko kuma gano cutar.
Idan an yi amfani da hanyar busawa a cikin iska, an maye gurbin murfin fuskar mai amfani da N95 ko FFP2.
Saboda karancin PPE a duniya, WHO ta ba da shawarar rage buƙatun PPE ta hanyar gwajin gwaji, abubuwan da suka shafi ƙofofi da kuma matsayi, wanda ke ba da damar shigar da PPE mai sauƙi a cikin asibiti don masu cutar COVID-19, amfani da PPE mai sauƙi a wurin aiki, amfani da PPE mai sauƙi da aka ajiye a cikin asibiti don kula da marasa lafiya daban-daban, da kiyayewa da kare abokan cinikin PPE, da kuma hana haɗari.
Daga: Katherine Maher, Wikimedia Foundation Shugaba
HA: Dukan ƙungiyoyin Wikimedia Foundation
HABBATARWA: [Covid-19] Yawaitar da cutar da kuma tsara makomar gaba
Lokaci/Lokacin da aka buga: 14 Maris, 2020, 00:24 UTC
CC0: Babu haƙƙoƙi da aka tanada
Mun sami kanmu a cikin matsala a farkon wannan watan.
COVID-19 wani lamari ne wanda ya tabbatar da cewa rayuwarmu ta ɗan adam dole ne ta kasance cikin tsari saboda muna fuskantar matsaloli da yawa a rayuwa.
Ba mu da wani abin da za mu yi magana a kai, amma mun san cewa amsar da muka bayar ta dogara ne a kan yadda za mu yi amfani da shi, mu yi amfani da shi, mu kuma yi aiki a cikin al'umma wadda ita ce cibiyar wannan rayuwa.
Kulawa da zamantakewar al'umma da muke samu daga abokanmu ta hanyar imel, imel, da kuma saƙonni na sirri sune mahimman ayyukan da muke da su a cikin lokaci da muke amfani da su.
Ba ni da wata bukata in yi godiya saboda ku fiye da wannan, domin kun yi wa 'yan'uwanmu gargaɗi.
A mako na ƙarshe, wani ya ba ni aikin da ya fi na dā.
Ya tunatar da ni yadda yake da muhimmanci ga duniya don canzawa zuwa Wikipedia a yanzu, kuma yana da matukar muhimmanci cewa wannan tsari yana da gaskiya kuma kowa zai iya samun damar yin amfani da shi.
Aikin da kake yi zai iya zama mai sauƙi, ko dai ta hanyar kula da shafukan yanar gizo ko kuma biyan kuɗi ko kuma al'ummomin lafiya.
Duniya na bukatar karin bayani da Wikipedia ke bayarwa fiye da yadda ake iya bayarwa a yanzu.
Lokaci ya yi da za a yi hukunci ba kawai game da abin da za mu yi ba, amma yadda za mu yi shi, kuma za mu yi hukunci a kan duniya.
Saboda darajar wannan aikin da kuma yadda kuke taka rawa, za mu yi bitar shawarwarinmu na hadin gwiwa, wanda za a fara a mako mai zuwa.
Rahotanni game da ayyukanmu da shirye-shiryenmu
Kamar yadda Robyn ya bayyana a takaice, c-team ya haɗu don tsara shirin da kuma tsara jadawalinmu na kwanaki da watanni masu zuwa.
A cikin wannan labarin, mun yi la'akari da abin da muke tsammanin zai zama amsar da ta dace game da abin da muke fuskanta a yanzu da kuma yadda ya fi dacewa da yanayin zamantakewar al'umma a wannan lokacin.
Ba ma so mu yi zaman banza, kuma ba ma so mu yi aikin banza.
Idan kana so ka koma, ka yi hakuri.
A cikin wannan rukuni, mai kula da ma'aikata da ma'aikata:
Aikin da za mu iya yi a kowane lokaci shi ne aƙalla awa 4 a rana, ko awa 20 a mako a wani yanayi.
Za mu yi bayani a gaba, idan za ku iya aiki a cikin sa'o'i da aka ƙayyade, aikin zai iya aiki a gare ku.
Amma, a duniyar yau, babu wanda ya san abin da zai iya faruwa gobe, kuma ko kana son ka kula da ƙaunataccenka, ka sayi kaya, ko ka je wurin likita, lafiyarka ita ce al'amarinmu.
Ba mu damu da abin da ka yi da lokacinka ba.
Idan kana da lafiya, ka yi aiki.
Ba ma bukatar mu yi fushi da shi, amma muna yin hakan.
Ba tare da wani rashin lafiya ko PTO ba, ka gaya wa mai kula da kai da kuma taimaka wa ƙungiyarka su shirya shirye-shiryen don gano wuraren da ke da muhimmanci.
(Idan an tabbatar maka da COVID-19, ka tuntuɓi Ofishin T&C Ops don tabbatar da cewa kana lafiya kuma ka kula da wannan al'amari.)
Duk wanda ya yi aiki a gonar, zai sami rabonsa.
Mun ce an gama, kuma mun shirya don gabatar da shawarwarinmu ga masu ba da sabis da abokan aikinmu.
Duk wanda ya yi aiki a wannan ma'aikata, zai sami albashi mai tsoka kamar yadda ya samu a lokacin da ba shi da aiki.
Ko da kuwa kana rashin lafiya kuma ba za ka iya aiki ba.
Idan kana son aiki, za mu taimake ka.
Mutane da yawa suna ganin aiki a matsayin hanyar magance matsalolin da ke damun su a duniyar yau.
Duk wani abu da muke yi a wannan lokacin yana da tsada sosai, musamman ma a irin wannan lokaci.
Amma, wannan ya haɗa da kula da kai da kuma kai kanka.
Muna roƙonku ku tuntuɓi shugabanku don ku san abin da za mu yi a wannan taro.
Wani abu kuma yana da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
SRE, HR Ops, Trust & Safety, da kuma ƙungiyoyin Tallafi (da sauransu) suna da muhimmiyar rawa da za su iya takawa wanda zai iya buƙatar ƙarin tallafi.
Za mu fara wani tsari tare da dukkan kungiyoyi don magance matsalolinmu na yanzu da kuma daidaita aikinmu a kan abin da ya fi muhimmanci a aikinmu.
Da yake akwai sauran aiki a yi, sai mu zaɓi abin da ya fi muhimmanci.
A yau, ba za a yi wahala ba, gobe kuma ba za a yi ba.
Muna fatan "ƙara tsawon lokaci don haɗawa" bayan barkewar cutar.
Ba za a ƙara bukatar wani abu ba, don a cika abin da za mu yi.
Mun san cewa abubuwa suna canzawa, kuma muna aiki don daidaita tsarinmu da tsare-tsarenmu a wuri mai dacewa.
Mene ne matsala da APP?
Don daidaita aikinmu na yanzu da kuma abin da za mu iya yi a nan gaba, muna so mu daidaita lokacin da za mu fitar da Shirinmu na Shekara na 2020-2021.
Muna fatan za a aiwatar da jadawalin 2019-2020 wanda zai ba da lokaci mai yawa don zaɓar kuɗin don ba da damar ba da damar ga ma'aikata su yi aiki mai mahimmanci, kula da kansu, da kula da ƙaunatattun su yayin da muke karɓar waɗanda suke son shiga ko waɗanda suke son rage jadawalin su a cikin mako mai zuwa.
Wannan lokacin yana da alaƙa da yawancin ayyukan da ake gudanarwa a cikin al'umma.
Za mu gabatar da sakamakonmu ga shugaban kasa a mako mai zuwa kuma za mu sanar da 'yan takara da kungiyoyi a taron da za a yi nan gaba idan mun sami wannan amsa.
Mun gode wa ƙungiyar APP don goyon bayanku.
Ƙididdigar ƙididdiga, ƙididdiga da kuma tsabta
A cikin makon da ya gabata, an gano cewa ɗayan membobinmu a SF ya kamu da cutar COVID-19.
Amma, bisa ga alhakinmu, mun ɗauki tawagar da ke da alhakin tsaftacewa da kuma tsabtace motocin da ke dauke da kwayar cutar a cikin San Francisco.
Ƙungiyar ta yi amfani da tsarin tsabtace jiki wanda asibiti ke amfani da shi wajen tsabtace gidaje, wuraren ajiye kaya, da kuma kayan aiki a cikin wani gida.
Ginin yana aiki da tsarin tsabtace muhalli kuma yana amfani da kayan aikin da ke tabbatar da lafiyar mazauna.
Muna fatan cewa za a yi aiki mai kyau a wannan lokacin.
Babban aikinmu na DC a cikin WeWork, wanda ke raba shirin COVID-19 tare da mu da mai kula da ƙungiyar DC.
A makon da ya gabata, ofishinmu na DC ya koma wani wuri mai nisa da ke bin hanyar da aka raba ta da San Francisco.
Kamar yadda abokanmu a NYC, mun kuma tattauna game da sayen wani gida a Brooklyn.
Wannan labarin ya ci gaba amma ba zai iya zama ba.
Waɗansu daga cikinku sun yi ta yin wannan aikin tun da aka fara aikin.
'Yan'uwanmu da suka yi aiki a wannan aikin tun daga ranar da aka gano cewa za a iya samun gwaji, suna so su ba ku wasu bayanai:
Ƙididdigar haɗuwa ta haɗu da haɗuwa da yawa da yawa ko fiye da ɗaya ko biyu.
Idan akwai buƙatar haɗin haɗin kai mafi girma, za mu iya yin gyare-gyare a cikin kwanaki da yawa.
Ka ba da damar wannan taron, wanda ba za mu tattauna ba, da kuma aika da kayan karatu a lokaci.
Sabis ɗin bidiyo na ƙarshe, da kuma aikace-aikace kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Akwai mai sauraro don ya jagoranci taron, wani don amsa tambayoyin da kuma mai magana da yawun da zai yi magana, da kuma wani don taimakawa wajen rubuta abin da ake karantawa (ko kuma yin amfani da rubutu).
Aika da imel zuwa ga masu ba da sabis na fasaha idan kana buƙatar kayan aiki masu kyau.
Ku yi wa juna addu'a, ku kuma yi wa juna ban kwana.
Haɗa #remoties channel a Slack don tattaunawa da abokan aiki game da ayyukan da aka yi.
HR na aiki yana tattauna hanyoyin da za a iya amfani da su a cikin yanar gizo don taimakawa wajen gudanar da ayyukan da aka tsara a cikin Foundation.
A makon da ya gabata mun yi kira ga masu sauraron taron jama'a da su yi magana game da ayyukan al'umma da Wikimedia ta ba da gudummawa, kamar edita, yayin da WHO ta sanar da barkewar cutar.
Mun kuma bayyana cewa mun fahimci cewa duk wani shiri da aka yi na hanawa ko hanawa na iya haifar da rashin cika al'amuran da aka tsara a ciki kuma ba za a iya hukunta kowa ba saboda rashin cikawa ko sauye-sauye.
A cikin makonni masu zuwa muna sa ran ci gaba da gabatar da Wikimania da sauran tarurrukan da kuma bayanan al'umma.
A cikin al'umma, akwai bukatar a yi aiki tukuru don a samu daidaito, amma kuma a samu daidaito da kuma samun damar yin amfani da al'ummomin da suka fito daga ciki, kamar Wikimedia da sauransu.
A halin yanzu, CRT na aiki don samar da bayanai game da Meta-Wiki don ba da damar yin amfani da al'umma don kare ikonta da kuma ci gaba da tattaunawa da su.
An yi bincike kan COVID-19 da kuma sauran abubuwan da suka shafi cutar.
Za mu aika da takardun zuwa ga al'ummar Alhamis na gaba, 14:00 UTC/07:00 PT don wani taron rukuni na musamman.
Za mu yi amfani da wannan lokacin don rarraba wasu gwaje-gwaje, amsoshin tambayoyinku kuma ku ciyar da ɗan lokaci don amsawa.
Muna cikin wannan kuma muna shirye mu taimaki duk wanda ya rasa.
A wasu lokuta, zaku iya ci gaba da samun damar yin amfani da imel ɗin da sauran bayanai masu mahimmanci game da COVID-19, ta hanyar Office Wiki.
CRT za ta tattara dukkan bayanan da aka tattara a cikin wani shafi.
Muna kuma aiki don samar da bayanai masu mahimmanci ga kungiyoyin da ke cikin ƙasashe masu tasowa a halin yanzu.
Idan kana da wata damuwa game da tafiya, aiki, aiki mai mahimmanci, ko damuwa game da haɗin kai, ko wani abu da za ka iya buƙatar shi, yi tunani game da yadda za a yi bayani da kuma amfani da CRT.
Muna nan don mu taimaka wa mutane kuma mu haɗa kai da su a duk lokacin da ake bukata.
Don ƙarin bayani ko kuma don neman taimako, don Allah tuntuɓi Bryan Judan - Manajan HR na Ƙasashen Duniya.
Babu wani daga cikin wadannan canje-canje da zai zama mai amfani da ayyukanmu ko ayyuka.
Duk da haka, yana da mahimmanci a san cewa a wannan lokacin, aikinmu da ayyukanmu dole ne a kimanta su kamar yadda muke yi.
Waɗannan su ne matakan da muke tsammanin za su taimaka wa mata da maza don samun damar ci gaba da aiki, ci gaba da dacewa da bukatunmu, da kuma duniya da ayyukanmu na yau da kullun.
Ayyukanmu da muka tsara za su kasance a shirye-shiryenmu har zuwa lokacin.
Yanzu, lokaci ya yi da za a farka daga barci kuma a yi tunani a kan muhimman ayyukan da za a yi a mako mai zuwa da kuma na shekaru masu zuwa.
Muna bukatar ku duka don cimma wannan burin, kuma muna bukatar ku duka don kula da kanku da iyalanku don ku kasance lafiya a lokacin da muka ziyarce ku.
Yanzu fa, sai ku yi zaman lafiya, hannuwanku kuma su yi sanyi, fuskokinku kuma su yi sanyi.
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, and Tony S), da sauran mambobin kungiyar (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Angiotensin-converting enzyme 2 (ACE2) yana da dogon lokaci yana wanzuwa a cikin ƙwayoyin cuta (duba ƙwayoyin cuta) a cikin huhu, jini, zuciya, tsoka, da kuma jijiyoyin jiki.
ACE2 yana hana aikin angiotensin-converting enzyme (ACE) ta hanyar rage yawan angiotensin-II da kuma ƙara Ang ((1-7) wanda ya sa ya zama magani mai mahimmanci a cikin maganin cututtukan zuciya. ACE2 kuma yana aiki a matsayin ƙofar shiga cikin ƙwayoyin cuta na wasu coronaviruses.
Kwayar halittar ɗan adam ana kiranta HACE2.
Angiotensin converting enzyme 2 shi ne zinc-containing metalloenzyme kuma yana samuwa a cikin endothelial da sauran kwayoyin halitta.
ACE2 yana da yankin N-terminal peptidase M2 da kuma C-terminal amino acid transporter domain.
ACE2 shine wani nau'in furotin mai suna type I membrane, wanda ke dauke da sinadarin dake aiki a jikin jikin kwayoyin halitta da kuma sauran kwayoyin halitta.
ACE2 yankin a waje na cell an haɗa shi da wani yankin transmembrane ta hanyar wani fili mai suna sheddase, kuma sunadarai masu gina jiki suna shiga cikin jini kuma a ƙarshe sun fita daga cikin mahaifa.
ACE2 yana samuwa a cikin mafi yawan kwayoyin halitta: ACE2 yana samuwa a cikin ƙwayoyin ƙwayoyin cuta na alveolar type II, ƙananan ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin arterial da venous endothelial da kuma ƙwayoyin arterial smooth muscle a cikin mafi yawan kwayoyin halitta.
An kuma gano wuraren ACE2 mRNA a cikin ƙwaƙwalwar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar.
Aikin ACE2 shine a matsayin mai daidaita daidaito a cikin ACE.
ACE tana mai da shi daga angiotensin I zuwa angiotensin II, wani sinadarin da ke rage karfin jijiyoyin jini.
ACE2 kuma yana karɓar karboxyl-karshen amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) zuwa angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana da ikon canza wasu peptides kamar [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana ƙunshe da mai karɓar amino acid mai tsaka tsaki SLC6A19 kuma yana da alaƙa da cutar Hartnup.
A matsayin furotin na transmembrane, ACE2 ya zama ƙofar shiga cikin wasu ƙwayoyin coronavirus, kamar su HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar da ke haifar da COVID-19).
Hakanan, haɗuwa da ƙwanƙolin S1 na SARS-CoV da SARS-CoV2 a cikin ƙwayar enzymatic ACE2 na ƙwayoyin cuta na haifar da endocytosis da translocation na ƙwayoyin cuta guda biyu da kuma ƙwayoyin cuta a cikin endosomes na sel.
Wannan ya haifar da ragewar S protein ta hanyar karɓar mai karɓar TMPRSS2 mai karɓar maganin, wanda aka yi la'akari da shi a matsayin hanyar da za a iya magance shi. Wannan ya sa muka yi tunanin cewa rage yawan ACE2 a cikin kwayoyin halitta zai iya taimakawa wajen magance cutar.
Duk da haka, ƙungiyoyi da yawa da kuma hukumomin da suka san aikin likitoci sun ba da shawara a ci gaba da amfani da maganin ACE da kuma maganin ARB.
A wani bincike da aka yi a ranar 11 ga watan Nuwamba, 2012, an gano cewa " amfani da masu hana ACEs ya sa an samu raguwar kashi 34% a cikin cutar huhu da aka kwatanta da na rigakafi. "
Duk da haka, "sanadin cutar huhu ya ragu a cikin marasa lafiya da aka yi wa maganin ACE inhibitors wanda ke da haɗarin kamuwa da cutar huhu, musamman ma a cikin waɗanda ke da hawan jini da kuma ciwon zuciya".
"Amfani da ACE inhibitors yana da alaƙa da raguwar mutuwar ƙwayoyin cuta, duk da cewa alamun sun yi ƙasa da haɗarin cutar ƙwayoyin cuta gaba ɗaya".
Recombinant human ACE2 (rhACE2) wani sabon magani ne na cutar huhu, wanda ke taimakawa wajen rage yawan jini a cikin huhu da kuma rage yawan iskar oxygen a cikin yara masu shekaru goma sha biyu da suka kamu da cutar huhu mai dauke da cutar lipopolysaccharide.
Rabin rayuwar rhACE2 a cikin mutane ya kai kimanin awa 10 kuma farkon aikinsa ya kai minti 30 tare da ƙaruwa a cikin lokaci (lokaci) na awa 24.
Akwai wasu shaidu da ke nuna cewa rhACE2 na iya zama magani mai amfani ga mutanen da suka kasa karɓar magungunan classic renin-angiotensin system inhibitors (RAS inhibitors) ko kuma a cikin cututtukan da angiotensin II ke hana su. An gwada rhACE2 a cikin gwaji na asibiti don magance matsalar numfashi.
Aikace-aikacen COVID-19 na b'COVID-19 an tsara su ne don taimakawa wajen gano mutane a matsayin martani ga cutar coronavirus ta 2019-20 coronavirus, kamar yadda ake kira tsarin gano mutane ("masu bincike") waɗanda za su iya kasancewa sun kasance tare da wanda ya kamu da cutar.
Aikace-aikace sun yi yawa ko sun kasa, tare da taimakon gwamnati da masu zaman kansu a wasu yankuna da larduna.
An yi amfani da wasu nau'ikan da aka sani da ake kira "tabbatarwa".
Tambayoyi game da amincin sun taso, musamman ma game da hanyoyin da aka tsara don gano yanayin rayuwar masu amfani da aikace-aikacen.
Ƙananan hanyoyin da za a iya gano bayanan mutum suna amfani da siginar Bluetooth don sadarwa ta hanyar wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar a lokaci guda cewa za su gabatar da kayan aiki don tallafawa aikace-aikacen Bluetooth a cikin tsarin aiki na Android da iOS.
A China, gwamnatin China, tare da Alipay, sun ƙaddamar da wata manhajar da ke ba da damar yin amfani da bayanai ga jama'a don tantance ko sun kasance tare da mutanen da ke da COVID-19.
A cikin biranen China, mutane suna amfani da shi a cikin birane 200. A Singapore, akwai wani app da ake kira TraceTogether.
A Macedonia akwai wani aikace-aikacen da ke aiki tare da Bluetooth da ake kira "StopKorona!", wanda ke nuna haɗarin da ke tattare da mutanen da ke fama da cutar kuma yana ba da amsa mai sauri ga hukumomin kiwon lafiya.
Aikace-aikacen ya samo asali ne daga ayyukan Ƙungiyar Bayanai da Fasaha da Lafiya.
A ranar 14 ga Afrilu, 2020, an ƙaddamar da aikace-aikacen ta hanyar Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta sanar da cewa za a fara amfani da manhajar don gano mutanen da ke cikin cutar, kuma za a rarraba su a cikin mako guda.An riga an kammala amfani da manhajar a Ireland, da Faransa ("StopCovid").
Australia da New Zealand suna nazarin aikace-aikacen da ke kan layi na TraceTogether Singapore da BlueTrace. Rasha na iya gabatar da aikace-aikacen da ke yin amfani da wayar hannu don masu cutar COVID-19 a Moscow, don ganowa da kuma ba da izinin barin gida.
Ross Anderson, masanin injiniyan tsaro a Jami'ar Cambridge, ya lissafa yadda matsalar tsaro da aikace-aikacen ke fuskanta, kamar nuna mutum a matsayin mai cutar amma ba mai laifi ba, zai iya zama da muhimmanci idan ya shafi ƙananan mutane.
Bayan ya yi watsi da wasu zarge-zargen da ake yi na cewa wasu aikace-aikacen da suka shafi cutar korona ba su da inganci ko kuma masu cutarwa, Apple ya nuna cewa akwai wasu sharuddan da hukumomi za su iya dauka na hana wasu aikace-aikacen da suka shafi cutar korona daga App Store, inda ya hana su ga "masu laifi" ko kuma kungiyoyi masu laifi.
Google da Amazon sun yi irin wannan gwaji a baya.
Masu bincike sun nuna damuwa game da yiwuwar yin amfani da aikace-aikacen coronavirus a cikin jama'a, musamman idan an dakatar da tsarin kariya da aka tsara don hana kamuwa da cutar coronavirus yayin da cutar ta sake barkewa.
Kungiyar Amnesty International da wasu kungiyoyi sama da 100 sun yi wani rahoto inda suka bayyana irin wadannan hare-haren.
Wadannan kungiyoyi sun yi rahoton wasu batutuwa da suka shafi ayyukan gwamnati:
kulawa za a iya kwatanta da "daidai, mai amfani da kuma daidaitacce";
Ƙaddamar da ƙididdigar da kuma kula da su kamar yadda aka tsara a cikin takardun shaida;
Ayyukan da bayanan sirri sun kasance masu rikitarwa bisa ga ƙa'idodin COVID-19.
bayanan sirri da kuma ba tare da rajista ba za a iya tabbatar da shi ba a cikin bayanan da aka samu;
kula da bayanan da aka adana a cikin hanyar da ta dace da kuma ingantaccen tsarin;
duk wani musayar bayanai da aka yi da wani dole ne a yi bincike a kansa;
Akwai iyakokin da za a iya bi don yin amfani da takardun jama'a don amsa tambayoyin;
Sa hannu a cikin wannan tsari ta "masu yaƙi da yaƙi" dole ne a yarda da su, kamar su likitoci da ƙungiyoyin da aka ba da izini.
A cikin shirin Google/Apple ana nufin a cire duk wani bayanan sirri da aka samu daga tsarin da aka tsara ta hanyar cire bayanan wurin da aka gano daga cikin umarnin da aka yi a baya idan ba a sake amfani da su ba.
Wasu ƙasashe suna amfani da umarnin sarrafawa ba tare da aikace-aikacen ba, wanda ke faruwa ba tare da shigar da aikace-aikacen ba kuma ba tare da wani mai sakawa ba.
A Isra'ila, an yi watsi da tsarin tsaro.
Hanyoyin da ke tattare da kula da yanki na iya samun matsala tare da bayanan sirri na mutane.
Duk da haka, ba duk tsarin da tsarin da ake bukata ba ne ya kamata ya shiga cikin bayanan da aka samu; wasu hanyoyin da aka tsara na adana bayanai sun saba da tsarin tsarin da aka tsara don canza bayanai (ƙananan rukuni).
A Koriya ta Kudu, akwai wata hanya ta musamman da za a iya amfani da ita wajen magance matsalar rashin lafiya.
A kan aikace-aikacen da aka bayar, hukumar ta tattara bayanan masu sa ido ta hanyoyi daban-daban kamar bayanan wayar salula da bayanan katin kuɗi, kuma ta haɗa su don aika saƙonnin imel zuwa ga waɗanda za su iya kamuwa da cutar.
Bugu da ƙari, don yin amfani da bayanan bincike na sirri, gwamnati ta ƙaddamar da bayanan sirri don buɗewa ga jama'a, wanda ya dace da wasu canje-canje da kuma dokokin bayanan bayan barkewar cutar MERS a kasar.
Ana buɗe wa jama'a wannan bayanai ta hanyar yin amfani da wasu aikace-aikace da kuma dandamali. Ƙasashen da suka haɗa da Jamus sun yi ƙoƙarin haɗa tsarin riƙe bayanai da na na'urar sarrafawa.
A ranar 6 ga Afrilu, 2020, za a sabunta bayanan kamar yadda aka saba.
A ranar 7 ga watan Afrilu, 2020, fiye da dozin ma'aikata sun yi amfani da hanyoyin sadarwa na zamani, kamar amfani da Bluetooth Low Energy (BLE) don tuntuɓar mai amfani da wasu wayoyi.
Duk da haka, PEPP-PT ne mai wuya m wanda ya ƙunshi biyu na tsakiya da kuma na sirri hanyoyin, kuma ba daya. The m hanyoyin hada Decentralized Privacy-Preserving kusanci bin sawu (DP-PPT / DP-3T), wucin gadi Contact Event Numbers (TCN), Privacy Sensitive Protocols da kuma Mechanisms for Mobile Contact Tracing (PACT) da sauransu.
A cikin wannan tsari, bayanan da za a iya samu ba za su iya zama a cikin tsari ba, kuma duk wani hulɗa da aka yi zai zama a cikin tsari.
Ƙungiyar Sirri a MIT Media Lab ta ba da shawarar SafePaths, tsarin da ke amfani da hanyoyin adana bayanai masu zaman kansu yayin tattara bayanai da kuma amfani da bayanan yanki da na gida don hana yaduwar COVID-19.
An yi amfani da wannan bincike ne a cikin littafin da aka buga a watan Maris na 2020 mai suna "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic".
SafeTrace yana amfani da tsarin fasaha na kare lafiyar ma'aikata don aika bayanai game da lafiyar jiki da kuma sauran mutane da hukumomi, ba tare da lalata bayanai ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Coalition ta hanyar kungiyoyin da suka haɗu a bayan abin da ya faru wanda ya kasance irin wannan tsari da kuma irin wannan ci gaba, wanda aka tsara don rage ƙarancin, kuma ya sa ya yiwu a iya hana yaduwar cutar ta hanyar aikace-aikace a duk faɗin duniya.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta gabatar da tsarin BlueTrace ga jama'a ta hanyar aikace-aikacen da aka ba da ita ga gwamnatin ta.
A ranar 10 ga Afrilu 2020, Google da Apple, kamfanonin da ke da wayoyin Android da iOS, sun sanar da wata sabuwar hanyar kula da wayar salula, wacce ake sa ran za ta iya kare mutane, ta hanyar amfani da fasahar Bluetooth Low Energy da kuma bayanan sirri.
Amma ba su da wani tsari na musamman na tsarin tsarin.
A cewar Apple da Google, umarnin ya zo ne a cikin matakai uku:
Aikace-aikacen da aka samar don samun damar shiga cikin gwamnati ya nuna cewa aikace-aikacen da ke kula da yaduwar cutar coronavirus na gwamnati da na ci gaba da kasancewa ba su da inganci.
Google da Apple sun yi amfani da wannan hanyar don samun amsa ga ƙuntatawa da matsalolin tsaro ta hanyar tura su zuwa ga masu bincike da yin amfani da umarnin, sannan kuma cire su kamar yadda aka yi a baya lokacin da matsalar ta ƙare.
Sake fasalin magani (wanda kuma aka sani da sake fasalin magani, sake fasalin, sake fasalin ko sauya fasalin magani) shine sake fasalin tsarin farko na wani magani wanda aka riga aka gama shi don magance wani cuta ko kuma wani cuta da aka riga aka yi amfani da shi.
Binciken bincike na gaba ɗaya ya biyo bayan binciken da aka yi na farko don samar da magani mai aminci da inganci don maganin COVID-19.
Sauran hanyoyin bincike sun hada da samar da maganin rigakafi da kuma maganin COVID-19 plasma. SARS-CoV yana da 66 sunadarai masu haɗuwa da magunguna, kowannensu yana da ƙwayoyin cuta masu yawa.
Kula da waɗannan haɗin kai yana da mahimmanci don samar da maganin rigakafi mai amfani da sunadarai don COVID-19.
Tsakanin sunadarai masu guba na SARS-CoV-2 akwai sunadarai masu guba na RNA, RNA mai dogara da RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein AA, et al. sun bincika abubuwan da aka gano a gwajin maganin da suka shafi amfani da shi a asibiti, kuma sun gano cewa akwai wasu magungunan da aka gano da za su iya magance cutar SARS-CoV-2 a cikin binciken da suka yi a baya don su iya magance shi a asibiti.
Chloroquine wani magani ne na gargajiya da aka yi amfani da shi don magance wasu cututtuka.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine za su iya kasancewa cikin magungunan da aka yi gwajin gwaji a asibitin Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin New York State na chloroquine da hydroxychloroquine zai iya farawa a ranar 24 ga Maris.A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin Dokar Amfani da Gaggawa (EUA).
FDA ta amince da gwajin asibiti, wanda ya nuna cewa wannan magani ne kawai da aka ba da izini a Amurka a matsayin magani na gwaji idan akwai gaggawa da kuma magani ga marasa lafiya da aka kwantar da su a asibiti amma ba su iya samun magani a cikin asibiti ba.
CDC ta ce "sayarwa, bayarwa, ko kuma amfani da hydroxychloroquine don rigakafin cutar ba shi da magani ga cutar SARS-CoV-2" har yanzu ba a amince da shi ba.
Masana kimiyya sun ce ana ba da maganin ne kawai "ba tare da wani zaɓi ba".
Wani rukunin bincike na Turkiyya a Istanbul ya gudanar da wani bincike kan chloroquine da zinc, bitamin A, bitamin C da bitamin D.
Wasu bincike na musamman sun shafi Duke University da kuma Jami'ar Oxford.
NYU Langone Medical School yana gudanar da gwaji kan aminci da ingancin amfani da hydroxychloroquine a matsayin hanyar kariya.
Gwaje-gwajen asibitocin kasar Sin a Wuhan da Shenzhen sun nuna cewa favipiravir yana da "tasiri sosai".
A cikin marasa lafiya 35 da ke Shenzhen an yi musu allurar rigakafin cutar a cikin kwanaki 4, kuma an yi musu allurar rigakafin cutar a cikin kwanaki 11 a cikin marasa lafiya 45 da aka yi wa allurar rigakafin.
A wani bincike da aka yi a Wuhan, an yi amfani da mutane 240 da suka kamu da cutar nimoniya, rabi sun sha favipiravir rabi kuma sun sha umifenovir.
Hukumar Kula da Magunguna ta Italiya ta sanar da jama'a cewa ba a tantance duk wani magani da aka tabbatar yana da tasiri ba.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin a Japan saboda akwai shi a can, sojoji za su yi amfani da shi don kula da lafiyar jama'a, kuma za a yi amfani da shi don magance COVID-19.
A cewar South China Morning Post, Shinzo Abe ya yi kira ga gwamnatin Trump da ta amince da sayan maganin. Wannan maganin zai iya zama mai matukar tasiri wajen magance cututtukan da ke fama da mutane, kuma ya kawar da cutar.
Hakanan yana da kyau ga mata masu ciki da waɗanda suke son yin ciki.
Wani bincike na lopinavir/ritonavir (Kaletra), mai dauke da kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar, ya ce "babu wani tasiri da aka gano".
An kuma samar da maganin da zai iya hana HIV ta hanyar yin aiki da shi ta hanyar yin hulɗa da shi.
Aikin bincike a Jami'ar Colorado ya shafi gyaran maganin don samun damar hadewa da SARS-CoV protease. Akwai kuma rashin amincewa a tsakanin masu bincike don sanya takardun shaida don tabbatar da cewa an samar da maganin cutar HIV/AIDS.
WHO ta yi amfani da kwayar cutar ta lopinavir/ritonavir a cikin gwajin kasa da kasa na Solidarity.
An samar da Remdesivir ta Gilead Sciences don maganin cutar Ebola da cutar Marburg. Gilead Sciences ta kuma gano cewa Remdesivir yana da tasirin kashe ƙwayoyin cuta a cikin vitro akan ƙwayoyin cuta da yawa kamar filo-, pneumo-, paramyxo-, da korona.
Daya daga cikin matsalolin da ke tattare da maganin kwayar cutar ita ce rashin iya jurewa ta hanyar maye gurbin kwayar cutar, wanda zai iya zama da wahala a cikin mafi munin yanayin kamuwa da cuta.
Wasu bincike da aka yi kafin a fara gwajin sun nuna cewa remdesivir na iya hana kwayar cutar ta kwayar halitta yin aiki na dogon lokaci. Akwai wasu gwaji na asibiti da ake gudanarwa a yanzu, ciki har da biyu da Cleveland University Hospitals ke gudanarwa; daya ga mutane masu rauni da kuma wani ga wadanda suka kamu da cutar.
Akwai gwaji na asibiti uku na bitamin C da aka ba da gudummawar jini ga mutanen da ke asibiti da COVID-19 mai tsanani; biyu na placebo (China, Kanada) da kuma wanda ba a kula da shi ba (Italiya).
Jihar New York ta fara gwajin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) ta shirya gwajin asibiti na maganin alvescocin na Teijin (ciclesonide), wani maganin hana cututtukan cututtukan fata, don kula da marasa lafiya marasa lafiya waɗanda ba su da alamun cutar da suka kamu da sabon coronavirus.
Aikin angiotensin-converting enzyme 2, gwajin Phase II ya dogara ne akan gwajin mutum 200 da aka zaɓa daga cikin marasa lafiya, a asibitoci a Denmark, Jamus, da Austria don gano amfanin magani.
Masu bincike a Cibiyar Kula da Zuciya ta Montreal a Kanada suna nazarin tasirin colchicine wajen rage yawan cututtukan zuciya da na huhu a cikin marasa lafiya da ke da alamun cutar COVID-19.
Binciken, wanda aka fi sani da COLCORONA, ya yi amfani da mutane fiye da 6000 masu shekaru 65 da haihuwa da suka kamu da COVID-19 kuma suna da alamun rashin lafiya da ba sa bukatar zuwa asibiti.
Mata masu juna biyu ko masu ciki ko marasa lafiya ba za a yi la'akari da su ba.
An yi amfani da maganin rigakafi da yawa a Italiya.
Heparin yana da ƙananan ƙwayar cuta a cikin maganin marasa lafiya, wanda ya sa Hukumar Kula da Lafiya ta Italiya ta ba da umarnin don amfani da shi.
Wani bincike na asibiti na mutane 300 da ke nazarin tasirin enoxaparin sodium a cikin rigakafin rigakafi da kuma kula da lafiya ya ruwaito a Italiya a ranar 14 ga Afrilu.
Tun da SARS-CoV-2 kwayar cuta ce, ya zama wajibi a yi amfani da maganin rigakafin don kawar da wasu cututtukan da suka riga sun bayyana kamar MERS, SARS, da West Nile virus.
Ribavirin: ribavirin an ba da shawarar don maganin COVID-19 bisa ga takardar shaidar kasar Sin ta 7
Umifenovir: an ba da umarnin umifenovir don maganin COVID-19 bisa ga jerin sunayen masu bincike na China 7
Wasu daga cikin sanannun maganin rigakafi na iya zama a matsayin magani na COVID-19:
Tocilizumab (Anti-IL-6 receptor): China ta amince da shi.
An kuma gudanar da gwaje-gwajen a Italiya da China. duba Tocilizumab don COVID-19.
Kwayar COVID-19 b'A ta zama rigakafin cutar coronavirus 2019 (COVID-19).
Duk da cewa babu wani maganin da ya kammala gwajin asibiti, akwai wasu matakai da ake dauka don samar da irin wannan maganin.
A watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta yi hasashen cewa ana sa ran samun rigakafin SARS-CoV-2, kwayar cutar da ke haifar da cutar, kafin shekaru 18.
An gudanar da gwaje-gwaje shida na gwaji a kan nazarin lafiyar na I a watan Afrilu.
COVID-19 ya bayyana a watan Disambar 2020.
An samu barkewar cutar a duniya a shekarar 2020, wanda ya sa an kashe makudan kudade da kuma masana kimiyya wajen samar da maganin.
Ƙungiyoyi da yawa suna aiki tare da ƙididdigar ƙididdigar ƙididdiga don samar da allurar rigakafin cutar SARS-CoV-2.
A watan Afrilu, an bayyana cewa, wasu daga cikin abubuwan da CEPI ke yi game da samar da allurar rigakafi shi ne, gaggawar samar da allurar rigakafi, da yin amfani da jama'a da yawa, da rashin isasshen abinci, da kuma wasu abubuwa masu yawa.
A watan Afrilu, CEPI ta sanar da cewa an riga an fara bincike da samar da allurar rigakafin COVID-19 mai inganci a farkon 2020.
Muhimmin mahimmanci shine a cikin koyarwar zaman lafiya na I-VIII wanda ya haɗa da:
nucleic acid (DNA da RNA) (mai taimakawa a cikin gwajin kwayar cutar Phase I: Moderna, mRNA-1273)
kwayar cutar (mai samar da kwayar cutar I da kuma gwajin rigakafi: CanSino Biologics, adenovirus type 5 vector)
Kamar yadda aka sanar da jami'an CEPI a watan Afrilu, ana shirin samar da alluran rigakafi guda 115, tare da 78 a matsayin aikin ci gaba (79, a cewar Cibiyar Milken), da kuma 37 da aka sanar, amma ba tare da bayanan jama'a ba (an shigar da su cikin tsari ko an zaɓa).
Gwajin gwaje-gwajen I-II ya ba da damar yin gwajin rigakafi na farko da na rigakafi, kamar yadda aka saba, ana sarrafa shi da placebo, kuma a cikin mafi yawan lokuta, ba a gano cutar da kyau ba.
Gwajin Phase III ya shafi al'umma da kuma kungiyoyin da ke gudanar da bincike, inda ake duba amfanin allurar rigakafi wajen hana yaduwar cutar, da kuma yadda za a iya kaucewa hadarin da ke tattare da ita.
Daga cikin alluran rigakafi 79 da ke kan samarwa (wanda aka tabbatar a farkon Afrilu 2020), 74 suna cikin gwajin ɗan adam (a halin yanzu a cikin binciken "pre-clinical").
A ranar 24 ga Janairun 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa ta sami kwayar halitta mai yiwuwa don samar da rigakafin da zai iya canza sunadarin ƙwayar cuta ta kwayar cutar don samun ƙwayar cutar.
A ranar 24 ga watan Janairun 2020 a Kanada, Cibiyar Harkokin Kiwon Lafiyar Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa ta fara aiki a kan allurar rigakafi, da nufin gudanar da gwajin ɗan adam a 2021.
An sanar da ayyukan samar da maganin ne a Cibiyoyin Kula da Cututtuka da kuma Kula da Cututtuka na kasar Sin a ranar 26 ga watan Janairun 2020, da kuma Jami'ar Hong Kong a ranar 28 ga watan Janairun.
A ranar 29 ga Janairun 2020, Kamfanin Janssen Pharmaceutical Companies, wanda Hanneke Schuitemaker ya jagoranci, ya sanar da cewa ya fara aiki a kan allurar rigakafi.
Janssen yana aiki ne a kan allurar rigakafin cutar sankara ta baki da mahaifiyarsa, Vaxart.
A ranar 18 ga Maris, Emmergent BioSolution ya sanar da cewa zai yi aiki tare da Vaxart don samar da rigakafin.
A ranar 8 ga watan Fabrairun 2020, OncoGen Laboratory a Romania ta fitar da wani rahoto game da tsarin samar da maganin da kuma irin fasahar da aka samu don maganin cutar sankara.
A ranar 25 ga watan Maris, ƙungiyar bincike ta sanar da cewa ta kammala gwajin rigakafin kuma ta fara gwajin ta ƙarshe.
A ranar 27 ga Fabrairu, 2020, kamfanin Generex na NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin bincike na rigakafi don samar da allurar rigakafin cutar COVID-19 na li-Key peptide.
Suna son samar da allurar rigakafin gwaji da za a iya gwadawa a cikin mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da cewa tana aiki don samar da allurar rigakafi.
A ranar 5 ga watan Maris, Kwamandan Cibiyar Bincike ta Sojojin Amurkan a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, duka a yankin Marvland da ke yamma, sun sanar da cewa suna aiki don samar da allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta yi amfani da Novavax Inc.
don gano da kuma samar da maganin.
Ma'aikatan likitancin sun ba da sanarwar cewa za a gudanar da gwajin farko na rigakafin tare da gwajin asibiti na I a cikin watan Satumba 2020.
A ranar 12 ga Maris, 2020, Hukumar Lafiya ta Indiya ta ba da sanarwar cewa tana aiki a kan allurar rigakafi guda 11, kuma ko da yake ana iya ɗaukar shekara ɗaya da rabi ko shekaru biyu don samar da allurar.
A ranar 12 ga Maris, 2020, Medicago, wani kamfani na biotechnology a Quebec City, Quebec, ya sanar da wani aiki na samar da wani samfurin rigakafin coronavirus wanda Cibiyoyin Kula da Kiwon Lafiya na Kanada suka ba da gudummawar kuɗi kaɗan.
An gudanar da gwajin a cikin dakin gwaje-gwaje, kuma an yi gwajin a kan mutane don Yuli ko Yuli 2020.
A farkon wannan makon, The Guardian ta ba da rahoton cewa Shugaban Amurka Donald Trump ya ba CureVac "babban tallafi don samar da rigakafin COVID-19", wanda gwamnatin Jamus ba ta amince da shi ba.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwarsu tare da kamfanin Jamus BioNTech don haɓaka allurar rigakafin mRNA.
BNT162 mRNA gwajin gwaji, a halin yanzu a gwajin kafin magani tare da gwajin gwaji wanda aka fara a farkon Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin biotech na Italiya ya ba da sanarwar cewa za su sami sakamakon gwajin gwaji na asibiti a watan Afrilu 2020 kuma gwajin rigakafin na ƙarshe zai iya farawa kafin ƙarshen wannan shekarar.
A Faransa a ranar 19 ga Maris, 2020, Ƙungiyar Ƙaddamar da Ƙaddamar da Ƙaddamar da Ƙaddamarwa (CEPI) ta sanar da bayar da dala miliyan 4.9 don bincike kan allurar COVID-19 tare da ƙungiyoyi kamar Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ke ba da gudummawar CEPI don samar da rigakafin COVID-19 a dala miliyan 29.
Sauran kamfanonin da CEPI ke aiki tare don samar da allurar COVID-19 sun haɗa da Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an gwamnatin Rasha sun sanar da cewa masana sun fara gwajin kwayar cutar a kan allurai shida na gwaji.
A ranar 20 ga Maris, 2020, masu bincike na Kwalejin Imperial na Landan sun sanar da cewa suna shirye su samar da allurar rigakafin NRA da ke hana yaduwar COVID-19.
Ana iya yin amfani da allurar rigakafin cikin kwanaki 14 bayan an karɓi kayan a China.
A ƙarshen Maris, Gwamnatin Kanada ta sanar da bayar da C$275 miliyan don tallafawa ayyukan bincike 96 na hanyoyin likita don COVID-19, ciki har da alluran gwaji da yawa a cikin kungiyoyi da cibiyoyin Kanada kamar Cibiyar Kula da Lafiya da Jami'ar Saskatchewan.
A halin yanzu, gwamnatin Kanada ta ba da sanarwar samar da dala miliyan C$192 don samar da allurar rigakafin COVID-19, tare da shirye-shiryen gina "taro na allurar rigakafi" don sabbin alluran rigakafi da za a iya amfani da su idan aka sake samun cutar coronavirus.
A ranar 2 ga Afrilu 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da sanarwar yin nazarin PittCoVacc, wani rigakafin COVID-19 da aka riga aka samar, suna mai cewa "MNA ya samar da rigakafin SARS-CoV-2 S1 wanda ya ba da damar yin amfani da rigakafin rigakafi ga masu rigakafin rigakafin rigakafin rigakafi [a cikin] farkon makonni 2 bayan an samar da rigakafin".
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta ba da rahoton gano DNA na yiwuwar allurar rigakafi a cikin wani asibiti.
Aiki tare da bacteriophages, DNA na iya yin aiki a cikin kwayoyin halittar mutum don samar da kwayar halittar da ba ta da kwayar cutar da za ta iya haifar da rigakafin jiki don samar da maganin rigakafin cutar SARS-CoV-2.
A watan Maris na 2020, Gwamnatin Amurka, masana'antu, da kuma likitoci sun haɗu don shiga cikin yarjejeniyar da aka yi da IBM, ciki har da kamfanonin fasaha na Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu hanyoyi suna da haɗari, kuma wasu suna da haɗarin haɗari.
Wannan yana nufin cewa ba za su iya samun riba ba idan suka yi rashin lafiya.
Wani gwaji a Ostiraliya yana neman ƙarin ma'aikatan kiwon lafiya 4170.
Hakanan ana iya samun alluran rigakafin da aka riga aka samar waɗanda ba su da lafiya ko kuma ba su da tasiri.
Bincike na farko don magance yiwuwar yin allurar rigakafi ta hanyar gano nau'in COVID-19 da ke tattare da kwayoyin halittar dabbobi kamar ƙwayoyin ACE2-transgenic, wasu ƙwayoyin lab, da kuma kwayoyin da ke shiga cikin kwayoyin halittar mutum, ya nuna buƙatar matakan kula da ƙwayoyin halittar 3 don hana cutar cutar, da kuma ci gaba na duniya don tabbatar da ingancin lafiya.
An yi gwajin rigakafin SARS da MERS a cikin marasa lafiya marasa lafiya.
A cikin 2020, babu wani magani ko rigakafin cutar SARS da aka gano da ya dace da lafiyar ɗan adam.
A cewar rahotannin bincike na 2005 da 2006, ganowa da kuma samar da sababbin kwayoyi da magungunan SARS ya kasance babban abin da ya fi damuwa ga gwamnatoci da kungiyoyin kiwon lafiyar jama'a a cikin kasar.
A lokacin da aka gano cutar MERS, an yi hasashen cewa binciken SARS na iya zama wata hanya ta samar da allurar rigakafi ko magani ga cutar MERS-CoV.
A ranar 20 ga Maris, 2020, an riga an sami allurar rigakafin MERS (wanda aka kafa ta hanyar DNA) wanda ya kammala gwajin gwaji na asibiti, tare da wasu uku, waɗanda duka sun kasance maganin rigakafin cutar virus, adenovirus, (ChAdOx1-MERS, BVRS-GamVac), da MVA-vectored (MVA-MERS-S).
Bayanan da aka bayar a kafofin watsa labarun sun ba da ra'ayi na yau da kullun ta hanyar nuna cewa kwayar cutar COVID-19 ta kasance daidai da yadda aka riga aka gano maganin.
Binciken da aka yi a kan al'umma ya dogara ne akan binciken da aka yi a baya don gano asalin kwayar halitta na wasu coronaviruses kamar su SARS coronavirus.
Cutar coronavirus ta 2019 (COVID-19) cuta ce ta numfashi mai saurin kamuwa da cuta mai saurin kamuwa da cuta mai saurin kamuwa da cutar sankara ta 2.
Mafi yawan cututtuka sun hada da tashin hankali, ciwon sukari, da kuma cututtuka na numfashi kamar cututtukan zuciya.
Sauran alamun cutar na iya haɗawa da gajiya, ciwon kai, ƙaiƙayi, ƙaiƙayi, rashin jin magana, da kuma ciwon ciki.
Lokacin daga kamuwa zuwa bayyanar cututtuka na farko shine kusan kwanaki shida amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Yawancin marasa lafiya suna da alamun rashin lafiya, amma wasu na iya kamuwa da cutar huhu da kuma cututtukan hanji.
Ya zuwa 17 ga Afrilu 2020, sama da mutane miliyan 2.24 aka ruwaito sun kamu da cutar a cikin ƙasashe da yankuna 210, kuma sama da mutane 153,000 suka mutu.
Fiye da mutane 568,000 suka kamu. An yada cutar a cikin al'umma ta farko ta hanyar kamuwa da cuta, musamman ta hanyar ƙwayoyin cuta da ke cikin gida, da ƙwayoyin cuta, ko kuma dabbobin gida.
A lokacin da aka yi ruwan sama a lokacin tashin jirgi, ana yin sallah a kasa ko a kan fuka-fukan jirgi don hana mutane kamuwa da cutar ta hanyar iska.
Mutane na iya kamuwa da cutar ta hanyar taba wasu gurbataccen abu sannan su taba idanunsu, hancinsu ko bakinsu.
Wannan kwayar cutar ta iya yaduwa a cikin kimanin minti 72.
Mafi yawan kamuwa da cutar na faruwa ne a cikin kwanaki uku na farko bayan kamuwa da cutar ta fara, ko da yake za a iya samun kamuwa da cutar kafin bayyanar cututtuka kuma a cikin kwanaki na ƙarshe na kamuwa da cutar. Hanyar da aka fi amfani da ita ita ita ce ta amfani da gwajin RT-PCR (mai amfani da sinadarin polymerase chain reaction) wanda ake yi wa ƙwayoyin cuta da ke bayan hanci ko kuma hanci.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake zaton suna da kwayar cutar da kuma waɗanda za su kula da su.
Matsayin rufe fuska a cikin al'umma ya bambanta, tare da wasu hukumomi ba za su yarda da sanya shi ba, wasu kuma suna ba da shawarar sanya shi, wasu kuma suna ba da shawarar yin amfani da shi.
A halin yanzu, babu wani maganin rigakafi ko maganin rigakafin cutar da ke da inganci don COVID-19.
An bayar da rahoton cewa an sami karuwar cutar a cikin al'umma a kusan dukkan ƙasashe a cikin yankin WHO.
Wadanda suka kamu da kwayar cutar ba za su iya yin rashin lafiya ba ko kuma su nuna alamun rashin lafiya irin su rashin jin daɗi, rashin lafiya, rashin ƙarfi, da rashin numfashi.
Alamun farko sun hada da wahalar numfashi, ciwo ko kuma ciwon zuciya na tsawon lokaci, ciwo, da ciwon ciki, da canjin fuska da baki; idan wadannan alamun suka bayyana ya kamata ka nemi taimakon likitoci.
A wasu lokuta, ana iya samun alamun cututtukan numfashi kamar su, rashin jin daɗi, rashin jin daɗi ko kuma rashin jin daɗi.
Abubuwan da ke haifar da ciki ko kuma abubuwan da suka shafi ciki kamar su ciki, rashin haihuwa, da kuma zubar da ciki suna da yawan canji.
Wasu likitoci a China sun fara nuna alamun rashin jin daɗi da kuma rashin jin daɗi.
A wasu, cutar na iya zama sanadin ciwon huhu, ciwon ciki da kuma ciwon ciki.
Wannan ya sa aka yi jinkirin lokacin da za a yi bikin.
Tsawon lokacin kamuwa da COVID-19 shine kwanaki shida zuwa shida amma zai iya zama tsakanin kwanaki biyu zuwa 14.
97.5% na mutanen da ke da alamun cutar sun kamu da cutar a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni na kiwon lafiya sun nuna cewa ba duk wanda ke da cutar ba ne ke da alamun cutar.
Ba a san yadda ake amfani da kwayoyin halittar jini wajen yaduwar cutar ba; duk da haka, wasu bincike na farko sun nuna cewa suna da amfani wajen yaɗa cutar.
Yawan mutanen da ke da cutar amma ba su da alamun cutar ba za a iya gano su ba, saboda Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta ce kusan kashi 20 cikin 100 za su sami alamun cutar a lokacin da suke asibiti.
Hukumar Lafiya ta kasar Sin ta fara shigar da sabbin marasa lafiya marasa bayyanar cutar a ranar 1 ga Afrilu; daga cikin mutane 166 da suka kamu a ranar, 130 (78%) ba su nuna alamun cutar ba a lokacin da aka yi bincike.
Dukansu suna iya haifar da sakamako mai kyau.
Magana mai ƙarfi tana da amfani fiye da magana mai sauƙi.
Wani bincike a Singapore ya gano cewa wani ɗan tsuntsu mai suna sundiyar na iya yin saurin kai har tsawon kafa 15 (mita 4.5).
Kodayake ba a iya samun kwayar cutar ta hanyar iska ba, Cibiyar Kimiyya ta Kasa ta ba da shawarar cewa za a iya samun isar da iska, kuma masu amfani da iska a cikin gidajen abinci suna da damar yin amfani da kwayoyin cutar da ke dauke da kwayar cutar RNA.
Wasu hanyoyin kiwon lafiya kamar su allurar bakin da kuma numfashi na zuciya da na huhu (CPR) na iya bayyana cutar numfashi wanda zai iya fitowa daga huhu kuma ya zama kamar iska.
Idan akwai matsala wajen tantance yiwuwar kamuwa da cutar daga kwayoyin cutar, wannan hadarin yana raguwa; idan kamuwa da cutar ya faru kafin a kamu da cutar, wannan hadarin yana raguwa.
Hukumar kula da cututtuka ta ECDC ta ce idan har an gano yadda cutar ke yaduwa ta hanyar yin iyo, mutum daya zai iya kamuwa da cutar zuwa mutum biyu ko uku. Kwayar cutar na iya yin yaduwa a cikin ruwan sama na tsawon kwanaki.
An gano cewa cutar na iya kamuwa da cutar a cikin kwana ɗaya a kan takarda, a cikin kwana uku a kan takarda (polypylene) da kuma nama mai laushi (AISI 304), kuma a cikin kashi 99% na ƙwayoyin cuta.
Duk da haka, wannan yana da sauƙin sauyawa da zafi.
Sabulu kuma yana da amfani idan an sha da shi; kayan sabulu suna saurin saurin lalacewa, cire shi, kuma ya sa su a jiki da sauran hanyoyin.
Wasu magungunan sunadarai kamar su benzalkonium chloride da chlorhexidine gluconate (wani abu da ake amfani da shi don wanke fata), sun fi sauƙi. Wani bincike da aka yi a Hong Kong ya nuna cewa ana iya samun cutar kansa bayan kwana biyu bayan an fara jinya.
Daga cikin mutane hudu da aka yi wa gwaji a rana ta shida, mutum ɗaya ya sami ƙwanƙolin ƙwayoyin cuta a rana ta farko, yayin da mutum shida suka sami ƙwanƙolin ƙwayoyin cuta a rana ta biyu.
Coronavirus na 2 (SARS-CoV-2) wanda ke haifar da cutar huhu shine sabon coronavirus mai saurin kamuwa da cutar huhu, wanda aka fara gano shi a cikin mutane uku tare da cututtukan huhu na huhu a Wuhan.
Kwayoyin cutar SARS-CoV na yau da kullun ba sa bayyana kamar na kwayar cutar corona.
A waje da jikin mutum, sabulu na gida yana kashe ƙwayoyin cuta, wanda ke hana numfashi mai laushi. SARS-CoV-2 ya yi daidai da asalin SARS-CoV.
Cutar COVID-19 ta fi sa cutar ta COVID-19 tasiri saboda ƙwayar tana shiga cikin ƙwayoyin mai karɓar mai karɓar mai karɓar angiotensin-converting enzyme 2 (ACE2), wanda ya fi dacewa da ƙwayoyin cuta na alveolar na II.
Kwayar cutar ta dauki wani glycoprotein mai suna "peplomer" wanda yake hade da ACE2 kuma ya shiga cikin kwayar mai karba.
An gano cutar sankara a cikin kashi 12% na mutanen da suka kamu da cutar da aka kwantar a Wuhan, China, kuma ya kasance mafi yawan masu kamuwa da cutar.
Alamar cututtukan zuciya na iya zama ba daidai ba, saboda ya dogara da tsarin kulawa da aiki da kuma kulawa da aiki a lokacin da cutar ta ci gaba, amma aikin myocard zai iya rinjayar mai karɓar ACE2 a cikin zuciya.
Ana samun masu karɓar ACE2 a cikin ƙwayar ƙwayar cuta kuma suna da tasiri a kan aikin ƙwayar cuta.
An gano cewa akwai wasu kwayoyin da ke cikin jini (31%) da kuma cewa akwai yiwuwar thromboembolism (25%) a cikin ICU marasa lafiya da ke da COVID-19 kuma ana iya samun su.Binciken likita na marasa lafiya na COVID-19 da suka mutu ya nuna cutar huhu (DAD), kuma ruwan jini mai dauke da cutar yana cikin huhu.
Duk da cewa SARS-COV-2 yana da tropism ga ACE2-yana bayyana ƙwayoyin epithelial na jijiyoyin numfashi, marasa lafiya da ke da COVID-19 mai saurin kamuwa da cutar ba su da alamun cutar.
Alal misali, GM-CSF mai cutarwa yana shafar T-cells kamar yadda yake tare da IL-6 mai cutarwa mai cutarwa yana shafar monocytes da cututtuka na cututtuka na cututtuka a cikin marasa lafiya COVID-19.
An kuma gano cutar lymphocyte a cikin mutum.
WHO ta bayyana hanyoyin da za a iya gano cutar.
Hanyar gwajin da aka fi sani da ita ita ce ainihin lokacin da aka juya juyin juyawar polymerase chain reaction (rRT-PCR).
Ana yin wannan gwajin ne da yawanci ana amfani da kwayar numfashi da ake dauka da hanci ko kuma da hanci; amma, ana iya amfani da kwayar hanci ko kuma da hanci.
Yawancin lokuta ana iya warware su cikin 'yan kwanaki ko fiye.
Gwajin jini na iya zama dole, amma wannan na bukatar a yi gwajin jini sau biyu a mako idan ba a ga sakamakon da wuri ba.
Masu binciken kasar Sin sun iya samar da wani nau'in kwayar cutar coronavirus kuma sun tabbatar da cewa cibiyar binciken kwayoyin halitta ta samar da wasu dakunan gwaje-gwaje a duniya wanda zai iya samar da gwajin gwajin sarkar polymerase (PCR) don gano cutar.
A watan Afrilu na 2020, gwajin ƙwayoyin cuta (wanda ke nuna alamun cutar da kuma yiwuwar kamuwa da ita) yana ci gaba, amma ba a yi amfani da shi ba tukuna.
Nazarin da kuma binciken da aka yi a kasar Sin ya nuna cewa yawan mutanen da ke mutuwa a kasar Sin ya kai 60 zuwa 70%.
FDA a Amurka ta amince da gwajin farko na likita a ranar 21 ga Maris, 2020 don amfani a ƙarshen watan.Hanyar gwajin da aka yi a asibitin Zhongnan na Jami'ar Wuhan ta ba da damar gano cutar ta hanyar bayyanar cututtuka da haɗarin kamuwa da cuta.
Bilateral multilobed ground-glass opacities tare da na waje, m watsa da kuma na baya aka gano mafi yawa a cikin farko mataki na cutar.
Subpleural dominance, crazy paving (ƙwanƙwasawar ɓangaren ɓangaren ɓangaren ƙwayoyin cuta da kuma lalacewar alveoli), da kuma rashin lafiya na iya zama wasu daga cikin hanyoyin da cutar ke ci gaba.
Babu cikakkun bayanai kan amfani da farantin da kuma yanayin COVID-19 na jiki.
Alamomin farko na alamun cutar a cikin binciken binciken shine:
Maganin gani da ido: pleurisy, pericarditis, na'urar numfashi da kuma na'urar numfashi
Cutar huhu ta kamu da ƙwayoyin cuta guda huɗu:
cututtukan huhu: ƙonewar huhu, pneumocyte hyperplasia, ƙaruwa a cikin ƙwayoyin huhu, ƙuntatawa na interstitial da kuma cutar lymphocyte tare da ciwon ƙwayoyin cuta da yawa
cutane mai cutar huhu: diffuse alveolar damage (DAD) da kuma diffuse alveolar exudate.
DAD ne ke haifar da cutar numfashi mai tsanani (ARDS) da kuma rashin isasshen ruwa.
Cutar huhu: tarin exudates a cikin alveolar cavities da kuma pulmonary interstitial fibrosis
Halin da ake ciki: ƙwayar cuta ta intravascular (DIC); leukoerythroblastic reaction
Matakan da aka dauka don rage yawan kamuwa da cutar sun hada da zama a gida, guje wa duk wani hulda da jama'a, wanke hannu da sabulu da ruwa a kai a kai na akalla dakika 20, tsaftace hanyoyin numfashin mutum uku, da kuma kaucewa taba idanu, hanci ko baki da hannaye masu laushi.
CDC ta ba da shawarar rufe baki da hanci yayin yin hanta da cizo da kuma sanya su a hannun da ba a rufe ba.
Yin wanka bayan barci ko kuma bayan barci yana da kyau.
CDC ta ba da shawarar sanya rigunan rufe fuska a cikin jama'a, don rage kamuwa da cutar ta hanyar mutanen da ba su da alamun cutar. Tsarin kula da jama'a ya yi niyyar rage yawan saduwa da masu cutar a cikin wuraren da jama'a ke da yawa ta hanyar rufe makarantu da wuraren aiki, rage yawan zirga-zirga da kuma hana masu yawon bude ido.
Tsarin tsaftacewa ya haɗa da zama aƙalla ƙafa 6 (1.8 m) daga wani.
Babu wani magani da aka gano da zai iya hana COVID-19.Tun da ba za a iya samun allurar rigakafin ba kafin a fara aiki a 2021 aƙalla, hanyar da za a bi don hana COVID-19 ita ce rage saurin kamuwa da cutar, wanda aka fi sani da "ƙuƙwalwar ajiya".
CDC ta kuma ba da shawarar cewa a wanke hannu da sabulu da ruwa a kai a kai na tsawon 20 seconds, musamman idan ka yi sauri ko kuma idan hannuwanka sun yi sanyi, kafin ka sha ruwa da kuma bayan ka sha iska, ka yi barci ko ka yi wanka.
WHO ta ba da shawarar a yi amfani da sabulu mai ƙarancin barasa wanda ya kai 60% na abin da ke cikinsa, amma a wanke shi da sabulu da ruwa. A wuraren da ba a sayar da sabulu ba, WHO ta ba da shawarar a yi amfani da shi da kanka.
A cikin wadannan lokuta, ana kashe kwayoyin ta hanyar amfani da ethanol ko isopropanol.
Hydrogen peroxide na iya taimakawa wajen hana kwayoyin cuta shiga cikin giya; kuma yana iya zama "wani abu da aka samu don wanke hannu".
Glycerol ya zama wani abu mai mahimmanci.
Ba a ba mutane kulawa ta hanyar rigakafi, wanda zai iya haɗawa da jinya, taimakon numfashi, da sauran taimako na jiki.
CDC ta ba da shawarar cewa duk wanda aka yi zargin cewa yana da kwayar cutar ya kamata ya sanya abin rufe fuska.
Ba a yi amfani da maganin oxygenation na membrane na waje ba (ECMO) don magance matsalar rashin numfashi, amma amfaninsa har yanzu yana cikin gwaji.
Ana ba da shawarar yin tsabtace jiki da rayuwa mai kyau da kuma abinci mai gina jiki don inganta rigakafi.
A cikin yanayin da ake ciki, ana iya amfani da maganin rigakafin cutar a farkon lokaci. WHO da Hukumar Lafiya ta Kasa ta Sin sun ba da shawarar cewa a kula da marasa lafiya da ke asibiti da ke fama da COVID-19 ya zama dole.
Ma'aikatan jinya a Amurka sun kai kara ga wata kungiya mai zaman kanta mai suna IBCC.
A watan Afrilu na 2020, an ba da shawarar maganin COVID-19 ga marasa lafiya.
A cewar rahotanni, ma'aikatan kiwon lafiya sun ba da shawarar amfani da paracetamol (acetaminophen) maimakon ibuprofen ga marasa lafiya.
Don haka ya kamata a yi taka tsantsan wajen rage yawan kamuwa da cutar, musamman a wuraren da ake samun rashin lafiya, yayin da ake yin wasu abubuwa da za su iya haifar da kamuwa da cutar, kamar sanya abubuwa a cikin bakin ko kuma yin amfani da iska ta hannu.
Ga ma'aikatan kiwon lafiya da ke da alhakin COVID-19, CDC ta ba da shawarar cewa a sanya mutum a cikin wani daki mai keɓewa na masu kamuwa da cutar a cikin iska (AIIR) kuma a yi aiki da tsabta.CDC ta ba da shawarar dabarun kare kai (PPE) a lokacin cutar.
Abubuwan da aka ba da izinin sakawa: PPE, rigar rufe fuska, rigar ido, da kayan aikin hannu. Idan akwai, rigar numfashi (a cikin abin rufe fuska) ya fi dacewa.
An ba da umarnin cire N95 don amfani a masana'antar masana'antu amma FDA ta ba da izinin yin amfani da shi a ƙarƙashin Dokar Amfani da Gaggawa (EUA).
Matsayinsu shi ne su kasance a shirye don abubuwa kamar hadari amma ba su da amfani domin ba za a iya ba da amsa ba a cikin yanayi mai kyau.
Idan ba a samun takunkumin fuska, CDC ta ba da shawarar sanya takunkumin fuska ko, a matsayin mafita ta ƙarshe, takunkumin fuska da aka yi a gida.
Mafi yawan mutanen da ke da COVID-19 suna da tsarin numfashi na numfashi na numfashi ko kuma na numfashi, NS
Irin wannan taimakon na numfashi ga mutanen da ke da COVID-19 da kuma matsalar numfashi yana cikin binciken da aka yi wa mutanen da ke asibiti, tare da yiwuwar hana shigar da na'urar numfashi a cikin bakin da kuma ciwon huhu mai tsanani da kuma matsalar numfashi.
Duk da yake duka biyun suna da alaƙa da juna, duk da haka, ba a fahimci ma'anar wannan ra'ayi ba.
Wasu masana sun ce ana iya amfani da iska mai tsabta a cikin gida a matsayin hanya don rage yawan iskar gas da za a iya hana idan aka kwatanta da ƙirar ƙwayoyin cuta. Wannan cuta yana da haɗari ga tsofaffi (mafi yawanci fiye da shekaru 60 kuma mafi yawan lokuta fiye da shekaru 80).
Kasashen da suka ci gaba da bunkasa ba su da isasshen allunan magani, wanda hakan ke nufin cewa ba kowa ke da isasshen allunan magani ba yayin da adadin masu cutar COVID-19 da ke buƙatar kula da su a asibiti ke ƙaruwa.
Wani bincike a China ya nuna cewa kashi 5% na yara sun shiga wani asibitin da ke kula da marasa lafiya, kashi 2.3% na yara sun shiga wani asibitin da ke kula da marasa lafiya, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na mutanen da aka kwantar da su a asibiti da COVID-19 an kwantar da su a cikin ICU.
Hanyar hana kamuwa da cutar ta zama matsala ga masu cutar ciwon huhu (ARDS) a cikin COVID-19 da kuma masu cutar numfashi.
Aikin gyaran iska wanda zai iya sarrafa hayakin da kuma gina PEEP zai iya taimakawa wajen inganta iska yayin da ya rage hadarin kamuwa da cutar huhu da kuma pneunomothorax saboda tsarin iska.
Ana iya samun PEEP a cikin farkon matakan numfashi.
Binciken don maganin ya fara ne a watan Janairun 2020 kuma an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an riga an fara
Remdesivir ya kasance mafi inganci.
Ko da yake sabbin magunguna za su iya zuwa 2021 kafin a fitar da su, da yawa daga cikinsu suna kan gwaji kuma an amince da su don wani aiki ko kuma an riga an kammala gwajin su.
Kwayoyin rigakafi na iya zama gwaji ga mutanen da ke da cutar.
WHO ta bukaci masu gwaji su shiga cikin gwajin don tabbatar da inganci da amincin maganin da za a iya bayarwa. FDA ta ba da izinin amfani da jini a matsayin maganin gwaji ga marasa lafiya masu saurin kamuwa da cutar.
Binciken asibiti na musamman zai taimaka wajen tabbatar da inganci da kuma amfanin cutar.
A watan Fabrairun 2020, China ta fitar da wata manhaja da ke hana yaduwar cutar.
Masu aikin kwantar da hankula suna daukan tufafin da aka yi wa wulakanci.
Wannan aikace-aikacen na iya zama "mai saurin ganowa" ta amfani da bayanan kariya da kuma yiwuwar kamuwa da cuta.
Kowane mai amfani da kayan aiki zai iya ƙayyade ko akwai wasu mutane uku masu amfani da shi.
Idan an gano wani dalili, manhajar za ta ba da shawarar ka ka keɓe kanka, amma kuma za ta sanar da ma'aikatan kiwon lafiya na yankin. Bayanan bincike da yawa na bayanan wayar, tsarin ganewa na gaba, bin diddigin wuri da kuma bayanan oda za a iya amfani da su don tuntuɓar mutanen da ke fama da cutar da kuma mutanen da suka yi aiki tare a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba da umarni ga hukumomin tsaro da su bi diddigin kiran da aka yi wa mutanen da suka kamu da cutar coronavirus.
An yi wannan ne don a iya samun damar keɓewa da kuma hana waɗanda za su iya hulɗa da waɗanda ke da cutar.
A watan Maris na shekarar 2020, Deutsche Telekon ta raba bayanan da aka samu na wasu cibiyoyin sadarwa da ke da alaka da wata cibiyar bincike ta gwamnatin Jamus, Robert Koch Institute, don bincike da kuma hana yaduwar cutar.
Rasha ta gabatar da wata hanyar bincike mai kyau don gano mutanen da ke son yin aure.
Ministan lafiya na Italiya Giulio Gallera ya ce jami'an tsaro sun ba shi rahoton cewa "kashi 40% na yawan jama'a na fama da cutar".
Gwamnatin Jamus ta gudanar da binciken ne ta hanyar rarraba bayanai a kan mutane 42,000 da ke cikin jami'o'i.
Amma, Firayim Ministan Estonia, Kersti Kaljulaid, ta yi kira ga jama'a da su yi taka-tsan-tsan a cikin gaggawa kan yaduwar cutar korona.
Mutane na iya samun matsala ta hanyar rashin zama a gida, haɗarin tafiya, haɗarin magani da kuma barazanar cutar.
BBC ta lura da abin da Rory O'Connor ya ce, "Rashin zaman jama'a, rashin zaman gida, damuwa da rashin lafiya, rashin lafiya da kuma asarar dukiya sun zama matakai na musamman wajen hana lafiyar jama'a da kuma walwala".
Wannan cutar za ta iya wucewa ta hanyar bayyanar cututtuka ko kuma ta ɓace, wanda ya dace da irin wannan cuta na numfashi kamar na mura.
Yara da ke da cutar ta hanji kawai yawanci suna cin abinci har tsawon makonni biyu, waɗanda ke da ciwo mai tsanani ko kuma mafi tsanani suna iya cin abinci har tsawon makonni uku zuwa shida.
Mata masu juna biyu na iya fuskantar haɗarin kamuwa da COVID-19 dangane da alamun cutar da aka gano daga nau'ikan coronavirus, kamar SARS da MERS, amma bayanai kan COVID-19 sun ragu. A cikin wasu mutane, COVID-19 na iya shafar huhu kuma ya haifar da ciwon huhu.
A cikin waɗanda suka kamu da cutar, COVID-19 na iya haifar da cutar ta numfashi mai saurin kamuwa da cuta (ARDS) wanda ke haifar da matsalar numfashi, rashin jin magana ko wasu cututtukan jiki.
Abubuwan da suka faru a sakamakon COVID-19 sun haɗa da rauni na jiki, rauni a ƙafari ko a cikin ƙafar, da kuma ciwon hanci.
An gano cewa an sami karuwar yawan jini a cikin kashi 6% na waɗanda aka kwantar da su a asibiti da COVID-19, tare da kashi 4% na marasa lafiya a cikin wannan rukuni.
Kusan kashi 20-30% na mutanen da ke da COVID-19 suna da ƙarancin transaminases.
Bisa ga kididdigar da aka yi a wannan labarin, matsakaicin lokacin da cutar ta fara bayyana a cikin jarirai ya kai kwanaki goma, kuma shida daga cikinsu sun kasance a asibiti.
A wani lokaci, marasa lafiya da aka tura zuwa ICU suna da kwanaki 62 tsakanin asibiti da mutuwa.
A cikin binciken farko na marasa lafiya, matsakaicin lokaci daga farkon bayyanar cututtuka zuwa mutuwa ya kasance kusan kwanaki 14, tare da kwanakin da suka kai daga shida zuwa 41.
A cewar wani bincike da Hukumar Lafiya ta Kasa (NHC) ta gudanar a kasar Sin, maza sun yi asarar rayuka da kashi 2.8 cikin 100, yayin da mata suka yi da kashi 1.7 cikin 100.
Tarihin bincike na cutar a cikin jikin mutum ya nuna cewa akwai lalacewar alveolar da ke yaduwa da kuma ƙwayoyin fibromyxoid a cikin jikin mutum.
An gano cewa akwai ƙwayoyin cuta a cikin ƙwayoyin cuta na cikin ƙwayoyin cuta.
Cutar da ke haifar da cututtukan cututtukan cututtukan zuciya (ARDS) ba a san su ba.
A cikin kashi 11.8 cikin ɗari na mutuwar da Hukumar Lafiya ta China ta bayar, an yi rahoton cewa an sami bugun zuciya ne ta hanyar yawan tropinin ko kuma ciwon zuciya.
A cewar wani rahoto na watan Maris a Amurka, kashi 89% na wadanda aka yi wa asibiti sun kamu da cutar.Rashin kula da lafiyar jama'a da na gida na iya haifar da asarar rayuka.
Yawan mutuwar da ke faruwa a sakamakon rashin lafiya ya bambanta saboda bambancin yanayin, amma kuma saboda matsalolin da ke tattare da rashin lafiya.
Yawan marasa lafiya da ba su da lafiya zai iya haifar da mutuwar mutum.
Duk da haka, gaskiyar cewa yawan adadin mutanen da suka kamu da cutar ya ragu ya nuna cewa yawan mutuwar da ake samu yanzu ya yi kadan.
Masu gwajin sun nuna alamun cutar COVID-19 sun ninka sau 1.4 kuma sun fi saurin bukatar magani fiye da sau 2.4 idan aka kwatanta da wadanda ba su yi gwajin ba. Akwai kuma wata damuwa kan ko cutar za ta iya raguwa bayan an yi mata magani.
Hukumar Asibitoci ta Hong Kong ta gano cewa an samu raguwar kashi 20 zuwa 30 cikin 100 na masu cutar a cikin mutanen da suka kamu da cutar, tare da gwajin numfashi na yau da kullum da ke nuna rashin lafiya.
Hakanan yana iya haifar da cututtukan cututtukan cututtukan cututtukan cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka.
A watan Maris 2020, an ba da sanarwar cewa cutar ta kamuwa da cutar ta haifar da rigakafi ga mutanen da suka warke.
Ko da yake yana yiwuwa, dangane da yanayin wasu coronaviruses, amma marasa lafiya da aka tabbatar da COVID-19 za a ci gaba da gwajin gwaji.
Irin wannan magani ana iya ɗauka a matsayin wani nau'i na cutar da ba a dogara da sabon kamuwa da cuta ba.
An yi imanin cewa cutar ta samo asali ne daga wata cuta da ta ɓace a cikin dabbobi.
Ba mu damu ba, amma a watan Disamba 2019 cutar ta fi karkatawa ga mutane fiye da miliyan ɗaya.
Wani bincike na farko na 41 da aka tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin Lancet, ya nuna cewa lokacin da mafi yawan alamun cutar suka bayyana ya kasance a ranar 1 ga Disamba, 2019.
WHO ta ba da sanarwar cewa an fara samun bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Yawancin hanyoyin sun fi dacewa da yawan adadin mutuwa.
Wadannan ƙididdigar sun bambanta daga lokaci zuwa lokaci kuma sun shafi gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓin magani, lokacin da aka fara bayyanar da cuta da kuma halayen jama'a kamar su shekaru, al'ada da kuma lafiyar jiki.
A ƙarshen 2019, WHO ta ba da lambar kamuwa da cuta ta ICD-10 U07.1 don mutuwar da aka gano daga ganewar SARS-CoV-2 a cikin dakin gwaje-gwaje da U07.1 don mutuwar da aka gano a asibiti ko ta hanyar COVID-19 ba tare da SARS-CoV-2 ya shiga asibiti ba. Lissafin cutar a cikin May ya haɗa da adadin mutanen da suka mutu daga kamuwa da cutar da kuma adadin mutanen da suka kamu da cutar a cikin lokacin da aka ƙayyade.
Dangane da bayanan Jami'ar Johns Hopkins, ƙimar cutar ta kasance 6.9% (153,822/2,240,191) tun daga Afrilu 17, 2020.
Yawan ya bambanta bisa ga yanki. Wasu ma'auni sun haɗa da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da ke da cutar da suka mutu, da kuma yawan adadin da aka kamu da cutar (IFR), wanda ke nuna yawan mutanen da suka mutu (har ma da wadanda suka kamu da cutar) saboda wasu cututtuka.
Wannan gwaji ya tabbatar da cewa cutar ta kamu da wani mutum a lokacin da yake jinya.
Ko da yake ba kowa ne zai iya yin amfani da rigakafin ba, amma idan sun yi, za a iya samun bayanai game da yawan mutanen da suka kamu da cutar.
A tsakiyar cutar a Italiya, Castiglione d'Adda, wani ƙaramin gari mai yawan mutane 4,600, ya yi sanadiyyar mutuwar mutane 80 (1.7%).
A Gangelt, cutar ta bazu ta hanyar bikin Carnival, wanda ya shafi yawan jama'a, tare da ƙananan mutuwar, kuma kusan kowane mutum da ya mutu daga COVID-19 ya shiga cikin wannan rukunin.
Duk da haka, tsarin kiwon lafiya na Jamus ya fi kyau.
A cikin Netherlands, kusan 3% na iya samun cutar, kamar yadda aka nuna a cikin bayar da jini.
69 (0.004% na yawan jama'a) sun kamu da cutar COVID-19.
Yawan kamuwa da cutar da yawan mutuwar mace-mace ya bambanta tsakanin maza da mata
Yawan mutuwar ya kasance mafi girma ga maza a cikin binciken da aka gudanar a China da Italiya.
Mafi yawan lokuta a cikin maza suna da shekaru 50, tare da bambanci tsakanin maza da mata a cikin shekaru 90.
A China, yawan mace-mace ya kai kashi 2.8 cikin 100 da kuma maza kashi 1.7 cikin 100.
Ba a san takamaiman hanyoyin da za a bambanta jinsi ba, amma ana iya samun kwayoyin halitta da halaye a cikin wannan hanya.
Bambance-bambance na rigakafi tsakanin maza da mata, rashin daidaituwa da kuma bambancin da ke tsakanin mata da maza da ke nuna haɗarin cututtuka kamar cututtukan jini da kuma rashin amincewa daga likitan mata na iya haifar da mummunar haɗari ga maza.
A Turai, 57% na masu kamuwa da cutar maza ne kuma 72% na masu kamuwa da cutar COVID-19 maza ne.
A watan Afrilu 2020, gwamnatin Amurka ta yi watsi da bayanan da suka shafi tasirin COVID-19.
Bincike ya nuna cewa cututtukan ƙwayoyin cuta kamar Ebola, HIV, zazzabin cizon sauro da kuma SARS suna shafar maza da mata a bambance.
Yawancin ma'aikatan kiwon lafiya, likitoci, mata, da ma'aikata suna da damar da za su iya jurewa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan cutar zai zama " COVID-19 ".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana nufin Corona, VI kuma ƙwayoyin cuta, D don cutar, da 19 don lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
Wannan sunan an zaɓa ne saboda yana da alaƙa da sunan wani wuri (kamar China), asalin dabba ko kuma ƙungiyar.
WHO ta kuma kara da cewa "Covid-19 virus" da "Covid-19 virus" a cikin jerin sunayen jama'a.
Dukkanin cutar da kwayar cutar ana kiranta "coronaviris".
A farkon barkewar cutar a Wuhan, China, an kira kwayar cutar da cutar "coronavirus" da kuma "coronavirus Wuhan".
A cikin watan Janairun 2020, WHO ta rarraba cutar ta 2019-nCoV da 2019-nCoV a matsayin sunaye kafin cutar ta zama cuta, kamar yadda aka yi a cikin 2015 don ba da sunan yankin cutar da cutar.
An fitar da takardun shaida na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙuntataccen tsarin sarrafa kayan, masana'antun sun samar da kayayyakin da suka shafi kiwon lafiya kamar su kayan kariya da na'urar numfashi.
A wani bincike, lokacin da aka ba wani asibiti a kasar Italiya umarnin gaggauta fitar da wani na'urar numfashi, sai mai amfani da shi ya kasa bayyana shi cikin sa'o'i, wani mai amfani da shi a wani wuri da ba a san shi ba ya duba na'urar kuma ya fitar da 100 a daren.
Bayan bayyanar COVID-19, bayanai, bayanai masu amfani da kuma bayanan sirri sun kasance da yawa a cikin intanet don dalilai da suka shafi ganowa, ganowa, kulawa, magani da bayyanar cututtuka.
Mutane na iya yada cutar daga dabbobi zuwa wasu dabbobi.
Binciken ya gano cewa akwai alamun kamuwa da kwayar cutar a cikin kwari, tsuntsaye, da tsuntsaye.
Babu magani ko maganin rigakafi da zai iya magance cutar.
Binciken duniya game da allurar rigakafi da magani don COVID-19 yana ta fafutuka don samar da shi ta hanyar ƙungiyoyi, ƙungiyoyin kiwon lafiya da masu ba da agaji.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da wani gwaji mai suna "SOLIDARITY Trial" don gano hadarin wasu magungunan da aka yi amfani da su wajen magance cutar da ke haifar da cututtuka da yawa.
Babu riga-kafin rigakafin da ke akwai, amma kungiyoyi da yawa suna aiki a kan rigakafin gwaji da kuma gwaji.
Ayyukan bincike na SARS-Cov ya nuna cewa SARS-CoV BE sars cOv-2 duka suna aiki tare da ACE2 don shiga cikin ƙwayar ɗan adam.
Akwai riga-kafi da yawa da ake gwadawa a halin yanzu.
Da farko, masu bincike sun so su gano maganin cutar.
Yin aiki tare da wannan nau'in kwayar cutar, ko a cikin yanayi mai haɗari ko mara kyau, yana buƙatar gano hanyoyin da za a iya magance cutar ta mutum a cikin sabon cutar COVID-19.
Mataki na biyu, na samar da rigakafi, yana buƙatar samar da maganin rigakafi wanda zai iya haifar da rigakafi ga wasu nau'in ƙwayoyin cuta.
A cikin yanayin SARS-CoV-2, irin wannan bincike ya shafi S-spike protein wanda ke hana kwayar cutar shiga cikin kwayar cutar ta ACE2.
Hanya ta uku ita ce ta allurar rigakafin nucleic acid (DNA ko RNA, sabuwar hanyar samar da allurar rigakafi).
A cikin waɗannan matakai, ana buƙatar a yi gwaji tare da kowane cibiyar don tabbatar da aminci da inganci. A ranar 16 ga Maris, 2020, an fara gwajin farko na rigakafin tare da gwaji huɗu zuwa huɗu.
Ba a ba da shawarar maganin rigakafi a matsayin maganin rigakafin SARS-CoV-2 ba, amma wasu masu bincike sun ƙi shi.
Akwai gwaji na asibiti sama da 300 da aka gudanar bisa bincike daga Afrilu 2020.
Nazarin gwaji guda goma sha biyu sun yi nazarin maganin da aka hana a cikin maganin ƙwayoyin cuta, da kuma nazarin gwaji hudu a kan hydroxychloroquine ko chloroquine.
An riga an fara gwajin maganin rigakafin cutar a China, kuma an fara gwajin Phase III na maganin rigakafin a kasashe da dama don gwaji a karshen watan Afrilu.
An fara gudanar da bincike kan amfani da maganin COVID-19 a watan Afrilun 2020.
Ana sa ran samun nasarar yin amfani da maganin rigakafin cutar remdesivir, a watan Maris 2020.
An sami ci gaba a cikin gwaji na asibiti a cikin marasa lafiya waɗanda suka ɗauki remdesivir akai-akai.
An gudanar da gwajin gwaji na Phase III a Amurka, China da Italiya. Chloroquine, wanda aka riga aka yi amfani da shi don maganin malaria, za a gwada shi a China a watan Fabrairun 2020, tare da sakamako na farko.
Duk da haka, akwai wasu maganganu game da wannan bincike.
Ma'aikatar lafiya ta Koriya da ta China ta ba da shawarar a yi amfani da chloroquine.
Koyaya, Cibiyar Nazarin Bayoyin Halitta ta Wuhan, ta ba da shawarar yin amfani da allurai na gram ɗaya a rana, tana mai cewa wannan adadin yana da haɗari sosai kuma yana iya zama mai haɗari.
A ranar 28 ga watan Maris, 2020, FDA ta ba da umarnin gaggawa game da hydroxychloroquine da chloroquine ba tare da an nuna su ga likitocin da ke kula da marasa lafiya da ke fama da COVID-19.Sakamakon alamomi 7 sun haɗa da interferon, ribavirin ko umifenovir don magance COVID-19.
Bayanan farko sun nuna cewa allurar ribavirin tana da tasiri a kan rigakafin SARS-CoV-2 a cikin in vitro.
Nitazoxanide an ba da shawarar don nazarin in vivo bayan an tabbatar da ƙananan ƙwayar SARS-CoV-2 na ƙwayoyin cuta.Bincike ya nuna cewa ganowar farko na furotin mai ƙwanƙwasa ta hanyar transmembrane protease serine 2 (TMPRSS2) yana da mahimmanci ga SARS-CoV-2 ta hanyar aiki tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba ya zama dole don hana jama'armu ta likitanci karɓar su ba tare da ƙarin bincike ba. Oseltamivir yana hana SARS-CoV-2 in vitro kuma yana da tasiri a cikin maganin COVID-19.
Rashin cytokine na iya zama haɗari a cikin wasu lokuta masu tsanani na COVID-19.
Akwai kuma wasu da suka ce hydroxychloroquine zai iya zama mai hana ƙwayoyin cuta yin aiki. Tocilizumab ya shiga jerin magunguna da Hukumar Lafiya ta China ta tsara bayan kammala wasu ƙananan karatu.
An ba da izinin gwajin gwaji na 2 na Italiya ba tare da an sami sakamako ko sakamako ba a cikin mutanen da ke da cutar.
Tare da gwajin ƙarancin jini don gano ƙarancin cytokine, aikinsa shine hana irin wannan ci gaba, wanda ke haifar da mutuwa ga wasu mutanen da ke fama da cutar.
FDA ta amince da wannan mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓa ta hanyar maganin rigakafin cutar ta CAR T cell, 2017.
A baya, wani bincike ya gano cewa tocilizumab ba zai iya magance CRS ba.
Bayar da tsabta da kuma hadaddun magunguna da aka bayar ga mutanen da suka kamu da COVID-19 ga waɗanda suke da buƙata an gwada shi azaman hanyar kariya ba tare da an sani ba.
Wannan maganin ya riga ya riga ya kamu da SARS amma bai haifar da cutar ba.
Kashe kwayar cutar ya zama wata hanya ta aiki ta hanyar maganin rigakafi wanda zai iya haifar da rigakafi ga SARS-CoV-2.
Wasu dalilai, kamar su cytotoxicity da/ko toxicity na sel, na iya zama dole.
Irin wannan magani na likitan ƙashi, alal misali, na likitan ƙashi guda ɗaya, ya zama ruwan dare.
Bayar da jinin jini ga wanda ake yi wa magani, wanda shine jinin da aka karba daga marasa lafiya da aka kamu da su kuma yana dauke da kwayoyin cutar, na iya zama mai saukin kamuwa da cutar.
Cutar coronavirus, wata ƙungiya ce da ke tattare da alamun cutar
Li Wenliang, likita a asibitin Wuhan, wanda ya kamu da COVID-19 kuma ya mutu bayan da ya yi kira ga jama'a game da yaduwar cutar.
